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Abstract
Gene expression variation is a quantitative trait that drives phenotypic diversity across populations.
On a cellular level, gene expression is an intermediate phenotype between stored genetic information
and the functional utilization of this information within the cell. Through Genome Wide Association
Studies (GWAS), thousands of genetic polymorphisms associated with numerous diseases have been
identified. These have provided many novel insights into the disrupted biological processes that
drive the etiology of various health conditions.expression Quantitative Trait Loci (eQTLs) provide an
additional layer of biological information about the physiological impact of common genetic variants.
Therefore, the study of the genetic regulation of gene expression (eQTL studies) has been useful both
in the validation and functional characterisation of GWAS polymorphisms. This has contributed to a
better understanding of the precise molecular processes that contribute to the development of disease.
Global transcriptomic analyses have provided as greater insight into the level of complexity that drives
biological systems. Transcriptomic data are often comprised of gene regulatory and co-expression
networks, an emergent property of transcriptomic and other omic data. These networks within each
omics fields interact with each other to further add layers of complexity that drive biological systems.
Variation contained with gene expression datasets can, therefore, provide detail into the flow of infor-
mation through these biological systems and how these can be influenced by genetic polymorphisms.
Transcriptome variation is highly influenced by genetic and environmental factors. Genetic regulation
of gene expression represents, with some exceptions, fixed regulatory points that strictly control the
expression of genes. Variance attributed to environmental effects, on the other hand, are often bio-
logical responses to specific stimuli. The dissection of the genetic and environmental influences on
expression levels will help to form a baseline upon which network models can be built to disseminate
the biological flow of information in healthy, latent or disease groups.
This thesis will detail both methodological methods to clean data, and statistical approaches analyze
the complexities found within the variance of transcriptomic data. The focus of this thesis is the
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dissection of three major influences of gene expression variability: technical artifacts, environmental
and genetic variation. Using statistical and quantitative genetic techniques on array-based genotype
and gene expression datasets, this thesis examines:
1. The use of Principal Components Analysis (PCA) to identify and correct for known batch ef-
fects
2. Season variation as a pervasive environmental contributor to gene expression variation
3. The genetic contribution driving robust gene co-expression modules
The Brisbane Systems Genetics Study (BSGS) is comprised of both unrelated and related individu-
als and was used throughout these three studies. The Center for Health Discovery and Well Being
(CHDWB) cohort was used as a replication study and the Multiple Tissue Human Expression Re-
source (MuTHER) cohort was employed to examine tissue-specific effects.
The first chapter provides a technical methodological analysis of the batch effect correction technique
PCA. Batch effects have a large impact on gene expression variability, often creating artificial sys-
tematic trends. By decomposing the data in Principal Components (PCs) we were able to quantify
the degree and distribution of technical artifacts within gene expression datasets and determine the
effectiveness of this correction method.
The second chapter examines the influence of pervasive macro-environmental factors on gene expres-
sion datasets and provides a statistical framework to identify seasonal variation. Since datasets are
often collected over time, samples may contain seasonal trends in gene expression that are environ-
mentally driven and are not regarded as technical artifacts. By using loess decomposition and cosinor
regression, 74 transcripts with a significant season trend were identified independently of seasonal
variation in blood cell count.
Chapter three examines the genetic contribution to gene expression covariance between transcripts,
called Blood Informative Transcripts (BITs) comprising of nine modules that have been previously
identified and validated. Using quantitative genetic techniques, the genetic and environmental compo-
nents driving phenotypic correlations for BIT transcripts were quantified. When compared to 10,000
bootstrap permutations of random probes the BITS demonstrate significant genetic correlation (aver-
age 0.63 across all BITs) and an average genetic contribution to phenotypic correlations of 0.42. The
high degree of genetic correlation demonstrates a strong genetic framework regulating the expression
of BITs modules. This chapter also examines the presence of this replicated modules in three separate
3
tissue types, identifying several tissue-specific coexpression modules.
Overall, this thesis explores the landscape of gene expression variability. A methodological frame-
work for the identification of technical artifacts and seasonal effects is investigated and the genetic
architecture driving transcriptomic co-expression is characterized.
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2.1 Principal Variance Components Analysis (PVCA) of gene expression datasets
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account for 23% of the variance in the non-corrected dataset (A) and are fully removed
in the corrected dataset (B). Batch effects present in PC corrected dataset are repre-
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between the modules. These values, however, are not pertinent to the module iden-
tity, for reasons described in section 4.4.1. Panel D represents the values from panels
A, B, and C as boxplots. Modules are ordered on the x-axis with ”R” representing
the empirical null values for the modules, collected from 10,000 randomly sampled
transcripts. From D) this is evident that the correlation values in all the modules are
higher than what would be expected by chance. This graph shows that rA values are
the highest for all modules, while the rP and rE approximately the same. . . . . . . . 113
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value on phenotypic correlations (all modules are significant when examining genetic
correlations). The parts of the graph that are hashed out represent modules that are
not significant using the modules minimum method for that particular measure. In (F)
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4.4 Chromosome location and LD map of the SNPs significantly associated with two
probes in module two. The -log10 (fdr) of the association between two SNPs is
plotted as dots (y-axes on the left) with the relevant effect size (r2) colored as per the
legend in the top right hand corner. The recombination of that section of the chromo-
some is represented by the blue line (y-axes on the right). The purple diamond is the
selected SNP for which from which the association analysis statistics are performed
(r2 and the FDR values). All SNPs are in moderate LD with each other. There appear
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Chapter 1
Introduction
1.1 Gene expression as a complex trait
Gene expression is a biological process that drives the formation of cellular phenotypes via recording
information within deoxyribonucleic acid (DNA) into proteins, the building blocks of the cell [2].
This flow of biological information from the DNA to the proteins is a highly-regulated multi-step
process that involves many different control points, regulatory molecules, and degradation processes.
The precise genomic regulation found in eukaryotes has enabled a significant degree of functional
complexity to arise. One feature of this is the generation of a vast array of proteins that result from
a relatively small number of genes. In humans, approximately 1% of the genome is comprised of
protein-coding genes. This percentage consists of 20,000 protein-coding genes [3] producing just
over 91,000 proteins [4]. The rest of genome is devoted to genomic regulation through various control
mechanisms such as transcription factors (TFs) or non-coding RNAs (ncRNAs). All these factors
create a complex regularity network that is required for maintenance of phenotypes [5], homeostasis
[6] and cellular rhythms [7–9].
Studies into the genetic regulation of single genes have been performed since 1962 [10]. The de-
velopment of genome-wide microarrays and RNA sequencing has facilitated the profiling of thou-
sands of transcripts in a high-throughput manner. Data from these arrays has enabled explorative,
hypothesis-generating research into transcript abundance and variation [11] and the identification of
the molecular mechanisms underlying the response to perturbations in a biological system. Differ-
ential expression of genes can arise from both environmental and genetic factors [12], and has been
used as a means of understanding the molecular mechanisms that drive phenotypic differences be-
tween cellular traits [13, 14], physiological differences [15] and diseases [16–19].
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Because multiple genetic and environmental factors influence transcript levels in a population, gene
expression phenotypes are complex traits. Transcriptional variation across a segregating population
(VP) is driven by several factors (Equation 1.1):
VP =VG+VE +VGxE (1.1)
These components include the portion of the variance that is attributed to genetics (VG), environment
(VE , described in section 1.5) and gene-by-environment (GxE) interactions (VGxE , described in section
1.4.3). Environmental variance can be described as the remainer of (VP− (VG+VGxE) and therefore
incorporated any variance that is not directly attributed to genetic variation. The genetic component
of this can be further decomposed into additive (VA, described in section 1.3) and non-additive ge-
netic components, which include dominance (VD, described in section 1.4.1) and interaction effects
(VI), otherwise known as gene-by-gene (GxG) interactions or epistasis (described in section 1.4.2)
(Equation 1.2).
VG =VA+VD+VI (1.2)
Additive genetic variation is the most interesting part of genetic variation to study as it drives the
largest portion of the variance [20] in complex traits and is the genetic variation inherited between
generations. The partitioning of additive genetic variance from total phenotypic variance can be
achieved using genetic similarities between related [21] and unrelated individuals [22, 23] (Equation
1.1).
In this thesis, we cover three aspects of transcriptional variation. Seasonal variation as a macro-
environmental and time-series component (Chapter 3), the genetic variance driving gene expression
coexpression (Chapter 4) and technical artifacts (Chapter 2), which are potential confounding factors.
1.2 Gene expression variability
Gene expression variability is one of the fundamental dynamics that drives differences in phenotypic
traits among individuals [24]. It occurs even in model organisms that have identical genotypes and
shared the same environment [25]. There is evidence that innate entropy in gene expression is an
30
essential feature in biological systems [26]. It is also possible significant portion of variation in gene
expression could be the result of technical variation arising during the generation of the data [27] as
demonstrated in Chapter 2.
Robustness is a universal property of biological systems that enables functionality and homeostasis in
spite of internal (e.g. genetic mutations) and external (environmental) perturbations [28]. One mech-
anism that contributes to the robustness of biological systems is the multiple control pathways and
redundancies found in cellular gene networks [28]. Robustness is important not only as a buffering
mechanism against otherwise harmful/lethal mutations and conditions but is also critical to evolving
populations [29]. By neutralizing the effects of non-critical mutations, scores of cryptic mutations
can accumulate across a population. These accumulated mutations could facilitate rapid evolution-
ary responses to drastic environmental changes [30]. This buffering effect could contribute to the
incomplete penetrance observed in certain diseases [31].
Canalization is the process of buffering genetic and environmental perturbations to produce normal
phenotypes [32]. Canalization is thought to contribute to the complexity of certain diseases and has
been suggested as a mechanism that drives the pleiotropy between genetic polymorphisms found
in GWAS for various psychiatric and neurological disorders [33]. The disruption of the trajectory
of normal neuronal development (through the expression of genes) outside normal developmental
variability, is hypothesized to contribute to a wide a range of clinical disorders can arise depending
on the where in the developmental trajectory the derailment occurred and the severity [34–36].
The variance of transcripts can be measured in terms of Coefficient of Variation (CV) (Equation 1.3)
CV =
σ
µ
(1.3)
.
The CV measures of transcripts were able to differentiate between individuals with Schizophrenia
and Parkinson’s disease [37]. Albeit this study has a small sample size it appears that schizophrenia
was associated with decreases in CV and, therefore, increase the robustness of the system whereas
responses to environmental perturbations are constrained. Robustness in a biological system is es-
sential to maintain homeostasis and in the presence of disruptive environmental forces and mutations.
However, too much constraint and the system no longer has the plasticity to adapt to new stressors.
The variance was lower in patients with Parkinson’s disease when compared to schizophrenic patients
indicates a derailment of normal compensatory mechanisms that maintain phenotypic integrity [37].
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This work demonstrates that transcript variability plays a key role in defining genetically controlled
responses to environmental conditions.
The robustness of a network of transcripts appears to increase with the importance of the pathway
to cellular function [37]. Core biological processes, such as signal transduction pathways seem to
have lower variance and higher connectivity since variations in this could disrupt the homeostasis of a
cell. Genes at the periphery of the signaling pathway (the receptors) demonstrate higher variance and
less connectivity as these receptors are often required to respond to a range of biological signals [37].
Evidence from studies on gene regulatory networks in starfish has demonstrated that variability and
connectivity change across larval development, with greater robustness in early development [30].
The robustness of the system appears to be in part maintained by molecular systems induced in the
presence of stress. Heat shock proteins present a biological mechanism that is key to maintaining
cellular function in response to stress. These proteins provide phenotypic stability in response to heat
despite varying degrees of susceptibilities that can naturally arise from genetic variation. Inhibition
of heat shock proteins increased the correlation between the genotype and the phenotype in response
to heat stress [38].
The dissection of the variance of gene expression has yielded valuable insights into the genetic ar-
chitecture of complex traits. Transcriptional variation appears to be an intrinsic feature essential for
maintaining phenotypes and contributing to the development of diseases. The incorporation of dif-
ferent facets of gene expression during development, over time, in response to specific environmental
stimuli and different tissues and cell lines will be imperative to furthering our understanding of the
intricate molecular mechanisms that control biological systems [39].
1.3 Genetical genomics
1.3.1 Genetic-regulation of gene expression
Genetic variation driving gene expression has been well established and reported in the literature,
with the majority of transcribed genes demonstrating additive genetic variation [2, 40–46], with 82%
of array-measured messenger RNA (mRNA) transcripts exhibiting h2>0 [44], 42% of transcripts
having additive genetic variance h2>0.3 and ˜5% with h2 > 0.5 [43].
Although proteins are the building blocks of cellular function, protein-coding genes account for
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around 1-2% [47]. It has been suggested that the remaining ˜98% of the genome is involved in
regulatory control mechanisms for gene translation and transcription [48–50]. This concept has been
supported by research which estimates that up to three-quarters of the genome is transcribed [51] and
by recent discoveries by Encyclopedia of DNA Elements (ENCODE) that 80.4% of the genome has
functional regulatory elements present [52].
The regulation of transcription or other biological mechanisms is likely to be the role played by the
majority of GWAS Single Nucleotide Polymorphism (SNP) that have been found in gene deserts and
intergenic regions [53] HINDORFF et al. 2009). The regulatory role of GWAS SNPs indicates that
the driving factors for complex diseases could be predominated by changes in gene regulation instead
of protein function. This hypothesis is supported by the finding that a major proportion of significant
SNPs from GWAS are located in regions enriched with functional elements [52]. Whole genome
methods [54] have found that the largest portion of heritability was from variants located in putative
regulatory regions [55].
The large number of GWAS SNPs that are located within regulatory regions of the genome indicates
that genomic variants that affect gene expression are the primary processes driving complex traits
which are in contrast to Mendelian disorders, which are affected predominantly by protein coding
changes [39].
1.3.2 eQTLs
eQTL mapping, has been remarkably successful in identifying genetic polymorphisms that regulate
gene expression [2, 42, 56–59]. The vast majority of the genetic variation driving transcriptomic
expression is additive, with one study showing that 21% of probes with a detectable eQTLs explained
up to 80% of the additive genetic variance [44].
Gene expression is often classified as an intermediate trait as it is the next step in which genetic
information is turned into the cellular building blocks [2, 60]. Gene expression has therefore been
useful in the functional characterization of GWAS hits. Many GWAS SNPs have been identified as
eQTLs, demonstrating biological functionality. This both verifies the GWAS association and provides
the first molecular step to understanding its mechanism of action [46, 61–64].
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1.3.3 Location of regulatory variants
The position of a eQTL to its target gene can reveal valuable information about its impact on tran-
scriptional regulation. Loci that occur within one megabase from the start or the end of the gene it
is associated with are termed local eQTLs while distant eQTLs are loci occurring outside this region
and on other chromosomes. Local eQTLs are the most common form of regulatory variant identified
in genetical genomic studies so far with up to 80% of expression genes in whole blood having a lo-
cal eQTL [65]. A number of these eQTLs were GWAS candidate loci indicating a large impact on
downstream phenotypic effects [57].
Local regulatory variants can act in both cis and trans. Cis-acting eQTLs are alleles that are located
proximal to the transcript. They can influence a gene in an allele-specific manner, for example by
affecting the binding of RNA polymerase and transcription factors, the expression of a gene on that
particular transcript [66]. Trans-acting eQTLs, on the other hand, affect both alleles simultaneously
through a diffusible factor. Therefore, while local regulatory variants are assumed to act primarily in
cis, it is possible that a local eQTL can work in trans by affecting a neighboring gene or via a feedback
loop [67,68]. Distal eQTLs therefore exert their allelic effects in trans. This feedback loop can occur
by either a mutation in a transcription factor that modifies how it regulates its target genes or by a
mutation in the Transcription Start Site (TSS) of a transcription factor that up or downregulates its
expression [68].
1.3.4 Distal regulatory variants
Distal eQTLs are trans-acting exerting their allelic effects through intermediate diffusible factors and
can influence some genes. Therefore, distant eQTLs have the potential to act as master regulators and
control the expression of networks of genes [69]. An example of this is with a GWAS locus associated
with type 2 diabetes and high-density lipoprotein. This locus cis-regulated the transcription factor
KLF14 which was a master-regulator of adipose gene expression [70].
Distant eQTLs are not detected in eQTL studies as frequently as local eQTLs, due mainly to smaller
effect sizes [71]. Furthermore, since distant eQTLs are located throughout the genome, their detec-
tion is often limited by the increased burden of multiple testing corrections. Adding to the difficultly
in their identification is the observation that distant eQTLs are also more variable, showing greater
context dependence [72, 73], tissue specificity [74] and are more likely affected by confounders [75].
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As sample sizes increase, more distant eQTLs are being discovered [45, 57, 76–79] with a number
of variants demonstrating large context specificity [76, 80]. Therefore, it is possible that while local
eQTLs appear to have direct genetic regulatory effects on complex traits, distal polymorphisms play
a more cryptic role of genetically regulating transcript variability in response to environmental expo-
sures and, therefore, sit at the interface between heritable genetic and environmental contribution to
gene expression variability.
1.4 Non-additive genetic variation
1.4.1 Dominance
Non-additive variation, consisting of dominance and overdominance, were replicated for a handful
of transcripts [44]. While having a significant impact on variance on these particular transcripts,
dominance effects had minimal impact on total transcriptomic variation [44]. Another way in which
the effects of strongly dominant loci can be ablated and even appear additive is when the recessive
gene is at a high frequency in a population [20].
Non-additive effects are harder to detect in association studies than additive genetic variation. SNPs
in GWAS studies are used as markers for causal variant in GWAS studies. These markers SNPs will
often explain less additive variance than the actual causal SNP. The discrepancy between markers
and causal SNPs is linearly dependent on the amount of Linkage Disequilibrium (LD) between the
two variants. Therefore GWAS relies on enough coverage of the genome to ensure high LD between
the genes. For dominance effects, this decrease in explained variance between markers and causal
variants is much higher, reducing at a factor of r4 [81]. Therefore in normal coverage, SNP arrays
provide a greater coverage of additive instead of non-additive genetic effects.
1.4.2 Epistasis
Genotype-dependent interaction effects, such as GxG, cause the effect size of a variant to be larger
than it’s additive components between other genetic loci or environmental conditions. The interaction
variances can be described statistically as the combination of two terms not explained by their inde-
pendent, additive effects. GxG or epistasis have been of interest in the study of complex traits [82].
Some papers have suggested that redundancy in biological pathways lead to overestimations of ad-
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ditive variation, thereby giving further weight to epistatic interaction to explaining the remaining
variance [83]. Common family environmental effects appear to drive these pathway estimations [84].
Common family environmental effects are environmental effects shared between family members
which can appear as additive genetic variation.
Epistatic interactions are tough to identify in human genomic data. Epistatic interactions, like domi-
nance effects have a greater loss in explained variance with lower LD between the marker and causal
SNPs, reducing by a factor ranging between r4 for additive by additive (AxA) variance, r6 for additive
by dominant (AxD) variance and r8 for dominant by dominant (DxD) interactions [81]. Therefore
imputed datasets or array with higher SNP densities are required to detect epistatic effects. Another
reason for the difficulty in detection the curse of dimensionality, where extremely stringent signifi-
cance thresholds, due to the sheer volume of required tests, leads extremely low signal-to-noise ratios
in detecting these associations. Therefore large sample sizes are needed to gain sufficient power to
detect associations. Other methods to increase power to detect GxG interactions focus on dimension-
reduction techniques or filtering out regions of interest [85] or variance eQTLS [86]
Epistatic interactions have been estimated to have little impact of total variability on gene expres-
sion [44, 85]. In [87] up to 16% of the variance in their datasets was expected to be driven by GxG
interaction effects. The authors extrapolated this results from the total SNP variance obtained from
variance eQTLs (eQTLs associated with gene expression variability) that had replicable epistatic ef-
fects. Some of these epistatic loci explained as much as 4.3% of phenotypic variance [87]. Altogether,
however, few studies have provided evidence of a substantial impact of epistatic variance and loci on
the total phenotypic variance of gene expression [44, 85] and other complex traits [81].
1.4.3 Gene-by-environment interactions
GxE interactions, otherwise denoted as genotype-environment interactions (GEIs), are a type genotype-
dependent interaction where responses to the environment differ between genomic regions. These ge-
netically regulated responses to the environmental could underlie the development of latent diseases
and conditions [37]. Interactions between smoking and genetic risk factors for rheumatoid arthritis
illustrate GEIs as factors driving disawfrasAWE3Rease susceptibility [88].
There is also evidence that GEIs drive the variance of many complex traits [89]. GEIs are a suspected
contributor to the missing heritability found between GWAS loci and common traits [90].
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Advances in high throughput genetic techniques have prompt an greater number of published stud-
ies examining GEIs since 2000 [91]. Numerous studies have identified genomic loci and transcripts
that exhibit GEIs for various phenotypes including psychological conditions [92–97], nicotine de-
pendence [88, 98], asthma [99–101], immune response [72, 102, 103] and drugs [104]. Genomic loci
exhibiting GEIs are often referred to as context-specific Quantitative Trait Loci (QTLs) or, in the case
of genetical genomics, eQTLs [79]
The environmental conditions in humans are much harder to control than for model organisms. There-
fore when studying GEIs in humans, there is the risk of unmeasured and unforeseen confounders. The
presence of these confounders, in addition to improper model fitting [105] in GEIs studies could ex-
plain the lack of replication of many context-specific GEIs loci [97]. In order to control environmental
conditions more precisely, the use of human cell lines instead [87, 106] or randomized control trails
(RCTs) [107] will facilitate more precise environment control GEIs [90]. Genetical genomic studies
have identified numerous GEIs loci and several notable features of these loci. The use of model or-
ganisms enables the precise environmental control required to characterize the genomic properties of
GEIs. In S. cerevisiae more than 5% of the genome had readily detectable GEIs [108]. Additional
studies in yeast calculated that GEIs drove around 9% of total transcript variance [109]. Studies
both yeast and C. elegans showed that it was predominately distal loci that regulated transcripts with
GEIs effects [109,110]. In human epithelial cells transcripts in response to proinflammatory oxidized
phospholipids had significant GEIs effects. These epithelial transcripts were also enriched for distal
eQTL [106].
Extensive distal regulation of transcripts with GEIs indicates that theses gene may be a part of larger
networks or modules. In fact, in C. elegans, a large portion of transcripts exhibiting GEIs fall within
functional networks [111]. This enrichment of GEIs in pathways suggests that the effects of GEIs
could propagate across a whole network of genes. The network effects of GEI loci may not be easy
to detected in systemic studies due to stringent significance thresholds. Network analysis of tran-
scripts may enable the detection of GEI regulatory effects. In addition to extensive distal regulation,
transcripts with GEIs effects are often non-critical genes [108]. Critical genes, such as housekeeping
genes of have shallow regulatory networks and are tightly constrained in their expression levels [89]
and are unlikely have many distal regulatory mechanisms. The protection of critical genes could be
one mechanism in which robust biological systems buffer against deleterious genetic and environ-
mental effects on the cell.
One means of distal regulation is from the regulation of TFs. TFs are proteins which regulate the
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expression levels of their downstream gene targets. In yeast, the increase in regulatory TFs in a set
of transcripts was positivity correlated with gene expression variation in these transcripts [112]. The
binding of some TFs is also environment-dependent [113].
In Chapter 4, we characterized nine modules of highly phenotypically correlated genes. These mod-
ules showed many characteristics of GEIs effects. Enrichment of TFs and regulation by distal eQTLs
indicated network effects across each of the modules extending to other transcripts in the transcrip-
tome. The transcriptional responses in each of these modules showed marked responses between indi-
viduals to various environmental responses [114, 115]. Another feature shared between the modules
and identified transcripts with GEIs is tissue-specificity. In a study of transcripts exhibiting allele-
specific expression (ASE) in twins, transcripts that had GEIs were tissue-specific, with GEI effects
only found in Lymphoblastoid Cell Line (LCL) and fat samples but not in skin and blood [116].
In usual genetical genomics studies, GEIs may not be detectable in association studies due to the
wide variety of environmental effects and genetic backgrounds that are present in population samples.
Therefore the study design of genetical genomics and GWAS make it difficult to determine the impact
of GEIs in human gene expression variability. One method to identify loci with interaction effects
is to prioritize analysis on variance eQTLs. Variance eQTLs exhibit interaction effects that have that
largest impact on gene expression transcripts [86]. In a study of 765 twins, 70% of 508 variance-
eQTLs had significant GEIs effects [87]. This study demonstrated that a considerable number of loci
in the human genome had GEIs [87].
In a study of 8,013 ASE sites in blood, 38-49% of the total variance was attributed to genotype
dependent interaction effects such as epistasis (GxG) and GEIs [116]. Since variance estimates for
epistatic effects are low [85], these results could be primarily driven by GEIs. Despite observing just
a subset of the genome, these estimates of GEI variability on transcripts with ASE demonstrates the
potentially large impact that GEIs have on transcript variability.
Context-specific genetic regulation is another level of complexity that regulates transcriptomic re-
sponses to environmental perturbations. The prevalence of GEIs in genetical genomic studies high-
lights the importance of cellular environment when dissecting the genetic architecture of the transcrip-
tome. A comprehensive catalog of GEIs across the genome will enable the prediction of phenotypic
effects from genomic information alone.
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1.5 Environmental regulation
1.5.1 Differential gene expression
Differential gene expression can be used to identify molecular mechanisms that influence response
to environmental conditions [73, 117–121]. In addition to GxE interactions, there is evidence that
transcriptomic responses to environmental conditions are genetically controlled, through direct inter-
actions between the genotype and environment [72] but also through the genetic control of stochas-
ticity [122–125]. Indeed, it has been proposed that many disease risk alleles primarily exert their
effects under specific environmental conditions. By only being present under certain environmental
conditions, these alleles will be, for the most part, invisible in a population and, consequently, avoid
negative selection pressure [126].
1.5.2 Classifying environmental conditions
Environmental conditions can be classified as either macro and micro environmental factors. Micro-
environmental factors are conditions that are unique to individuals such as diet, exercise, exposure to
drugs and toxins [125]. Over a large enough sample size, the effects of microenvironmental effects
on a population scale are usually negated. Environmental factors that affect the majority of individ-
uals in a population and can be measured (e.g. temperature) are classified as macro-environmental
effects [127]. Variation between the months, seasonality, which can encompass a range of macro-
environmental factors, shows transcriptomic signatures for DNA repair and binding and cell count
fluctuations in erythrocytes, platelets, neutrophils, monocytes and CD19 cells. The impact of season-
ality as a macro-environmental factor on the transcriptome is discussed in chapter 3.
1.5.3 Epigenetic variation
Epigenetic DNA modifications are heritable changes in gene function that are independent of direct
changes to the DNA sequence [128]. Since these changes have a heritable impact on phenotype,
methylation has been suggested an important non-genetic factor contributing to heritable phenotypic
variability [129].
The most prevalent form DNA methylation occurs on cytosine located at CpG sites, which are a linear
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pattern of cytosines followed by a guanine. Adenine nucleotides are also methylated in several species
but, for mammals, it has only been observed in mouse embryonic cells [130, 131]. Several enzymes
are involved in the DNA methylation process, with the two main types being DNA methyltransferases,
involved in adding the methyl group and methyl-CpG binding proteins, which interpret the methyla-
tion markers [132]. 70% of human promoters have CpG islands [133] and 40% of all promoters occur
nearby CpG islands [134]. Methylation of cytosines has been associated with suppressed [135] or
silenced gene expression [136]. In mammals, the majority of cysteines are unmethylated [137]. The
high presence of CpG islands in gene promoters and the considerable amount of unmethylated sites
in highly expressed genes indicates that they are often present in transcriptionally active sites [132].
Methylation patterns appear to be closely related to gene expression. Across the genome, there is
significant genetic covariance between gene expression and methylation patterns [138]. Methylation
has also demonstrated tissue-specific effects [139], which is also prevalent in the transcriptome [41].
There are two methods in methylation patterns is inherited. One of these means involves varia-
tion in the genome whereby specific loci regulated the amount of methylation that occurs in the
genome [140]. The use of genome-wise bisulphite sequencing has enabled methylation to be studied
as a quantitative trait. Studies have also revealed that epigenetic changes are genetically regulated.
Numerous CpG site across the genome have been identified to be highly heritable and have strong
local regulatory elements [141].
The second type of epigenetic inheritance is when there is incomplete erasure of the epigenetic DNA
markers during the development of the gamete. This lead to trans-generational methylation patterns
[142]. This mechanism could represent an interface between genetic and environmental influences
[143] since methylation patterns can be affected by environmental effects [142,144,145]. The effect of
environment on the epigenome has been quantified in monozygotic twins, whereby initially identical
epigenomic profiles can develop larger differences over time [146]. Epigenetic inheritance can enable
transcriptional changes from environmental exposures to be directly passed down generations [143].
1.5.4 Batch Effects
Gene expression transcripts are sensitive to the cellular environment that surrounds them. Slight dif-
ferences in technical or environmental conditions within the laboratory can create synthetic changes
in expression levels, called ’batch effects’ [147–150]. Batch effects can be severe confounders in
gene expression studies. Technical artifacts are ubiquitous in gene expression datasets even in well-
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designed experiments generated under ideal circumstances [150]. Batch effects can be the most
prominent source of variation, even surpassing biological variation [77, 151]. For example, in the
BSGS [42] comprising of 335 unrelated individuals, around 25% of the variance the raw gene expres-
sion dataset was attributed to batch effects [152]. There are several sources of batch effects, which
include type and age of reagents [153], temperature [154] and ozone levels [155] to name a few.
Appropriate normalization of the datasets is required to minimize between sample variation aris-
ing from sample quantity and to remove large batch effects driving distributional changes between
genes [156]. Careful measures are needed when collecting and measuring samples to reduce the pres-
ence of these artifacts. The reduction in batch effects can be best achieved by carefully recording
all information on sample processing and handling [157]. These variables can then be included in
statistical models to remove any batch effects [154, 158–160]. Failure to correct for batch effects has
led to spurious results in downstream analyses [161, 162].
Without processing records, batch effects can be removed from the data by using PCA or Singular
Value Decomposition (SVD) [77, 163–165]. These unsupervised methods can be effective at remov-
ing batch effects, particularly when a large number of Principal Components (PCs) are used [152].
However, since the selection of PCs is often arbitrary and there is often a mix of genetic and non-
genetic factors in each component, there is a risk of removing heritable genetic variation when using
these methods [152].
1.5.5 Principal Components
Recently, the removal of PCs has been used to correct for batch effects in large gene expression
datasets [77,163]. Within the field of statistical genetics, this approach has previously been employed
to remove signals from genes that saturated biological signals of interest. For example, Alter et al.
2000 found that the first PCs were mainly associated with genes related to steady state growth in the
cell [166]. Removal of that PC left the genetic signals associated with cell-cycle progression, which
was of interest to the investigators. Removal of PCs to correct for confounding became popular
in genomic research after it was demonstrated to be an efficient method to correct for population
stratification within SNP data [167]. This approach was based on a strong statistical footing [168]
but also required manual inspection of the data to observe clustering of different populations. PC
correction was also later employed to correct for stratification in gene expression data [169].
The use of PCs in gene expression datasets to correct for batch effects became prevalent following
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the use Surrogate Variable Analysis (SVA) to correct for expression heterogeneity by removing PCs
[170]. However, SVA requires that the primary variable of interest be adjusted for in the dataset via
linear model before PC analysis is performed. However, as batch effects constitute a large proportion
of the dataset [77, 158] the removal of PCs directly from the whole dataset was later used as the
method to correct for these factors [164, 165]. Some studies removed up to 50 PCs [77, 163], which
can constitute a large proportion of the total variance within a dataset. These correction methods were
even used when suitable technical effects were recorded [171] that could have been used to correct
for batch effects using linear models [154] or Bayesian methods [172]. As PCs can pick up multiple
sources of variation, there was a concern that such approaches would remove genetic data [157,173].
The clustering of different groups within principal components has been used not only for correction
but also to determine differential gene expression observed between specific experimental conditions
[174], populations [175] and tissue types [176]. As the changes in variances constitute not only
batch effects but also genetic components driving gene expression variability in the population, the
arbitrary removal of PCs could delete regulatory information from the datasets. Since batch effects
present such a ubiquitous and pervasive source of variation in transcriptomic datasets, PCs provide an
ad-hoc means of removing such confounders when no processing dates have been recorded, and no
other statistical technique can be otherwise applied [152].
1.6 Cell type and tissue specificity
Many gene expression studies have been performed on LCL, which are purified B-cells that are im-
mortalized with Epstein Bar virus. Immortalized cell provide a continuously replenishable and stable
source ribonucleic acid (RNA) and DNA from an individual [177] and also a homogeneous envi-
ronment between samples, which can minimize environmental variability. There have been some
concerns about the use of these cells in expression studies, as there is evidence that the immortal-
ization step causes changes in the transcriptional landscape such as random patterns of monoallelic
expression [178]. Variables such as the titers of the Epstein-Barr virus can also have a noticeable
effect on expression levels obtained [179]. However results from studies done on LCLs have been
concordant [56], comparisons with adipose tissue have found over 50% overlap [46], and comparisons
with skin have shown overlap in cis-eQTLs of around 70% [180].
Between different cell types and tissues, there are notable differences in the expression levels and ge-
netic regulation of transcripts [40,41,71,74,181,182]. One of the mechanisms driving the differences
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is differential binding of transcriptions factors between the cells [183]. A study of eQTLs found that
between fibroblasts, LCLs, and T-cells, only 6.8% of detectable eQTLs are shared between all three
tissues, 9.7% in two tissues and up to 83.4% are cell specific [184]. eQTLs shared between tissues
were found to cluster tightly around the TSSs, which corresponds to the finding that there is stronger
tissue specificity in enhancer elements found further away from the gene [185]. The eQTLs that are
shared between tissues also demonstrated much larger effect sizes [102,184]. A comparison between
fat, LCL, and skin cells showed 12.3% overlap between all three tissues, 16.2% shared in two tissues
and 71.4% found in one tissue, with skin showing the least amount of unique eQTLs [182]. A study
of two different tissues, liver, and adipose, found a much higher percentage (70%) of sharing between
these tissues [186] as opposed to what was found among specific blood cells. The larger degree of
shared regulation between these tissues could be due to the greater number of diverse cells found in
tissues drowning out cell-specific effects. Comparisons between brain and whole blood are largely
concordant with the exception of some regulatory regions [187].
Examination of regulatory variants between monocytes and B-cells showed that 21.8% variants were
shared between cell types, while 32.2% were B-cell specific and 45.9% were monocyte-specific [102].
This study found a that a large number of cis-eQTLs were cell-specific, with some showing differ-
ential allelic effects between cells and 4.6% of cell-specific eQTLs being associated with a different
gene in another cell type. These cis-eQTLs also exhibited enrichment for known cell-specific GWAS
hits accordingly. A large number of shared eQTLs were in trans which have also been identified in
another independent population [41]. Other studies have found the opposite whereas cis-eQTLs are
the predominant type of polymorphism shared between tissues [40]. Averaged across the genome,
the mean genetic control between LCLs and whole blood was close to zero with only core, house-
keeping genes showing higher estimates of positive and negative genetic correlation [40, 181]. These
studies demonstrate that while blood can provide a useful proxy for other cell types, caution should
be exercised if results are used to infer effects in other tissues.
1.7 Omics
Genetical genomes integrated genetic polymorphisms and gene expression revealing an intricate regu-
latory system that controls the transcript levels [188].Biological systems are comprised of many tiers,
starting with the encoding of genetic information within the genome.
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1.7.1 Proteomics
Proteomic studies focus on the global quantification of proteins within the body. Functional proteins
are the building blocks of the cell and are more direct determinants of cellular function than transcript
levels [189]. Proteomic information can also provide additional information on post-translational
modifications, such as acetylation, phosphorylation, and ubiquitination, that impact protein function-
ality, cell and time specificity and protein-protein interactions and cannot be so easily detected from
the genome and transcriptome alone [190]. Of the 20,000 genes annotated in Swiss-Prot and UniProt,
the protein-coding characteristics of many proteins are still unknown [191, 192]. While there have
been many studies examining various aspects of the proteome, there have only been a few systematic
characterizations of the global proteome [190, 193, 194]. The low number of global proteome studies
are primarily due technological problems in data accuracy, collection, and distribution. The number
of proteins detected in a proteomic study using mass-spectrometry is between 16,000-17,000. 70%
of detect proteins are expressed ubiquitously across cell types and represent regulatory proteins that
have core cellular functions. The number of core proteins is estimated to be around 10,000 [195,196].
These core proteins are enriched for metabolic processes, with over 60% of all metabolic enzymes
being present in all tissues [196]. Between tissues, however, proteins can have up to five orders of
magnitude changes in abundance. Proteomic studies have even identified transcripts produced by long
intergenic non-coding RNA (lincRNAs) [190,197] indicating the utility of the proteome in uncovering
downstream functionality of genes.
Correlation between mRNA levels and proteins have yielded conflicting results in model organisms
[198]. However, they have been relatively concordance ranging between 0.41-0.55 in different tissues
[190].The ratio between protein and transcriptomic abundance between cell lines has been shown to
be a more stable measure of the relationship between transcripts and proteins [199]. The differences
between transcript and protein levels can reflect the translational speed of a transcript, which remains
relatively constant in the cells [200]. Therefore, the ratio between transcripts and proteins can enable
the prediction of protein abundance from mRNA levels alone [190].
There have been notable differences found between eQTLs and protein Quantitative Trait Loci (pQTLs)
[201]. While some eQTLs are also pQTLs, the majority demonstrated zero to low attenuated effects
between the two levels of regulation [202]. Quite a number of pQTLs that only demonstrates an effect
on protein levels [203]. One study in LCL cells demonstrated that 90% of ribosome occupancy Quan-
titative Trait Loci (rQTLs) were eQTLs, however this was not the case with pQTL. The attenuation
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between eQTLs and pQTLs appeared to be occuring not at the translational level, since rQTLs had
little impact on the pQTLs. Instead, there was evidence that the pQTLs work independently through
protein degradation mechanisms, futher supported by the enrichment of pQTLs near acetylation sites
and the prominent role of lysine degradation in protein degradation [204].
One of the possible reasons for the lack of concordance could be technical difficulties and differences
between the array-based measurement of mRNAs and the isolation and quantification of proteins
using mass spectrometry. Another potential problem is that global quantification of mRNA transcripts
only represents a steady-state measurement of the expression levels of probes, which are in a constant
state of flux between transcription and decay [205]. In fact, a study in LCLs identified 195 RNA Decay
Quantitative Trait Loci (rdQTLs) associated with RNA decay rates and also found that 10% of genes
had a significant correlation between steady-state levels and variation in decay rates [206]. Finally,
transcripts also undergo phenotypic buffering, which a rate-limiting step during translation that leads
to the degradation of transcripts [207]. The effect of a phenotypic buffering has been documented
for multisubunit proteins, which are rate-limited by the least abundant protein subunit. Transcript
levels for homopolymers demonstrate a much higher degree of correlation between protein levels and
transcripts than multisubunit proteins [201]. One mechanism that can lead to such buffering is the
greater evolutionary constraints placed on proteins as opposed to transcripts [208].
Integrative omics between the transcriptome and the proteome has highlighted the importance of the
metabolic processes. Genome-scale metabolic maps have identified notable differences between the
genetic profile and metabolic reactions that occur. These studies demonstrate that there is considerable
variability in the enzymes used in catalyzing these reactions [196]. Since these enzymes are critical
to the core functioning of the cell, the incorporation of enzymatic protein abundance, as well as
metabolomic information, will enable the creation of a global image of biological processes.
1.7.2 Metabolomics
Metabolomics involves the quantification and study of metabolic substrates within these bodies.
These metabolic substrates are a part of vast networks of complex chemical reactions that make
up the metabolism of a cell. These can involve the recycling of nucleotides, lipids and protein, pro-
cessing of waste products and the chemical reactions required to produce energy within the cell.
Advances in Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) technologies have
facilitated the profiling of hundreds of metabolites simultaneously. The chemical snapshots obtained
45
from these techniques give a readout of the current physiological state of the cell [209]. Metabolic
readouts, unlike gene expression or proteins, provide a direct measurement of cellular function that
cannot become attenuated from post-translational regulations. These chemical measures have also
demonstrated great utility in discovering new gene functionality [210–213]. There is also additional
evidence that metabolites can act as signaling molecules that can regulate gene expression [214]. This
further increases the complexity of interactions between the different tiers of omics data.
Correlation values between enzyme transcripts and their associated transcripts are largely similar,
particularly when viewing these correlations on the scale of entire metabolic pathways [214]. Many
metabolites demonstrate high heritability with some studies showing up to 40% of measured metabo-
lites having a heritability of > 0.6 [215]. The effect sizes for GWAS hits in metabolite concentration
levels are larger than for phenotypes [214], with effect sizes ranging between 10-60% [214]. Results
have also largely been concordant with the metabolic pathways of the metabolites, and their asso-
ciated GWAS hits in particular enzymes [216, 217]. Metabolic markers could also be the results of
microbial metabolism [218]. While appearing to be an environmental effect, microbial metabolism is
similar between dizygotic and monozygotic twins [219]. Microbial biomasses play a critical function
in the body, ranging from digestion to regulating the immune system [220].
When integrated with transcriptomic and genetic date, metabolomics had provided greater biological
context and information to the molecular process that drives cellular systems. While metabolomics
has been considered the apogee of omics data [209], there are still a growing number of omics fields
which are involved in the collection of global information on specific biological properties. These
include the methylome (discussed in section 1.5.3), the lysine acetylome (the post-translational mod-
ification of proteins) [221], lipidomics (the study of lipids) [222] and even microbiomics (collection
of metagenomes of the bacteria cells living within organisms) [223]. Information of the baseline state
of an individual can provide valuable information into the various cellular process. Further under-
standing the processes occurring in active biological systems can be achieved by examining how the
internal physiological state changes in response to the environment or within other actively changing
physiological states such as growth [224].
1.8 Systems Genetics
Systems genetics [39] incorporates molecular phenotypes (section 1.7), to study the flow of infor-
mation from the genome to the phenotype of interest [39]. Using whole-genome transcriptomic,
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proteomic and other -omic datasets, complex networks of interactions can be studied. The increasing
levels of organization from the genome to multitudes of intermediate phenotypes gives rise to emer-
gent properties, new features and capabilities that would not otherwise be observed if examining the
expression of a single gene [225]. The advent of technologies that can cheaply and quickly mea-
sure intermediate phenotypes such as whole-genome gene expression, metabolites, and proteins have
facilitated the opening of the black box between genetic information and phenotypic traits.
1.8.1 Dimension reduction
Gene expression demonstrates a highly networked structure, with many genes showing a high degree
of co-expression. Co-expression can occur when genes interact with each other, either as a part of a
biological network or a protein complex. This feature of -omics data enables the data to be reduced
down to smaller sets of highly correlated sets of variables. Cutting down the number of variables
reduces the dimensionality of a dataset while increasing the power to detect meaningful associations
otherwise lost due to the stringent multiple testing significance thresholds.
1.8.2 Coexpression
Modules of correlated transcripts can also provide a great deal of functional information about the
genes. These covariance structures, also called modules, have been found by decomposing vari-
ance using principal components analyses [226, 227], hierarchical clustering [228], Weighted Cor-
relation Network Analysis (WGCNA) [229], and Modulated Modularity Clustering (MMC) [230].
These modules are topological, sub-networks within a much larger network of interactions and rep-
resent functional units within a much bigger network that have hierarchical and scaled-free proper-
ties [231]. The significant enrichment in Gene Ontology (GO) terms, Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathways, TF binding sites and other biological interactions [232] indicates
that biological plausibility of these modules. Regulatory polymorphisms governing gene modules
have been identified in yeast [226] and humans [233].
Modules are often identified based on the phenotypic variation of the transcripts [114]. Phenotypic
variance can be attributed to both genetic and environmental factors. Chapter 4 uses Identity-By-
Decent (IBD) methods to partition the genetic and environmental variances driving modules identi-
fied a previous study [114]. Chapter 4 illustrates the extent that genetic and environmental factors
influence the co-variation between transcripts clustered within a co-expression modules.
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1.9 Network analysis
The vast majority of Genetics of Gene Expression (GOGE) studies have focused on the analysis of
single gene targets. However, gene products within a cell often do not function alone, but instead exert
their effects through complex networks ranging from intracellular signaling and metabolic function
[110,179]. Perturbations across multiple regulatory genes in a network can have a much a larger effect
on disease than single gene changes [234]. Analysis of variants affecting gene networks has elucidated
interesting processes with regards to complex diseases such as obesity [46], regulatory networks in
stem cells [235] and immune response [236]. Analyzing systems affected by mutations can also give
biological insight into the function of identified eQTLs and can even identify novel functions. For
example, a study of obesity susceptibility discovered novel interactions between TFG-β and genes
outside its known signaling pathway [237].
Groups of correlated genes are likely to respond environmental perturbations together [238], replicate
across different microarray platforms [228] and can be highly conserved in populations [114] These
networks of interacting genes could also be a driving factor behind phenotypic stability and robust-
ness [234], by providing genetic redundancies. Transcripts within these modules are associated with
disease [228, 232] and different environmental conditions [114, 115]. The ability of the modules to
provide information on both genetic and environmental states individuals demonstrates their utility
as indicators of disease susceptibility and physiological state. This particular information based on
different conditions is the basis of personalized medicine. This vision may be possible through the
integration of various -omics data (as discussed in 1.7) by providing highly detailed biological profiles
and physiological responses of individuals [239].
Additional uses of gene networks include searching for epistatic interactions among a small number
of correlated genes, analyzing pleiotropic effects, identifying the function of predicted genes from
’guilt by association’ and determining differences between tissues [179]. Being able to test for these
factors can enhance our understanding of mechanisms maintaining quantitative genetic variation. The
integration of eQTL data alongside gene modules can facilitate the identification of causal variants
driving gene expression and can increase our understanding of network functionality by providing
directionality to the flow of information from the genetic polymorphisms to endophenotypes [179].
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1.10 Clinical applications of gene expression
Thus, the study of global gene expression can provide information on the functionality, constraints,
and controls of biological systems that give rise to higher order phenotypes, such as disease suscepti-
bility. These statistical models of gene expression regulation can have significant applications in the
clinical setting. Gene expression can be utilized as a clinical diagnostic tool to identify individuals
with high disease risk. The incorporation of genetic information plus information on gene expression
responses to environmental factors can aid in the development of personalized medicine [240–243].
Hypothesis-free, predictive medicine can shift diagnostic focus to the identification and treatment of
non-symptomatic, early stages of the disease and will focus primarily on maintenance of health [11].
An example of the diagnostic potential of gene expression was with the classification of healthy
individuals and patients with latent and pulmonary tuberculosis [114]. Chapter 4 continues this
study by examining the genetic architecture of the gene expression transcripts used in this predic-
tive model [114].
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Chapter 2
Genetic and non-genetic variation revealed for the principal components of hu-
man gene expression
The work presented in this chapter has been published in:
Goldinger A, Henders AK, McRae AF, Martin NG, Gibson G, Montgomery GW, Visscher PM, Powell
JE: Genetic and non-genetic variation revealed for the principal components of human gene
expression. Genetics 2013, 195:1117-28
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2.1 Abstract
PCA has been employed in gene expression studies to correct for population substructure, batch,
and environmental effects. This method typically involves the removal of variation contained in as
many as 50 PCs, which can constitute a large proportion of total variation present in the data. Each
PC, however, can detect many sources of variation including gene expression networks and genetic
variation influencing transcript levels. We demonstrate that PCs generated from gene expression data
can simultaneously contain both genetic and non-genetic factors. From heritability estimates, we
show that all PCs contain a considerable portion of genetic variation while non-genetic artifacts such
as batch effects were associated to varying degrees with the first 60 PCs. These PCs demonstrate
an enrichment of biological pathways including core immune function and metabolic pathways. The
use of PC correction in two independent datasets resulted in a reduction in the number of local- and
distal-eQTLs detected. Comparisons of PC and linear model correction revealed that PC correction
was not as efficient at removing known batch effects and had a higher penalty on genetic variation.
Therefore, this study highlights the danger of eliminating biologically relevant data when employing
PC correction in gene expression data.
2.2 Introduction
Microarray technology can simultaneously capture the expression of thousands of transcripts within
an individual. However these arrays are sensitive to environmental or experimental perturbations, for
example due to different laboratory technicians and reagents [153, 244] microarray chip and chip po-
sition [159], temperature [154], and even ozone levels [155]. These effects can constitute a substantial
proportion of variance within a dataset [158].
Normalization strategies have become standard in gene expression studies to correct for non-normal
distributions and inconsistencies between arrays [245]. However, normalization techniques do not
control for batch effects caused by technical artifacts. These batch effects require additional correction
techniques [154] and failure to do so has led to spurious associations [161, 162].
Many different correction and normalization techniques are currently used in gene expression studies
(for review see: [157, 160]). PCA is one method that has been used for the correction of widespread
batch effects [77, 157, 164, 170]. PCA determines linear combinations of variables and projects them
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into orthogonal vectors that are ranked on variance explained [246]. PCA can be used for a variety
of analytical approaches such as; dimension reduction [247], identifying gene correlations [248], de-
termining co-expressed networks [249], classifying gene expression modules [248], analyzing time-
series data [250], and determining differentially expressed genes across tissues.
PCA is a powerful tool to analyze and understand high dimension gene expression data. However,
while PCA is commonly used to decompose variation into common axes, the components of variation
contributing to each PCs are often unknown. Information on the components of variation captured
by PCs is important if the correct inferences of PCA results are to be made. A clear example is in
the use of PCs to correct for batch effects, where variation in the first 1-50 PCs is removed from
the dataset by fitting these PCs as covariates in a linear model and using the residuals as a corrected
phenotype [77, 157, 163, 165, 169, 170]. Though this method has been demonstrated to increase the
power to detect eSNPs by eliminating confounding batch and environmental effects [77], there is a
risk of the indirect removal of biologically relevant information due to the large amount of variance
held in the first few PCs [157].
In this study, we investigated the sources of variation driving PCs generated on a gene expression
dataset produced from whole blood. This dataset is comprised of 860 individuals from 314 families
from the BSGS [42]. We combine the power of pedigree and SNP-based designs to quantify and
dissect the total genetic variance of PCs. From these results, we demonstrate that the PC correction
methods used in published literature (for example in [77, 163]) simultaneously remove both genetic
variation and batch effects. We also show that with careful analysis, the information contained within
PCs can be leveraged to provide an understanding of gene expression pathways underlying complex
disease. We use these results to emphasize the importance of using other correction methods when
applicable instead of removing PCs to correct for batch effects.
2.3 Materials and Methods
2.3.1 Samples
A total of 335 unrelated individuals were selected from BSGS, a cohort comprising of 860 individuals
from 314 families [42]. Individuals were selected on two criteria; the first was to obtain the maximum
number of unrelated individuals by choosing parents (n=165) and a single individual from families
with no parents (n = 170). Unrelated individuals were chosen from this dataset to exclude family
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effects from being present within the PCs. All individuals were genotyped on Illumina 610-Quad
Beadchip (Illumina Inc, San Diego, USA) by the Scientific Services Division at deCODE Genetics,
Iceland. A total of 488,462 SNPs were present after appropriate quality control (see GWAS section
below).
RNA was obtained from whole blood samples that were collected in a PAXgeneTM tube (QIAGEN,
Valencia, CA), analyzed for purity on an Agilent Bioanalyzer, converted to cDNA, amplified and pu-
rified using the Ambion Illumina TotalPrep RNA Amplification Kit (Ambion). The expression levels
were quantified on an Illumina HumanHT-12 v4.0 Beadchip (Illumina Inc, San Diego, USA). Sam-
ples were randomized across the chip to minimize batch effects due to families, sex and generation.
Quality control methods for selecting highly expressed probes in the samples was described in detail
in [42]. After appropriate QC, the probes were further filtered for expression in 100% of samples.
Probe names starting with HS, KIAA, LOC, were removed from the dataset, as they did not map to
characterized ref-seq genes. After filtering, a total of 9,086 probes remained.
2.3.2 Replication sample
The CHDWB study is a population-based cohort consisting of 139 individuals collected in Atlanta
USA [115]. Gene expression profiles were generated using Illumina HT-12 V3.0 arrays from whole
blood collected in Tempus tubes that preserve RNA. Whole genome genotypes were measured using
Illumina Omni Quad arrays.
2.3.3 Normalization and batch effect correction
The gene expression levels of the 9,086 probes were normalized using the quantile, log2, and z-score
transformation. Correction methods were then applied to create four different datasets that were used
for further analysis, these are; (a) standard normalization (log, quantile and z-score transformation)
(b) standard normalization with linear model correction for batch effects (c) standard normalization
with correction for 1-25 PCs and (d) standard normalization with correction for 1-50 PCs. These
datasets/correction procedures will be referred throughout the paper as datasets (a)-(d).
Batch effects arise from various sources during the generation of the data, and processing date records
can provide a useful estimate of differences between subsets of groups [157]. In previous work [42],
we showed that chip identifier (ID) and chip position comprehensively account for batch effects.
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Dataset (b) was created using the residuals from a linear model with the batch effects of chip ID and
chip position as well as sex and age as covariates. This model was fitted as follows:
y= Xβ + e (2.1)
Where:
y=

y1
...
yn

is a vector of probe values from dataset (a) with n = 335 individual values.
X =

1 x1 · · · x1c
...
... . . .
...
1 xn . . . xnc

is a matrix with c = 86 covariates: chip position (11 levels), chip ID (73 levels) and sex and generation,
which were coded as dichotomous variables.
β =

µ
β1
...
βc

is a vector of parameters for the model. The parameter µ represents the mean expression level across
all the individuals. The vector:
e=

e1
...
en

holds the model residuals. The parameters in β are estimated by:
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β = (XTX)−1XTY (2.2)
Datasets (c) and (d) were created from the residuals obtained after correcting for the first 25 and 50
PCs using Equation 2.1, where y was the normalized dataset (a) and the PC scores values (Equation
2.3, see below) obtained from dataset (a), were fitted as covariates in X. The first 50 PCs were selected
to follow the procedure used in previously published gene expression papers [77, 163].
2.3.4 Principal Components
PCs were calculated on dataset (a) to facilitate PC correction, which was used to generate datasets (c)
and (d). PCs were also calculated on all four datasets (a)-(d) to analyze the extent of batch effect asso-
ciations. To follow the methods used in previous gene expression studies [77, 163, 170], the principal
components used in this study were generated using SVD. SVD decomposes the high dimensional
dataset:
M =

m11 · · · m1p
... . . .
...
mn1 · · · mnp

with n= 335 (samples) and p = 9,085 (probes), into a set of uncorrelated, orthogonal vectors:
M =UΣV T (2.3)
Where:
U =

u11 · · · u1n
... . . .
...
un1 · · · unn

is a matrix with scores values for each PC (columns), which gives the correlation values between the
samples (rows).
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Σ=

e1
...
en

is a diagonal matrix containing the eigenvalues, which represent the amount of variance each PC
explains.
V =

v11 · · · v1n
... . . .
...
vp1 · · · vpn

are the eigenvectors that hold the correlation values for each probe (rows) to the PC (columns) [251].
Dataset (a) demonstrates a homogenous variance structure within the scores plots with no clear popu-
lation stratification or substructure comprising of independent clusters of individuals. As this dataset
contains the same information as (b)-(d), this indicates the uniform nature of the samples within the
BSGS dataset.
The eigenvectors values in V (Equation 2.3) represent the correlation between the probes and the
principal component. As multiple probes are correlated with each PC, the selection was based on
the eigenvector values for each probe. The minimum eigenvector demonstrates the largest negative
correction, while the maximum eigenvector shows the largest positive correlation. Across all PCs the
maximum eigenvector values ranged between 0.02 and 0.08 and the minimum values ranged between
-0.02 and -0.08 (Figure 2.7A). The PCs that exhibited the smallest maximum and minimum values
were the first 1-20 PCs. As the number of probes selected for each PC can impact later enrichment
analysis, we wanted to select a consistent number of probes between all PCs. Therefore, a cut-off
eigenvector value was used to select probes as this produced the most consistent results and provided
a standard approach to use for all PCs. This cut-off value, chosen to be less than -0.02 or greater than
0.02, incorporated the maximum and minimum values for all PCs to ensure that only the most highly
correlated probes for each PC were selected. This eigenvector cut-off value chose a consistent number
of probes (approx. 550) across all the PCs (Figure 2.7B). The eigenvalues for the first 10 PCs were
confirmed via linear regression with the relationship tested using an F-test and p -values corrected for
multiple testing using a Bonferroni adjustment.
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2.3.5 Association with Batch effects
PVCA was used to quantify the extent of the batch, age and sex effects within datasets (a)-(d). This
method has been described fully previously (see ref [252]). PCs are generated by an eigenvalue
decomposition of a covariance matrix, and the batch effects are quantified with a linear mixed model
using the batch effect terms as covariates. The variance components in each model are estimated
using Restricted Maximum Likelihood and are scaled by the eigenvalues obtained for each PC. The
variance attributed to each factor is divided by the variance (determined from the eigenvalue) of the
corresponding PC and then standardized across all factors.
A similar method was used to quantify the extent of batch effects on the principal components ob-
tained from SVD. Scores values obtained from the SVD of datasets (a)-(d) were tested for batch
effect association using a multiple linear regression (Equation 2.1 and Equation 2.2), where y is a
vector of scores values for one PC, with n = 335 individual score values. X is a matrix with c = 86
covariates: chip position (11 levels), chip ID (73 levels) and sex and generation, which were coded as
dichotomous variables.
The R2 values for the linear regression are calculated as the sum of squares explained by the Sum of
Squares Regression (SSR) divided by the Sum of Squares Total (SST), which gives the percentage of
variance in each PC that is associated with batch effects,
R2 =
1−SSR
SST
(2.4)
and adjusted for multiple covariates using:
R2ad j = 1−
(1−R2)(n−1)
(n− c−1) (2.5)
P-values were obtained from an F-test of the total variance explained by the model as opposed to total
variance. Multiple testing was accounted for by Bonferroni correction.
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2.3.6 Estimation of heritability
To assess the extent of genetic variability held within the PCs were adjusted for in datasets (c) and
(d), estimates of heritability were calculated for all PCs generated from dataset (a). To compute
heritability for the PCs the score values for related individuals had to be estimated, which minimizes
the presence of family effects retains the same PCs for eQTL and heritability analyses. The estimated
scores were calculated by multiplying the probe values for those individuals with the eigenvectors
calculated from the PCA decomposition:
Uest = XV (2.6)
Where:
Uest =

u11 · · · u1n
... . . .
...
un1 · · · unn

is the resulting matrix of estimated PC scores values with n= 425 individuals.
X =

x11 · · · x1p
... . . .
...
xn1 · · · xnp

is a matrix of probe values with p = 9,085 probes.
V =

v11 · · · v1n
... . . .
...
vp1 · · · vpn

is a matrix of eigenvectors, previously derived from the analysis of data from the 335 unrelated indi-
viduals.
Uest was combined with U from the original PCA to create a R860x335scores matrix containing values
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of all individuals for the 335 PCs.
Heritabilities were estimated for the PCs generated from dataset (a) using Quantitative Trait Dise-
quilibrium Test (QTDT), which partitions variance components attributed to additive genetic, envi-
ronmental or common family variance [253]. This method utilizes the complete pedigree structure
within the data. Two models were compared in this analysis, an Additive genetic and Environment
(AE) model, which includes an additive genetic component and unique environment component, and
a Common family effects and Environment (CE) model, which includes common and unique envi-
ronment components. Additive genetic, common and unique environment variance estimates were
divided by the total phenotypic variance to determine the proportion contributed by each factor.
Heritability estimates for all probes were calculated using QTDT on the full dataset of 860 individuals.
The full dataset was corrected using the same four methods used for datasets (a)-(d). The distribution
of probe heritability estimated obtained from the four different correction methods were compared.
QTDT heritability estimates are constrained to have a minimum value of 0.
2.3.7 Genome-wide association study on PCs
A genome-wide association analysis for each PC was performed using PLINK software [254] on
dataset (a) to provide an independent assessment of genetic effects present for PCs. SNPs were fil-
tered based on a Minor Allele Frequency (MAF) > 0.05, missingness >0.10 and Hardy-Weinberg
Equilibrium (HWE) p-value < 1e-6. After filtering, 488,462 SNPs remained for analysis. Signifi-
cance was determined at a Family-Wise Error Rate (FWER) with Bonferroni correction (α = 0.05)
and with an empirical p-value estimation for each PC using 1000 permutations in PLINK [254].
2.3.8 eQTL analysis
To determine the impact of each of the different correction methods employed in datasets (a) - (d), an
eQTL analysis was performed for each probe within these four datasets using the same procedure as
described above. To replicate the effect on eQTL detection we performed the sample analysis for an
independent sample comprising of 139 unrelated individuals (CHDWB). local- and distal- eQTLs at
multiple False Discovery Rate (FDR) levels [255] were extracted and compared between the datasets.
local-eQTL associations are defined as being within +/- 1MB of the gene tested.
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2.3.9 Biological Pathway Analysis
The pathway analysis was performed on the online Database for Annotation, Visualization and Inte-
grated Discovery (DAVID) Bioinformatics Resources 6.7 [256]. Probes associated with the PCs of
interest were submitted as a list of Illumina probe IDs and KEGG pathway enrichment was performed
using Functional Annotation Chart implemented by DAVID [257]. The significance of pathway en-
richment was determined from a modified Fisher’s test, which calculates the chance that a set of genes
of related terms are presented at a certain percentage in the list. Multi-testing was accounted for using
a Benjamini-Hochberg FDR of 0.05 [255].
2.4 Results
2.4.1 Non-genetic contributions to PCs
PVCA was used to estimate the extent of batch, sex and age effects within the whole dataset [252,258].
This method involves firstly decomposing the dataset into a series of PCs and estimating the effects
of each covariate on these components. The total variance of each covariance is then summed across
all PCs and scaled by the respective eigenvalue. PVCA was applied to datasets (a)-(d) to compare
the effectiveness of these methods in removing batch effects from the data. For dataset (a), batch
effects explained 23.1% of the total variance, with chip ID having the largest effect (Figure 2.1A).
This proportion is far less than the 75.5% cumulative variance explained by the first 50 PCs (Figure
2.2A), which were removed in previous studies to correct for batch effects [77,163]. The results from
linear model correction (Figure 2.1B) and PC correction (Figure 2.1C and Figure 2.1D) show that the
majority of batch effects have been removed using these methods.
To analyze how batch effects are distributed across PCs, each of the four datasets (a-d) was decom-
posed using SVD into 335 PCs. Multiple regression of each PC on chip ID, chip position, sex and age
was used to analyze the distribution of these effects across all PCs. The majority of variance attributed
to batch effects in the normalized dataset (a) was held within the first 58 PCs of the dataset (Figure
2.3A), with the proportion of variance explained by batch effects ranging from 24-74%. This indicates
that unknown sources of variance, not associated to batch, sex or age effects are also present within
these PCs. As the first PCs pick up the majority of variance within the dataset (Figure 2.2A), sig-
nificant associations to these PCs indicate a much larger impact of batch, sex and age effects within
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Figure 2.1: PVCA of gene expression datasets (A)-(D). PVCA calculates the proportion of variance
in the entire dataset that is attributed to certain batch, sex and age effects. Altogether batch, sex and
age effects account for 23% of the variance in the non-corrected dataset (A) and are fully removed in
the corrected dataset (B). Batch effects present in PC corrected dataset are represented in (C) PC25
and (D) PC50. The residuals represent the remaining variance in the dataset not attributed to these
batch effects.
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Figure 2.2: Variance explained by PCs. Calculated from the eigenvalues obtained from the Singular
Value Decomposition. Variance explained by each PC is plotted in black and cumulative variance
in blue. A) The normalized dataset, B) Corrected with linear models, C) PC25 corrected D) PC50
corrected. All variances sum to 1.
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the dataset. Batch effect associations to the first few PCs are expected to occur more frequently
than in later PCs, because the initial PCs can capture the majority of correlation structure within the
dataset [246]. Therefore whilst the dataset (b), corrected for batch effects with linear models, demon-
strated as association with PC 330, the significance of this association is negligible (Figure 2.3B) as
confirmed by PVCA (Figure 2.1).
Overall it is evident that batch effects have a large impact on gene expression variation. However,
fitting these as covariates in a linear model during the correction procedure removes the presence of
these batch effects (Figure 2.1B). This correction procedure (dataset (b)), which fits all batch effects
as individual factors in a linear model (see methods), removes the vast majority of associations with
batch effects in the principal components generated on the residuals (Figure 2.3B). There was only
one significant association with PC330 present in this corrected dataset, and that accounted ˜0% of the
variance, which explains why the variance attributed to batch effects was calculated to be zero with
PVCA (Figure 2.1B). Batch effects were also efficiently removed in datasets (c) and (d) which were
corrected for the first 25 PCs (68.4% of the variance), and 50 PCs (75.5% of the variance) (Figure
2.1C and Figure 2.1D respectively). However, there is still a 6% and 2% association to batch effects
in datasets (c) and (d) respectively, and analysis of PCs generated on these two datasets show many
components capturing these residual batch effects (Figure 2.3C and Figure 2.2D respectively). These
results indicate that PC correction does not remove known batch effects as efficiently as correcting
for chip ID, chip position, sex and generation with linear models.
Traditionally the last few PCs, which contain only a small fraction of the variance, are removed as
they are attributed to noise or experimental error [259]. However, the correlation structure present in
the dataset can drastically change which PCs are attributed to noise or batch effects [260]. In gene
expression data, it has been demonstrated that the final PCs contain genetically relevant information
[174, 261]. Due to the large variance that is due to batch effects [158], removal of PCs has recently
focused on the initial PCs (up to 50) that explain the majority of the variance [77, 157, 163, 165].
We have demonstrated that the initial PCs indeed have the highest association to these batch effects.
However, the variability in which PCs are associated with the batch effects (Figure 2.3A) makes it
difficult just to select an arbitrary number of components for normalization. Removing an uninformed
number of PCs could lead to inefficient correction as opposed to using linear models with recorded
batch effects. Other factors including biological information could be present alongside these artifacts
in these PCs although we acknowledge that additional batch effects, not recorded, may also be present.
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Figure 2.3: Batch effect associations to PCs. Significant values (after Bonferroni correction p <
0.05
335 ) are shown in red. (A) R
2 from a regression analysis of each PC on batch, sex and age effects in
a dataset that is not corrected for any of those factors. (B) R2 from a regression analysis of each PC
on the batch, sex and age effects in a dataset that is corrected for these factors. There is no significant
association to batch effects present. (C) Association to batch effects in a dataset corrected for the first
25 PCs. (D) Association for batch effects in dataset corrected for the first 50 PCs.
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2.4.2 Genetic contribution to PCs
To determine the total genetic component of the PCs that would be removed when using PC correction
(as in datasets (c)-(d)), heritabilities were estimated for all 335 PCs generated from the normalized
dataset (a) (see methods). The heritability estimates showed that there was a considerable genetic
component to nearly all 335 PCs generated (Figure 2.4). The mean heritability for all PCs was 0.429
(sd 0.1), and 0.39 (sd 0.13) for the first 50, demonstrating a large genetic component despite the strong
association with batch effects. Comparisons between models for AE and CE revealed a significant
association between the estimates of genetic (VgV p ) and common family effects (
Vc
V p ) with an R
2 of 0.08
(p = 8.57e-08) (Figure 2.5). The association between the estimates of the two models indicates that
there is a small amount of confounding between of measured genetic variance due to common family
effects. This would most likely result in heritability estimates that are slightly biased upwards [262].
Figure 2.4: Narrow-sense heritability estimates of each PC obtained from QTDT. These results
indicate that nearly all PCs hold genetic information.
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Figure 2.5: Correlation between additive genetic and common environmental factors.Significant
association (p = 8.57e-08 and R2=0.08) between the common environment and genetic components
estimated in an AC and AE models. The proportion of common environment variance was calculated
by dividing the variance attributed to common environment (Vc) by the total phenotypic variance
(Vp). The proportion of genetic variability (heritability) was calculated by dividing the additive ge-
netic component (Vg) by the total phenotypic variance (Vp). This result indicates that the heritability
estimates obtained are confounded with common environment variance and, therefore, inflated up-
wards by common family effects.
To assess the impact of linear model and PC correction on genetic variation, we estimated the heri-
tabilities of the 9,086 probes in the entire dataset of 860 individuals using the same four correction
methods (a)-(d) (see methods). Mean heritabilities for the 9,086 probes from the four normalization
strategies were 0.32, 0.23, 0.21 and 0.18 respectively (Figure 2.6). The high mean heritability from
strategy (a) is likely due to inflation from batch effects such as the date of RNA extraction, which
was performed in family groups and, therefore, could not be corrected without removing heritable
variation. With PC correction (c) and (d), there was a much higher proportion of zero heritability
probes as opposed to strategy (b). The lower mean estimate and the higher proportion of zero heri-
tability probes when correcting for 1-50 PCs suggests that PC correction has a much higher penalty
of genetic variation than linear model correction.
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Figure 2.6: Distribution of heritability estimates for 9,086 probes from four different correction
methods.Black - standard normalized, Red - standard normalization with linear model correction for
batch effects, Blue - corrected for batch effects using the first 25 PCs, Purple - corrected for batch
effects using the first 50 PCs. There is a drop in heritability using the correction methods; however,
this is more pronounced in the PC corrected dataset. The heritability estimates are constrained to zero
due to the nature of genetic variance component estimating in QTDT.
To investigate the impact of PC correction on eQTL detection, we ran a series of eQTL analyzes for
each probe in the unrelated BSGS datasets (a)-(d). Associated local and distal variants were extracted
at multiple FDR thresholds (Table 2.1). The results demonstrated a much higher number of both
local and distal eQTLs detected within the dataset corrected with linear models (b) as opposed to PC
corrected datasets (c) and (d). PC correction, however, enhanced eQTL detection when compared
to non-corrected datasets (a), likely reflecting a removal of false positives caused by batch effects.
The improved removal of batch effects in the PC50 (d) vs. PC25(c) corrected dataset (Figure 2.1 and
Figure 2.2) is also reflected by an increased number of local and distal eQTLs in dataset (d). These
same trends were also observed in our replication sample (CHDWB) (Table 2.1). The results from
these eQTL studies indicate that PC correction method negatively affects the number of eQTLs that
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can be detected within gene expression datasets.
Table 2.1: eQTL results for all four datasets (a-d) in two cohorts. Local regions were defined as
+/- 1MB either side of the TSS and distal as elsewhere in the genome. The numbers of probes with
local or distal associations significant at various study-wide FDR thresholds is provided for each of
the four correction methods. Study replicated in CHWBD
Dataset Dataset Position FDR = 0.2 FDR = 0.1 FDR = 0.05 FDR = 0.01 FDR = 0.001 FDR = 0.0001
BSGS a local 1586 840 596 449 349 273
BSGS a distal 8056 2144 170 99 75 56
BSGS b local 2824 1914 1746 1199 1005 848
BSGS b distal 9085 3025 490 264 218 183
BSGS c local 1676 929 650 502 402 316
BSGS c distal 9085 2530 254 137 104 88
BSGS d local 1707 1149 806 737 640 510
BSGS d distal 9085 2564 301 169 114 91
CHDWB a local 743 513 345 189 143 101
CHDWB a distal 8102 1249 90 51 22 9
CHDWB b local 1164 822 627 594 470 385
CHDWB b distal 8841 2076 388 215 136 141
CHDWB c local 815 597 373 252 207 168
CHDWB c distal 8234 1471 98 46 31 15
CHDWB d local 909 684 457 366 295 183
CHDWB d distal 8695 1538 152 120 86 27
To investigate loci driving genetic variation captured within PCs generated from dataset (a), we per-
formed a GWAS for each PC. The PCs were tested for association with 488,462 genotyped SNPs
using linear models implemented in Plink software [254]. At a study-wide significance level deter-
mined by Bonferroni correction (0.05 /(488,462 SNPs x 335 PCs) = 3x10−10), no significant SNPs
were found. We next examined the top SNPs that were significant after Bonferroni correction on each
PC (0.05 / 448,462 = 1.0x10−7). There were 23 SNPs that were significant at this threshold, and these
were confirmed using permutations (Table 2.2). The lack of genome-wide significant associations
could be attributed to the study not having enough power due to a small sample size [263]. Another
explanation is that the genetic variance attributed to PCs is highly polygenic. As multiple probes
are driving each PC (Figure 2.7B), the magnitude of different signals can prevent the detection of
individual SNPs effects.
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Figure 2.7: Selection of probes driving PCs. 2A) Maximum (blue) and minimum (black) eigenvector
values for each PC. The eigenvector values represent the extent of the correlation between a probe and
a PC, with 0 indicating no association. Selection of probes driving each PC is based on the optimal
number of probes for each PC that have the same eigenvector value cut-off. As multiple probes can
contribute a small amount of variance to each PC it is reasonable that a low cut off value can pick up
many of the significant probes driving each PC. Probes that have an eigenvector value of greater than
0.02 or less than -0.02 were selected for further biological enrichment analysis as this incorporated all
the maximally and minimally expressed probes in this section. (2B) Selection of probes at this cut-off
value enabled approximately similar numbers of probes to be selected for each PC. The slightly lower
number of probes that are selected in the initial PCs is due to the lower maximum and minimum
eigenvector values in these PCs as shown in (2A).
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Table 2.2: Results from the GWAS for each PC. Probes that were found to be significant after a Bonferroni correction (α = 0.05488,462 ) on each PC are
listed in this table. Though none of these are significant after correcting for all PCs, they are significant at an empirical p-value of 0.05 for each PC after
1000 permutations. PC - principal component, CHR - chromosome, SNP - SNP ID, BP - base pair, BETA - regression coefficient, STAT - Coefficient
T-statistic, P - Asymptotic p-value for t-statistic, EMP - empirical p-value after 1000 permutations, G LOC - the location (in relation to the gene) of the
SNP, GENE - genes nearby/containing the SNP, GENE DESC - description of the gene name.
PC CHR SNP BP BETA STAT P EMP G LOC GENE GENE DESC
22 10 rs11004899 56960734 3.754 5.487 8.14E-08 0.036 intron-variant PCDH15 protocadherin related 15
35 2 rs1516174 51724845 2.826 5.43 1.09E-07 0.049 intron-variant LOC730100 uncharacterized LOC730100
81 16 rs9673242 14078070 -3.404 -5.524 6.69E-08 0.021 intron-variant MKL2 MKL1/myocardin like 2
81 16 rs1004637 14113245 -3.404 -5.524 6.69E-08 0.021 intron-variant MKL2 MKL1/myocardin like 2
100 16 rs7190803 77375823 -1.444 -5.535 6.33E-08 0.021 intron-variant WWOX WW domain containing oxidoreductase
106 2 rs10497190 158347486 -1.741 -5.585 4.87E-08 0.021 intron-variant ACVR1 activin A receptor type 1
106 13 rs17072974 21351926 2.275 5.501 7.53E-08 0.027 upstream-variant-2KB LINC00424 long intergenic non-protein coding RNA 424
106 13 rs12428031 21355249 2.275 5.501 7.53E-08 0.027 intergenic LINC00424 long intergenic non-protein coding RNA 424
110 11 rs10501384 59950456 2.555 5.482 8.31E-08 0.033 intergenic MS4A14 Membrane Spanning 4-Domains A14
110 11 rs17542525 59958103 2.555 5.482 8.31E-08 0.033 intron-variant MS4A5 Membrane Spanning 4-Domains A14
119 8 rs4596672 88124581 -1.641 -5.488 8.23E-08 0.032 intron-variant CNBD1 cyclic nucleotide binding domain containing 1
119 8 rs2974279 88144159 -1.385 -5.517 6.95E-08 0.028 intron-variant CNBD1 cyclic nucleotide binding domain containing 1
156 1 rs825113 221564768 1.762 5.503 7.45E-08 0.026 intron-variant SUSD4 sushi domain containing 4
157 2 rs11674634 132055980 -1.305 -6.005 5.02E-09 0.004 intron-variant POTEI POTE ankyrin domain family member I
175 4 rs6848983 298010 1.736 5.71 2.50E-08 0.005 intergenic ZNF732 Zinc Finger Protein 732
214 5 rs1279627 55966337 -1.095 -5.562 5.50E-08 0.019 intergenic C5orf67 Chromosome 5 Open Reading Frame 67
225 10 rs7919814 109720733 -1.055 -5.502 7.52E-08 0.03 intron-variant LINC01435 long intergenic non-protein coding RNA 1435
245 8 rs17128272 19257994 -1.516 -5.449 9.85E-08 0.042 intron-variant SH2D4A SH2 domain containing 4A
323 9 rs10813262 30474037 1.542 5.538 6.22E-08 0.044 intergenic LINC01242 Long Intergenic Non-Protein Coding RNA 1242
323 9 rs4878432 30490252 1.542 5.538 6.22E-08 0.044 intergenic LINC01242 Long Intergenic Non-Protein Coding RNA 1242
323 9 rs7866981 30548222 1.568 5.639 3.65E-08 0.034 intergenic LINC01242 Long Intergenic Non-Protein Coding RNA 1242
324 14 rs10498517 64832534 1.619 6.112 2.74E-09 0.002 intergenic CTD-2509G16.5 Clone-based
324 14 rs4902382 64834310 1.44 5.662 3.24E-08 0.017 intergenic CTD-2509G16.5 Clone-based
2.4.3 Biological pathway analysis:
We next sought to evaluate if the first 50 PCs generated from dataset (a) contained linear combinations
of genes involved in an expression pathway. Pathway analysis was performed using DAVID Bioinfor-
matics Resources 6.7, Functional Annotation Tool [256] on the first 50 PCs (Table 2.3). For numerous
PCs we can demonstrate significant enrichment for multiple different KEGG pathways (FDR = 0.05).
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Table 2.3: Pathway analysis for the first 50 PCs. Pathway analysis for PC1-50 was performed using
DAVID Bioinformatics Resources 6.7, Functional Annotation Tool. PC = Principal Component, Term
= name of KEGG pathway, Count = count of probes in each hit, % = percentage of all submitted
probes that are present within the pathway, P= the p-value calculated using a modified Fisher’s exact
test for enrichment, FDR = correction of p-values using the Benjamini-Hochberg FDR method.
PC Term Count % P FDR
1 Ribosome 8 7.9 1x10−6 4.5x10−5
3 Fc gamma R-mediated phagocytosis 14 2.7 4.3x10−5 5.4x10−3
7 Porphyrin metabolism 7 1.5 1.6x10−4 2x10−2
8 Proteasome 12 2.6 2.7x10−7 4x10−5
8 Oxidative phosphorylation 18 3.9 1.2x10−6 8.7x10−5
8 Huntington’s disease 21 4.6 1.9x10−6 9x10−5
8 Parkinson’s disease 15 3.3 8.5x10−5 3.1x10−3
8 Alzheimer’s disease 15 3.3 1.1x10−3 3x10−2
12 Hematopoietic cell lineage 13 2.5 1.4x10−5 2x10−3
12 B cell receptor signaling pathway 10 1.9 5.6x10−4 3.8x10−2
12 Antigen processing and presentation 10 1.9 1.2x10−3 5.3x10−2
12 Graft-versus-host disease 7 1.3 1.3x10−3 4.4x10−2
12 Non-small cell lung cancer 8 1.5 1.5x10−3 4x10−2
12 Asthma 6 1.2 2x10−3 4.4x10−2
13 RNA degradation 11 2.3 1.3x10−5 1.8x10−3
13 Oxidative phosphorylation 15 3.1 7.8x10−5 5.6x10−3
13 Ribosome 11 2.3 5x10−4 2.4x10−2
18 Ribosome 14 2.9 9.4x10−7 1x10−4
24 B cell receptor signaling pathway 14 2.9 2x10−7 2.7x10−5
25 B cell receptor signaling pathway 11 2.2 1.1x10−4 1.6x10−2
2 Primary immunodeficiency 8 1.7 7.9x10−5 1.2x10−2
32 Oxidative phosphorylation 13 2.7 2.9x10−4 3.7x10−2
Immune function was the most common process with PC3, PC12, PC24, PC25 and PC26 all showing
significant enrichment for immune functional pathways. PC3 showed enrichment for Fc-gamma R-
mediated phagocytosis ( p = 5.4x10−3). PC12 showed enrichment for hematopoietic cell lineage (p
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= 2x10−3), B-cell receptor signaling (p = 3.8x10−2), graft-vs-host disease (p = 4.4x10−2), non-small
cell lung cancer ( p = 4x10−2) and asthma (p = 4.4x10−2 ). PC24 and PC25 were also enriched for
B-cell receptor signaling ( p = 2.7x10−5 and p = 1.6x10−2 respectively) and PC26 showed enrichment
for primary immunodeficiency ( p = 1.2x10−2). Metabolic processes were enriched in PC8, PC13 and
PC32. Enrichment for oxidative phosphorylation was found in PC8, PC13 and PC32 (p = 4x10−5,
p = 5.6x10−3 and p = 3.7x10−2). PC8 also showed enrichment for genes known to be involved in
susceptibility to Parkinson’s (p=3x10−3), Alzheimer’s (p = 3x10−3 ) and Huntington’s disease (p
= 9x10−5) and proteasomal components involved in peptide processing (p = 4x10−5). These brain
conditions have been linked to oxidative metabolic dysfunction, due to oxidative damage to neurons
[264–266] and neuronal energy deficiency [267] and also improper peptide processing that leads to
the build-up of amyloid plaques [268].
Enrichments for ribosomal components were found in PC1, PC13 and PC18 ( p = 4.5x10−5, p =
2.4x10−2 and p = 1x10−4). PC13 also showed enrichment for RNA degradation processes (p =
1.8x10−3). PC7 was enriched for porphyrin metabolism (p = 2x10−2) involved in heme biosynthe-
sis.Of the 11 PCs that showed a significant enrichment (1, 3, 7, 8, 12, 13, 18, 24, 25, 26 and 32),
most of them also demonstrated relatively high heritability estimates (0.4, 0.4, 0.58, 0.49, 0.4, 0.45,
0.37, 0.39, 0.57, 0.37, 0.49, respectively), with an average heritability of 0.45. These results together
demonstrate that biologically relevant and interesting probe enrichments are present within the first
50 PCs despite the high association with batch effects within the dataset.
2.5 Discussion
The removal of genetic variation alongside batch effects when using PC correction has been alluded
to, but never formally investigated, in several papers [77, 163, 165, 171]. Due to the unique study
design of BSGS, which contains both unrelated and family information, we can quantify the genetic
components driving each PC with two independent approaches: SNP association analysis and her-
itability estimates. From this, we have demonstrated that all PCs obtained from the decomposition
of a gene expression dataset contain relevant genetic information. Most importantly, we show that
the first 50 PCs, which have been removed in previously published papers to correct for batch ef-
fects [77, 157, 158, 163, 165, 169, 170] contain both a considerable proportion of genetic variation
influencing gene expression (Figure 2.4) and also an enrichment for biological networks. The consid-
erable genetic variation found within the initial PCs cautions against the removal of such components
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in the dataset due to the potential loss of genetic information.
We also show that batch effects are distributed across the first 59 PCs with varying effect sizes. As
these initial PCs contain a combination of both genetic and batch effects, there appears to be a trade-
off between removing batch effects and removing biologically relevant data when employing PC
correction. Removing higher number of PCs improves batch effect correction while at the same time
increasing the amount of genetic variation that is removed (Figure 2.6 and Table 2.1) and the removal
of a smaller number of PCs (as in some studies e.g. [164]) can lead to the incomplete removal of batch
effects. Whilst the exact proportions of genetic and batch effect variance observed in the PCs here
are unique to this dataset, similar patterns of variance distributions are expected to be present in other
high-throughput expression datasets.
PC correction became prevalent in gene expression studies after being used to correct for expression
heterogeneity by a method called Surrogate Variable Analysis (SVA) [170]. This method corrects for
noise in the dataset that is not accounted for by the primary variable of interest, which may be different
experimental conditions or genes. It has been demonstrated as an effective means of enhancing the
genetic signals of interest and minimizing false discovery rates. One fundamental difference between
SVA and PCA correction is that the principal components were generated on the residuals of the
data that was corrected for the primary variable of interest. These principal components contain
residual ’noise’ in the dataset and their subsequent removal enhanced the power to detect signals
associated with the primary variable. Later studies removed principal components from the whole
dataset without former corrections for variables of interest [77, 163–165]. We have demonstrated
here that this can remove genetically driven variation in the gene expression dataset that could be of
interest to the researcher, due to the ability of PCs to pick up multiple sources of variation [157,173].
As the PCs pick up linear combinations of factors in the dataset, they also have the power to detect
gene regulatory networks and co-expressed modules [247]. Gene regulatory networks have a con-
siderable impact on disease as opposed to single gene changes [234], as groups of genes are known
to interact and respond to environmental perturbations together [238]. These networks are made
up co-expressed gene modules that are robust to environmental changes and even different microar-
ray platforms [228]. Principal components have been used to quantify regulatory SNPs governing
metabolic networks in both yeast [226] and human data [233]. We observed in our dataset that there
was an enrichment for biological networks within the initial PCs. These were dominated by immune
function processes, which have been detected previously with clustering analysis of gene expression
data [228] as well as metabolic, ribosomal, protein and heme biosynthesis pathways. As these PCs
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also demonstrate a high heritability, this indicates that a considerable proportion of the variance in
these PCs is being explained by biological factors. The removal of such PCs to compensate for batch
effects would have led to the removal of this interesting information. It has also been demonstrated
previously that PC correction also removes a large proportion of covariance in a dataset, which could
constitute these gene networks and interactions [157].
Our results show that PC correction negatively impacts both average probe heritability (Figure 2.6)
and the number of eQTLs hits detected (Table 2.1). While the removal of a larger number of PCs
improved batch effect correction (Figure 2.1) and increased the number of eQTLs identified in the
dataset (Table 2.1), it had a much larger impact on mean probe heritability. This genetic variation
could be comprised of additional factors such as genetic covariance contributing to gene networks that
may not necessarily be found in an eQTL study. Linear model correction, on the other hand, demon-
strated superior eQTL detection and retained a much higher probe average heritability. Therefore, if
recorded processing dates are present, these values can be used to correct for batch effects in the data
by incorporating them as covariates in a linear model [172]. This improves eQTL detection [165]
but ensures that, unlike PC correction, large amounts genetic variance are not removed (Figure 2.6.
Strong associations with PCs explaining large proportions of variance in a dataset can be used to se-
lect for appropriate batch effects if a large number of different factors have been recorded [269]. We
demonstrate here that linear model correction also has the advantage over PC correction in that it is
more effective in correcting for known batch effects (Figure 2.3).
We have shown that the removal of PCs from gene expression datasets to correct for batch and en-
vironmental effects should be treated with caution, as many different sources of variation can be
present within them. This comes from the ability of PCs to detect many linear combinations of trait
values [261]. As it can be difficult to distinguish between which factors are driving the PCs without
the prior knowledge of the batch and environmental trends in the dataset, removal of PCs runs the
risk of removing biologically interesting data. However, removal of the first 50 PCs can sometimes
provide a useful method to account for technical artifacts that can lead to spurious associations when
no batch effects have been recorded. Our results here show that it is clearly preferable to record
such information during the generation of the data and correct for them using standard linear ap-
proaches [154].
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Chapter 3
Seasonal effects on gene expression
The work presented in this chapter has been published in:
Goldinger A, Shakhbazov K, Henders AK, McRae AF, Montgomery GW, Powell JE: Season effects
on gene expression. PloS One 2015, 10:e0126995
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3.1 Abstract
Many health conditions, ranging from psychiatric disorders to cardiovascular disease, display notable
seasonal variation in severity and onset. To understand the molecular processes underlying this phe-
nomenon, we have examined seasonal variation in the transcriptome of 606 healthy individuals. We
show that 74 transcripts associated with a 12-month seasonal cycle were enriched for processes in-
volved in DNA repair and binding. An additional 94 transcripts demonstrated significant seasonal
variability that was largely influenced by blood cell count levels.
These transcripts were enriched for immune function, protein production and specific cellular markers
for lymphocytes. Accordingly, cell counts for erythrocytes, platelets, neutrophils, monocytes and
CD19 cells demonstrated a significant association with a 12-month seasonal cycle.
These results show that seasonal variation is an important environmental regulator of gene expression
and blood cell composition. Notable changes in leukocyte counts and genes involved in immune
function indicate that immune cell physiology varies throughout the year in healthy individuals.
3.2 Introduction
The expression levels of the majority of transcripts are heritable [40, 42–44]. However, environ-
mental variation, which can be considered as 1-H2 contributes the largest source of variation [44].
Identifying and quantifying the influence of the environmental factors can provide a more thorough
understanding of the differences in expression levels between individuals and between populations.
Knowledge of environmental effects will also provide information on gene function and potentially
gene-environment interactions, which will aid in understanding how expression profiles are affected
by certain environmental conditions, such as geographical location [270].
One environmental factor that has a well-documented effect is seasonal variation. Changes in gene
regulation have been associated with seasonal effects such as photoperiod in animals [271, 272] and
plants [273, 274]. Previous research into the effect of seasonal variation has identified a relationship
between circannual patterns and clusters of genes, most likely stemming from seasonal variation in
blood cell counts [275].
Seasonal changes include, but are not limited to, differences in day length [276], Ultraviolet (UV)
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index [277], humidity [278] and temperature [279], all of which could potentially influence expres-
sion levels either independently or interactively. Several health conditions are affected by seasonal
changes, including asthma [280], cardiovascular disease [281], depression [282], diabetes [283], bipo-
lar disorder [284], schizophrenia [285] migraine [286] and multiple sclerosis [287, 288]. Environ-
mental changes between seasons also influence infection rates of influenza and respiratory syncytial
virus [289], and vitamin D deficiency has been attributed to seasonal UV changes [290, 291]. Ad-
ditional factors that can create seasonal trends in physiological state are behaviours changes such as
staying indoors [289], exercise [292] and diet [293].
Identifying genes, the expression levels of which change in response to the season could potentially
shed light on some of the mechanisms that might be driving these health conditions. Here we report
results from a systematic, genome-wide analysis of the effect of season on gene expression levels in a
human population. We identified significant blood cell count changes in erythrocytes, leukocytes, and
platelets associated with seasonality and enrichment for expressed cellular gene markers for lympho-
cytes. Furthermore, after correcting for blood cell counts, we identified 135 probes whose expression
levels were significantly associated with a 12-month seasonal cycle.
3.3 Materials and Methods
3.3.1 Samples
This study comprised of 606 individuals from 246 families in the BSGS [42]. Genotype, gene expres-
sion and cell counts were measured for each individual.
3.3.2 Genotyping
All individuals were genotyped on an Illumina 610-Quad Beadchip (Illumina Inc, San Diego, USA)
by the Scientific Services Division at deCODE Genetics, Iceland. Full details of the genotyping
procedure are given in [42].
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3.3.3 Gene expression
RNA levels were measured from whole blood collected with a PAXgeneTM tube (QIAGEN, Valencia,
USA). The expression levels were quantified on an Illumina HumanHT-12 v4.0 Beadchip. Samples
were randomized across the chip to minimize batch effects due to family, sex, and age. Full details
of the procedures used to generate the expression levels are given in [42]. Pre-processing of the
microarray data, including calculation of average bead signal, removal of outliers and the calculation
of detection p-values, was performed in the Illumina software Genome studio. Probes were considered
significantly expressed above background noise at a p<0.05. All probes falling below this threshold
were considered non-expressed and denoted as such for further analysis. Probes that did not map to
characterized Ref-Seq genes were removed. Probes with non-expression in > 50 of samples were
excluded, leaving 13,311 probes for further analysis.
3.3.4 Cell counts
Cell counts measured in BSGS include individual measures of single cell types, along with measures
representing a composite of multiple cell types. For example, total white blood count includes mea-
sures of several cell types such as monocytes, lymphocytes, basophils, neutrophils, and eosinophils.
We chose to correct for the individual blood cell types, rather than composite measures. The cell types
that were selected for correction were red blood cell (RBC), Platelet (PLT), Monocyte (MONO),
Basophil (BASO), Neutrophil (NEUT), Eosinophil (EOS), B-cell (CD19), Two subtypes of T-cell
(CD4), T-cell (CD8) and Natural Killer Cell (CD56). Cell counts were log transformed and converted
to z-scores. Linear regression was used to correct expression levels for effects due to the cellular
composition.
3.3.5 Normalization
A rank-based Inverse Normal Transformation (INT) was used to transform probe expression to a
normal distribution. The normalization was done using the R package GenABEL [294].
As the BSGS contains related individuals, the polygenetic (cryptic and family) effects were removed
by fitting the relationship matrix (A), determined using an Identity-By-State (IBS) Genomic Rela-
tionship Matrix (GRM) calculated in the software package, Genome-wide Complex Trait Analysis
(GCTA) [295]:
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y1 = g+ e1 (3.1)
Where g ∼ N(0,Aσ2g ) and e1 ∼ N(0, Iσ2e1). Variation in expression levels can be attributed to batch
effects such as chip and chip processing. Corrections were made for batch effects using (Equation
3.2):
y2 = Xβ +Zb+ e2 (3.2)
Where y2 = e1, Z is the incidence matrix for the chip ID fitted as a random effect (b) with b ∼
N(0, Iσ2b ) ande2 ∼ N(0, Iσ2e2). Fixed effect covariates (X) were selected from a list of recorded batch
effects using forward stepwise regression with model selection based on the lowest Akaike informa-
tion criterion (AIC). Covariates that had a significant association with gene expression levels included
chip position, age, sex, and length of sample storage, which is the difference between the date that the
tissue sample was collected and the date that the mRNA was extracted. The values calculated from
e2 (Equation 3.2)were used for further analysis and referred to as the ”uncorrected” dataset.
3.3.6 Cell count correction
The expression dataset was corrected for cell counts using (Equation 3.3):
y3 = Xβ + e3 (3.3)
Where y2 = e2, e3 ∼ N(0, Iσ2e3) and X is the fixed effect cell count covariates selected previously. The
values obtained in e3 (Equation 3.3) were used for further analysis and referred to as the ” corrected”
dataset.
3.3.7 Conversion to time series
BSGS tissue samples were collected over a six-year period, between February 2005 and March 2010.
Expression levels and cell counts were averaged by the month of sample collection, creating a monthly
time series for each probe. Of the 606 samples, 597 were collected between February 2005 and
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February 2008. The remaining nine samples, which were collected between March 2008 and March
2010, were excluded from further time series analysis due to the low number of samples per month.
3.3.8 Seasonal decomposition
The gene expression and cell count time series data were decomposed into seasonal (s), trend (t) and
error components (ε) using loess function [296].
y3 = g(t)+g(s)+ e3 (3.4)
Where y3 are the residuals, e2, from (Equation 3.3). g(s) and g(t) are estimated by loess smoothing
functions, which allow the estimation of repeating periodic variation without any constraint to a par-
ticular cyclical pattern. The trend component represents the overall changes that occur over the whole
time series.
3.3.9 Autocorrelation
Autocorrelation within time series data indicates the presence of periodic repeating patterns. A Ljung-
Box test [297] was used to test for significant levels of autocorrelation in the g(s) estimates:
Q= n(n+2)
h
∑
k
rk2
n− k (3.5)
Where n is the sample size, k is the lag, rk is the autocorrelation, and h is the number of lags [297].
The test statistic (Q) follows a chi-square distribution with h degrees of freedom.
3.3.10 Cosinor regression
Cyclic seasonal patterns, which have periodical cycles repeating over set time frames, can be modeled
by the cosine function:
f (t) = a× cos[(2pit
T
)−θ ] (3.6)
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where t = month (1-12 for January to December), T = time period (in months) over which the
cycle repeats, a = amplitude and θ = horizontal shift or phase of the cosine function [298]. This
transformation creates the cosinor regression model [299].
y4 = βo+β1× sin(2pitT )+β2× cos(
2pit
T
)+ e4 (3.7)
Where y4 = s, the seasonal component from (Equation 3.4). Cosine and sine curves with repeating
cycles (T ) of 12 months was fitted. Significance was determined with Analysis of Variance (ANOVA)
F-statistic and multiple testing accounted for using a Bonferroni correction.
3.3.11 Measured weather variables
The cosinor model was applied to following environmental variables that were recorded monthly:
mean maximum temperature, mean minimum temperature, mean daily ground minimum temperature,
mean rainfall, mean number of rainy days, maximum wind gust speed, mean daily sunshine, mean
daily solar exposure (MJ/m2), mean number of sunny days, mean number of cloudy days, and mean
daily evaporation (all obtained from the Australian Bureau of Meteorology - http://www.bom.gov.au/)
and mean UV levels (obtained from the Australian Radiation Protection and Nuclear Safety Agency
- http://www.arpansa.gov.au/). The association of weather variables to a 12-month repeating cosine
curve was determined with a Kendall tau rank correlation test. Kendall tau rank correlation is a
nonparametric test that determines dependence between two ordinal variables. Weather variables for
all samples are provided in (Table 3.1).
3.3.12 Biological enrichment analysis
Probes that demonstrated significant association to seasonal cyclic variation were tested for biological
enrichment using DAVID (v6.7) [256, 257]. Functional annotation clustering was used to identify
groups with shared annotation. Statistical significance of the clusters is given by an enrichment scores,
where a score >= 1.3 is equivalent to a p-value of 0.05. Molecular pathways were identified from the
KEGG pathway enrichment implemented by DAVID functional annotation tool. Significance of GO-
terms obtained from KEGG pathway enrichment and the functional annotation chart was determined
using modified the Fisher’s exact test [256, 257], corrected for multiple testing using the Benjamini-
Hochberg FDR [255].
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3.3.13 Blood cell specific markers
Enrichment for blood cell-specific markers was determined using the userListEnrichment() function
in the WGCNA R package [229]. This function compares the gene lists obtained from the seasonal
analysis to 11 other gene lists for known indicators of blood cell variation and batch effects found in
previously published studies. The lists include a 224,66,23,74,51,988,56 for B-cell, CD4, CD8 T-cell,
Natural Killer Cell (NK) cells, neutrophil, red blood cell and reticulocyte cellular abundance. Two
lists for platelets were present, which included 48 and 431 genes and a composite measure comprising
of 57 genes for lymphocytes, which includes B-cells, T-cells and NK cells. An additional list was
available which included 30 genes associated with the batch effect ”time of blood draw.” Significant
overlap between each list of genes and the cell markers was determined using a hypergeometric test.
Significant enrichment was determined by a study-wide significance threshold of p < 0.05/11 [300].
3.4 Results
3.4.1 Decomposition of time series data
The BSGS dataset [42], comprising gene expression levels for 606 individuals and 13,311 probes,
were decomposed into seasonal, trend and irregular (remainder) components using the loess smooth-
ing function (Figure 3.1 and Methods). This enabled regular cyclic components for each probe to be
isolated from residual or background noise.
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Figure 3.1: Time series decomposition for TRIM23 (ILMN 1752741) using loess decomposi-
tion.Original = The raw time-series data for the probe. Seasonal = The regular cyclic component.
Trend = The linear drift over time. Remainder = The irregular (error) component that is not explained
by the seasonal and trend components.
3.4.2 Effect of season on gene expression
Cosinor regression was used to test for the effect of season (based on when the expression levels
were sampled) for each of the time series adjusted probes. Cosinor regression is a linear model
with sine and cosine terms that estimate the parameters of repeating cyclic variation across multiple
phases (see Methods). To investigate the effect of season on blood cell counts, we performed the
cosinor regression analysis on expression levels that had been adjusted for cell counts (”corrected”,
see Methods) and unadjusted (”uncorrected”).
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Significant associations with season at study-wide threshold of p < 0.05/13,311 were identified for
169 (uncorrected) and 135 (corrected) probes (Table 3.1). The significant probes from these models
also demonstrated significant autocorrelation, an alternative statistical test for repeating patterns, in
160 (uncorrected) and 121 (corrected) probes (Table 3.1). Of these probes, 75 (approximately 50%
of the significant seasonal probes) were shared between the uncorrected and corrected datasets.
The probes that were significantly associated with season were located throughout the genome (Figure
3.2), indicating a diverse range of probes affected by seasonality. The mean proportion of phenotypic
variation in expression levels explained by the seasonal effect was 0.13 (uncorrected) 0.12 (corrected)
(Figure 3.3). The variance explained by the models (R2) values for probes with significant levels of
association were much higher with both corrected and uncorrected datasets having and R2of 0.59 for
(Table 3.1).
Table 3.1: Significant probes for the 12 month cosinor regression. Results for 12-month cosinor
model and autocorrelation on two datasets: not corrected (NC) and corrected (CC) for cell count.
Probes = number of significant probes for the 12-month cosinor model. E(R2) and Std(R2) = statistics
for the R2 values obtained from probes significant for the 12-month cosinor model. Autocorrelation
= The number of probes with significant autocorrelation.
Dataset Probes E(R2 ) Std(R2 ) Autcorrelation
NC 169 0.59 0.07 16
CC 135 0.59 0.07 121
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Figure 3.2: Manhattan plot of the cosinor seasonal analysis. The -log10(p) of each cosinor re-
gression model is plotted against the chromosomal location of each probe. Bonferroni correction
significance line is added. A) Not corrected for cell count B) Corrected for cell count. Includes
autosomal chromosomes 1-22, X(23), Y(24) and Mitochondrial(25).
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Figure 3.3: Histograms showing the distribution of the variance explained by the model.R2 Blue
denotes probes with a statistically significant association of gene expression levels and cyclic variation
A) Not corrected for cell count B) Corrected for cell count.
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3.4.3 Cell count seasonality
Cell counts for ten blood cell types representing distinct subgrouping in erythrocytes, platelets, gran-
ulocytes, monocular cells and lymphocytes were selected for an association with seasonal variation
using cosinor regression with a 12-month repeating cycle. Five cell types demonstrated a signifi-
cant association with season: Erythrocytes ( p=1.78e-3, R2=0.3), Platelets (p =5.46e-6, R2=0.51),
Neutrophils (p=4.41e-3, R2=0.27), Monocytes (p=1.58e-5, R2=0.48) and CD19 cells (p=4.89e-6,
R2=0.51). The R 2 value denotes how much variance in the cell counts the linear model explains.
The fitted 12-month seasonal cycle explained between 30-51% of variance in the cell counts. The
change in cell count levels throughout the year demonstrates differing seasonal highs and lows (Fig-
ure 3.4). The CD19 cells, Monocytes, and Platelets share a similar seasonal cycle that peaks in autumn
and drops in spring. Red blood cells and Neutrophils demonstrate a slightly shifted pattern peaking in
late winter/early spring and dropping in summer. These seasonal patterns have been reported before
for platelets [301] and red blood cells [302].
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Figure 3.4: Seasonal variation in cell count. Five cells types that demonstrate significant association
to seasonal variation (p < 0.0510 , Bonferroni correction). The black lines represent the fitted values in
a cosinor regression. The red lines represent the actual cell values. From these figures, it is evident
that the cells follow complex repeating patterns of peaks and troughs throughout the year. However,
it can be observed that they show a consistent seasonal trend following one clear peak and trough per
year. These values were collected over a three-year period and are plotted in sequential order. The
year of sample collection is labeled in the axis as a number (5-8) after the month, corresponding to
2005, 2006, 2007 and 2008 respectively.
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3.4.4 Environmental variables
The cosinor regression models a regular cyclic wave that represents natural seasonal variation. For 12
measured environmental conditions ranging from temperature to UV exposure, there was a significant
association with a 12 month repeating cosine curve (Figure 3.5) with tau-rank correlation coefficient
of τ ˜1 for temperature (ground, maximum and minimum), τ ˜0.7 for UV, clear days, cloudy days,
evaporation, rainy days, rainfall and solar exposure and τ ˜0.16 for wind speed and hours of sunshine
(Figure 3.5). The 12-month cycle closely represents environmental conditions, in particular tem-
perature, and could account the effect of seasonal environmental changes on gene expression levels
(Figure 3.5).
Figure 3.5: Standardized monthly values for 12 weather conditions. Measured weather variables
that exhibit seasonal variation in Brisbane (black dots and connecting lines). The red dots represent
the cosine curve with a 12-month repeating cycle.
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3.4.5 Enrichment analysis
We next sought to identify a shared biological function of genes exhibiting significant levels of cyclic
seasonal variation by performing an enrichment analysis using the DAVID [257].
DAVID Functional Annotation of the significant seasonal probes for the uncorrected dataset showed
enrichment for several KEGG pathways and GO terms related to immune function. This included a
number of autoimmune disorders (autoimmune thyroid disease (p=2.3e-3), type 1 diabetes (p =4.77e-
4), asthma (p=2.1e-4)), antigen process and presentation (p=1.97e-3) (Figure 3.6) cellular activation,
differentiation and development (cluster enrichment score 1.8) as well as Major Histocompatibility
Complex (MHC) class 2 immune response (cluster enrichment score 2.28) (Table 3.2). There was
also enrichment for protein production and modification including translation, post-translation modi-
fications and localizations (cluster enrichment score >1.4). Cellular components involved in protein
production, the endoplasmic reticulum (p=1.24e-3) and the Golgi apparatus membrane (cluster en-
richment score 1.44) were also enriched (Table 3.2). However, The significant seasonal probes for
the corrected dataset only showed enrichment for DNA repair and binding (Table 3.2), a pathway that
was also identified for the uncorrected seasonal probes.
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Figure 3.6: KEGG enriched pathway for Antigen Processing and Presentation. Significant sea-
sonal genes in our study are highlighted with red stars.
92
Table 3.2: Table C2C2: Biological enrichment for 12-month cosinor model. Dataset = Datasets
corrected (CC) and not-corrected (NC) for cell count. General process = Overall biological function
, Terms= GO terms or pathways, Significance = Determined with a Cluster Enrichment Score (CER)
or FDR corrected p-values
.
Dataset General process Terms Significance
CC DNA DNA repair CER= 1.68
CC DNA DNA binding CER= 1.5
NC Protein production and modification Acetylation p=3.21e-5
NC Protein production and modification Ubiquitin CER= 1.64
NC Protein production and modification Ribosome biogenesis CER= 1.48
NC Protein production and modification Protein localization CER= 1.46
NC Protein production and modification Translation CER= 1.44
NC Protein production and modification Peptidase activity CER= 1.42
NC Cellular component Endoplasmic reticulum p=1.24e-3
NC Cellular component Golgi apparatus membrane CER= 1.44
NC Immune response Allograph rejection p= 4.19E-4
NC Immune response Asthma p=0.00021
NC Immune response Intestinal immune network for IgA production p=4.29e-4
NC Immune response Type 1 diabetes mellitus p=4.77e-4
NC Immune response Autoimmune thyroid disease p=2.3e-3
NC Immune response Antigen processing and presentation p=1.97e-3
NC Immune response Lymphocyte differentiation CER= 1.6
NC Immune response Antigen processing and presentation CER= 1.5
NC Immune response Immune cell activation, differentiation & development CER= 1.8
NC Immune response MHC class two immune response pathways CER= 2.28
NC DNA DNA binding CER= 1.75
NC DNA Nucleotide metabolism CER= 1.67
NC Cellular function Apoptosis CER= 1.93
3.4.6 Cell-specific mRNA markers
As the expression levels were measured in whole blood, which is composed of many cell types, we
attempted to determine whether a specific cell type drove the seasonal expression patterns. Using the
userListEnrichment() function incorporated in the WGCNA R package, we tested 11 lists of different
blood cell markers for enrichment. This analysis revealed that the non-corrected seasonal probes
were significantly enriched for lymphocyte markers (Table 3.3) after Bonferroni correction (0.05/11
test sets). After correction for cell count, no association to any cell markers were observed, indicating
that cellular markers can reflect the cell counts present for the individuals. This demonstrates that
fluctuations in cell count can be observed within the transcriptome through the presence of specific
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cellular markers and also through the enrichment of seasonal genes involved in immune function.
Table 3.3: Gene list enrichment analysis for blood cells. . Enrichment for blood cell signature was
found using the userListEnrichment function in the WGCNA R package.
User Defined Categories Type No.
Genes
Corrected
p-values
Genes
Bcell Blood (composite) Blood 31 3.52E-06 BANK1, BCL11A, C22ORF13, C4ORF34,
CCDC106, CCR6, CD24, CD79A, CD79B,
CXXC5, CYBASC3, EIF2AK3, GJB6,
GNB5, HLA-DOA, HVCN1, ITPR1, IVD,
MEF2C, NOC3L, P2RY10, PACAP, PNOC,
SMARCB1, SP100, SPIB, TLR10, TPD52,
TTC21A, ZDHHC23, ZNF165
Lymphocytes
genesCorrelatedAcrossIndividuals
Whitney
Blood 11 3.20E-02 BTG1, CD74, CD79A, CSF1R, HLA-DMB,
HLA-DPA1, HLA-DRA, HLA-DRB4,
MS4A1, SPIB, TCL1A
3.4.7 Discussion
There are seasonal differences in the prevalence and severity of conditions such as psychiatric dis-
orders [280, 282, 284, 285, 303] and cardiovascular diseases [281, 304]. The effect of seasonal vari-
ability has also been recorded for several molecular phenotypes such as homovanillic acid [305],
serotonin [306, 307], monoamine neurotransmitters [308], 25-hydroxyvitamin D3 [309] and N-3
poly-unsaturated fatty acid [310]. Gene expression provides an intermediate phenotype between the
genome and higher order phenotypes such as metabolites and can provide clues as to the underlying
biological functions that are being altered in response to seasonal changes.
We investigated whole blood gene expression for seasonal variability in a cohort of 606 individuals.
Using cosinor regression models we were able to identify 135 probes (1% of all probes tested) that
showed significant seasonal variation after being corrected for blood cell composition. Significant
autocorrelation, an alternative statistical technique, was also identified for 90% of these probes further
confirming the presence of repeating cyclic trends in expression levels of numerous transcripts. To
examine how this impacts seasonal gene expression, we examined the expression levels with and
without corrections for cell counts.
Transcripts showing seasonal variation in the uncorrected data were enriched for immune pathways
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and protein production. The enriched KEGG immune pathways included (Table 3.2) allograph rejec-
tion, antigen processing and presentation (Figure 3.6), lymphocyte differentiation, immune cell acti-
vation, differentiation, and development, MHC class two immune response and autoimmune diseases;
type 1 diabetes, autoimmune thyroid disease, and asthma. The enrichment for immune responses
would indicate a reaction to a seasonal pathogen, of which influenza is one of the most prevalent. In-
fluenza outbreaks occur primarily in winter [289]. Influenza peaks are concordant with the significant
seasonal peaks (in late autumn/early winter) and troughs (mid to late spring) observed for MONO and
CD19 immune cells as well as for PLT. The autoimmune pathways enriched for these transcripts are
likely to represent diseases that arise from disorders in the same immune pathways used for fighting
pathogens. However, these pathways have also been shown to exhibit seasonal effects. Asthma also
displays similar seasonal trends with autumn peaks and summer troughs [311–313]. Type 2 diabetes
has demonstrated similar seasonal patterns, with the highest frequency of new patients occurring in
winter and the lowest in summer [314]. While documentation on the seasonal effect of autoimmune
thyroid disease is minimal, there is a link between the condition and vitamin D deficiencies [315].
Vitamin D serum levels can exhibit considerable seasonal variation, which can be related to seasonal
changes in sun exposure that are higher in summer months and lower in winter [316]. These results
suggest that seasonal variations in cell counts may be occurring in response to environmental stimuli
such as sun exposure and pathogen exposure, which in turn lead to the presence of various diseases.
Asthma is a chronic inflammatory disease condition, which has been observed to exhibit seasonal
variability [280], potentially through the cellular mechanisms identified here. Other cellular function,
such as protein modification and apoptosis, were found in the uncorrected gene expression dataset
(Table 3.2). There were 74 seasonally associated genes shared between the corrected and uncorrected
datasets, and these demonstrated enrichment with for DNA binding genes. The enrichment for DNA
binding among these seasonal transcripts suggests that transcripts encoding genes involved with DNA
binding experience significant seasonal variation, independent of seasonal fluctuations in cell count.
A previous study by De Jong et al. 2014 [275] identified three modules, comprising 5,062 probes
(mapping to 1,458 unique genes), that were associated with cyclic seasonal patterns. However, these
probes were primarily driven by changes in red blood cells and platelets [275]. Here, we did not
identify cell type specific gene signatures for red blood cells but instead identified enrichment for
leukocytes markers. This difference could be attributed to the single-gene approach we employed and
that we only shared 2,406 genes (18% of our dataset) with the De Jong et al. analysis [275].
Here have demonstrated that the 12-month cosinor regression has perfect correlation (τ ˜1) with tem-
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perature, a high correlation (τ ˜0.7) with UV index, number of clear, cloudy and rainy days, evapora-
tion, rainfall and solar exposure, and a low correlation (τ ˜0.16) for wind speed and hours of sunshine.
This relationship suggests that temperature could be an important factor driving the seasonal variation
in gene expression levels identified with the 12-month cosinor regression model.
A limitation of this study is that each time point represents the mean expression levels of a group
of samples collected during the same period. Therefore, estimates of effects represent population
variation, rather than intra-individual variation. To more accurately assess the impact of seasonal
environmental factors of gene expression, repeat measures should be collected for samples throughout
the year.
3.4.8 Conclusion
Our results demonstrate the effect of seasonality on cell count and gene expression levels. We ob-
serve that the cellular composition of erythrocytes, platelets and leukocytes varies throughout the
year, following seasonal patterns. This trend was also evident in gene expression levels, with signifi-
cant seasonal changes in the expression of genes involved in immune function and protein translation.
However, we are unable to determine the direct route of causation for these transcriptional changes.
Seasonal transcriptomic variation that are independent of cell counts, were enriched for DNA binding,
a biological process that is essential to transcriptional control. Collectively, our results show that sea-
sonality is an important environmental regulator of physiological processes, which can be identified
through transcriptional variation.
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Chapter 4
Common genetic control drives the co-expression of mRNA transcripts
4.1 Abstract
Amongst the expression levels of mRNA transcripts, there is an extensive correlation structure, arising
from the co-regulation of genes. Statistical and computation methods can be used to identify discrete
modules of systematically co-regulated transcripts, based on phenotypic correlations (rP), which form
networks that share biological processes and functions. These modules, robustly identified in previous
studies, have been utilized to classify individuals based on defined environmental and immunological
conditions. Here, we sought to determine if the rP driving the formation of expression modules is due
to common genetic regulation shared between pairs of transcripts. We firstly identified transcripts in
whole blood that comprise co-regulating modules of gene expression. Using the GREML estimation
method implemented in GCTA [22], we calculated significant heritability measures for the majority
of transcripts in the modules. We extended these methods to estimate the degree of shared genetic
control between pairs of transcripts - termed a rA. All pairs of transcripts within a module have
highly significant rA (p<0.001), suggesting that shared genetic control strongly influences expression
networks. Furthermore, we identified and replicated trans -eQTLs that were associated with two
or more transcripts within a given module, further supporting the evidence for shared genetic co-
regulation of transcripts within a module. Finally, we investigated tissue specificity of the genetic
control of co-regulation using expression levels measured in subcutaneous fat, LCLs, and skin. We
show that there is little evidence for shared genetic co-regulation across different tissues. Our results
provide strong evidence for the role of shared genetic variation in the coordination of regulation across
mRNA transcripts, acting in a tissue-specific manner.
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4.2 Introduction
The majority of Gene transcripts function together with other genes, either due to regulation by factors
such as miRNAs or TF or by shared functionalities that occur after translation, i.e., part of a metabolic
network. The prevalence of co-expressed genes within the transcriptome is indicative of vast networks
of co-regulated genes that interact with each other and share biological functionality. Computational
and statistical methods have been used to identify transcriptional networks, and use these to elucidate
some of the cellular processes underlying complex diseases and traits in humans [228, 317–320].
By using the covariance structure amongst the expression levels of transcripts, dimension reduction
methods [37,114,115,317] can identify modules of correlated genes [228,229,231,321–323]. Chauss-
abel et al. 2008 [114] used the correlation structure in peripheral-blood mononuclear cell (PBMC)
gene expression. Patterns of up and down regulation in modules were able to distinguish patients with
various degrees of disease activity from control patients in several conditions including Systemic Lu-
pus Erythematosus (SLE), melanoma, immunosuppression from liver transplantation, Streptococcus
pneumoniae infection, Crohn’s disease and ulcerative colitis [228]. Preininger et al. 2013 [114] estab-
lished that these 28 coexpressed disease modules were present in healthy individuals. The presence of
these axes in healthy individuals indicates that the architecture of gene expression variation is highly
structured and constrained along regulated axes of variation. A person’s transcriptomic values within
these axes of variation can provide value information on their metabolic or immune status that can
change over time depending on specific environmental conditions. These values can highlight a pre-
existing medical condition, indicate the degree of susceptibility to disease or can be used to map the
progression of an illness and response to drug treatments.
These modules were condensed down from 28 modules obtained in patients with various autoimmune
and bacterial infections [228]. Within two datasets of comprised of healthy individuals, the CHDWB
containing 189 samples and a study consisting of 208 samples from Morocco [270], these 28 modules
were condensed down into six distinct meta-modules. After correcting for these six modules in the
transcriptome, the authors identified three additional modules from the unexplained residual variance.
7,538 transcripts (out of 14,343 tested) were significantly associated (after Bonferroni correction) with
the first PC in one or more of the modules in both the CHDWB and Morocco dataset. In total, these
nine modules captured up to 39% and 51% of the total transcriptome variance in the CHDWB and
Morocco cohorts respectively [114].
Since these modules had demonstrated great utility in as a diagnostic procedure, Preininger et al.
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2013 [114] wanted to select a smaller number of representative SNPs for each module. The high
correlation structure present within these transcripts would mean that the selection of representative
transcripts is possible. One selection criteria for the representative transcripts was an association
with only one module. From this list, the transcripts with the highest correlation values became the
representative transcript for each module. These 90 probes had Pearson or phenotypic correlation
values >0.88 (px10−70 compared to the empirical null correlation values obtained from 10,000 sets
of randomly sampled transcripts) These transcripts were named blood informative transcripts (BITs).
This number of transcripts was sufficient to recreate the correlation structure (axes of variation) for
the entire module. The selection of ten transcripts per modules, 90 transcripts in total, is ideal for
the creation of a Real Time, Reverse Transcription Polymerase Chain Reaction (qRT-PCR) panel
applicable for use in a hospital or clinic.
These BITs showed promise as a diagnostic tool, classifying patients with latent and pulmonary
tuberculosis [114]. They could also classify individuals based on other environmental conditions,
such as different geographical location [114, 115], demonstrating the ability of the PCA axis scores
derived from each BITs module to classify individuals based on particular environmental condi-
tions [114, 115]. The gene expression variance of an individual can define their transcriptomic posi-
tion in the nine axes of variation. Preininger et al. 2013 hypothesized that an individuals’ position
on the axes could constitute a map to determine susceptibility to various types of diseases and condi-
tions [114].
The correlation structure of the nine modules was replicable in seven different datasets. The presence
of these strongly coexpressed genes suggests a robust regulatory mechanism driving the transcripts
of interest. Covariance between the transcripts arises from a combination of additive genetic and
environmental covariances (for the rest of the article, the term ”genetic” will refer to ”additive genetic”
variation), which is defined (assuming all genetic-environmental covariances are zero) as:
σP(x,y) = σA(x,y)+σE(x,y) (4.1)
Phenotypic correlations between transcripts (rP), is the metric employed by Chaussabel et al. 2008
[228] and Preininger et al. 2013 [114] to cluster genes into specific modules. The covariance between
two transcripts (σ2P(x,y) from Equation 4.1) can be written as a function of phenotypic(rP), genetic
(rA) and environmental (rE) correlations scaled by the covariance:
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rPσP(x,y) = rAσA(x,y)+ rEσE(x,y) (4.2)
The variance (self-covariance) measures of individual transcripts (σ2P(x)) can be decomposed into
corresponding genetic and environmental components as per Equation 4.2. Heritability (h2) is defined
as:
h2 =
σ2A
σ2P
(4.3)
e2 = 1−h2
e2 =
σ2E
σ2P
(4.4)
Taking the square root and rearranging Equation 4.3 and Equation 4.4 results in: σA = hσP and
σE = eσP, which can be substituted into Equation 4.2:
rPσPxσPy = rAhxhyσPxσPy+ rEexeyσPxσPy
rP = rAhxhy+ rEexey
(4.5)
rA ranges between {-1,1} and indicates the level of shared genetic variation between a pair of tran-
scripts. For example, an rA = 1 suggests that the same genetic variants influence the expression of the
two transcripts. The impact of rA on the measured covariance between two transcripts, rP, is deter-
mined by the degree of h2 between the two transcripts. The rA and h2 values can be estimated using
genetic relationship data from families or large samples of unrelated individuals [324].
Technical artifacts, such as batch effects, can be severe confounders in gene expression studies. The
application of appropriate statistical techniques can control systematic batch effects [44]. Since the
covariance structure of the nine BITs modules found in Preininger et al. 2013 [114] were replicated
in nine datasets, representing several populations, these modules are unlikely to be driven by random
batch effects. rE represents the degree of shared environmental effects and accounts for the remainder
of the phenotypic correlation (after the genetic correlation, scaled by heritability is removed). rE
are very broad measurements comprised of many factors including environmental conditions that
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influence two traits simultaneously.
In this paper, we quantified the degree of genetic and environmental contribution driving the high
covariance structure and rP between the BITs in each module. We estimated rA values in the BSGS
dataset [42] using 85 BITs across the nine modules (3528 transcript pairs). rP values between tran-
scripts is the standard measure used to detected covariance structures in transcriptomic data. Taking
the rP values between the BITs and composing them into their constituent genetic and environmen-
tal components, provides a fresh approach to understanding the regulatory architecture that underlies
gene co-expression.
We found that it was indeed a high genetic component that was driving the BIT modules with high
rA values found across all modules in the BSGS dataset. Interrogating validated eQTL databases
from previous studies [57], we identified 13 previously replicated trans-eSNPs as the physical loci
driving the high rA estimates between BITs in blood. The BITs also demonstrated enrichment for TFs,
indicating that TFs provide the mobile medium regulating genes across the genome. We next wanted
to determine whether this modular structure was present in other tissues. We examined the presences
of the modules in three additional tissue types, lymphoblastoid cell lines (LCLs), subcutaneous fat and
skin from the MuTHER cohort. From this, we found that the vast majority of modules demonstrated
tissues specificity to blood. Two modules (four and six), however, were present in all four tissues.
These results show that the modules comprising of BIT represent biologically relevant covariance
structures that are regulated by genes and represent distinct cellular processes that are both tissue
specific and non-specific.
4.3 Materials and Methods
4.3.1 Brisbane Systems Genetics Study
BSGS comprises of 846 individuals from 274 extended twin families, recruited as part of the Brisbane
Twin Nevus and cognition studies [42]. The QIMR Berghofer Medical Research Institute’s human
research ethics committee approved these studies, and all participants gave informed written consent.
Genotyping was performed on Illumina 610-Quad Beadchips (Illumina Inc, San Diego CA) by the
Scientific Services Division at deCODE Genetics, Iceland. Full genotyping procedures are described
in [325].
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Whole blood was collected using a PAXgeneTM tube (QIAGEN, Valencia, CA) and RNA was ex-
tracted using the whole blood gene RNA purification kit (QIAGEN, Valencia, CA). The RNA expres-
sion levels were measured on Illumina Human HT-12 v4.0 Beadchips (Illumina Inc, San Diego CA).
The samples were randomized across microarray chips to minimize batch effects. Full details of the
RNA extraction and quantification can be found in [42].
4.3.2 Normalization
Average bead signal and detection p-values were calculated with Genome Studio software. Probes
with a detection p-value < 0.05 were considered significantly expressed above background noise, and
any probe with non-expression in > 50% of samples were excluded. Likewise, probes that did not
map to a characterized Ref-Seq gene were removed, leaving 13,306 probes for further analysis.
Two corrected datasets were used in this analysis. Dataset ε1 from Equation 4.6 was corrected for
batch effects, including chip position and ID, sex and age effects as fixed effects (X) in a linear model
(Equation 4.6). This dataset was used for estimations for heritability and genetic correlations.
y= Xβ + ε1 (4.6)
Since the BSGS [42] cohort contains related individuals, which facilities the estimation of genetic
components, the samples do not meet the independently and identically distribution (iid) assumption
underlying phenotypic correlations (rP). A mixed model with a random additive polygenetic effect (g
) corrected for relatedness and created an iid dataset:
y= Xβ +g+ ε2 (4.7)
With g ∼ N(0,Aσ2g ) and ε ∼ N(0, Iσ2ε ). Where y is a nx1 vector of the expression levels of a probe,
and n is the sample size. g is a nx1 vector containing the estimated total additive genetic effects
from all SNPs, and A is a genomic relationship matrix (GRM) created using a SNP-based identity
by state method [22, 295]. The resulting σ2g was estimated using Restricted Maximum Likelihood
(REML) implemented in GCTA [295]. Residuals ε1 and ε2 were normalized by a Blom rank-based
transformation [326,327], ensuring that the expression levels for each probe follow a standard normal
distribution.
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4.3.3 Multiple Tissue Human Expression Resource
The MuTHER dataset comprises of gene expression and genotype data from healthy female twins
with mRNA collected from three tissues: LCLs, (n=777), skin (n =705) and subcutaneous fat (n=776).
The MuTHER consortium supplied raw, non-normalized gene expression data, and imputed genotype
data. Gene expression levels were quantified using Illumina HT12 v3.0 Beadarrays and samples geno-
typed on Illumina 1M-Duo and 1.2M Duo chips. Details of the sample collection, RNA extraction
and genotyping can be found in [182].
We performed the same sample quality control and normalization procedures as applied to the BSGS
cohort. Initially, probes that did not map to Refseq genes were removed, and remaining probes trans-
formed to the log2 scale, followed by quantile normalized to standardize the variance across indi-
viduals. Batch effects, consisting of microarray run, were corrected using a linear model (Equation
4.6). Polygenic effects were corrected for with a GRM in a linear mixed model as per Equation 4.7
to ensure independent samples for rP calculations. The residuals were scaled to a normal distribution
using a Bloom rank transformation [326, 327].
4.3.4 Modules
The 90 BITs identified in [114] were analysed in this dataset. In the BSGS cohort, 85 of the transcripts
were present after appropriate quality control (Table 4.3, Table 4.5, see Normalisation, Methods). In
the MuTHER cohort [182], all 90 transcripts were ability for analysis.
The presence of the modules was confirmed in Preininger et al. [114] through the replicable high
correlation values between the transcripts. We established the presence or significance of the modules
across the tissues based on the null empirical values obtained in blood. The empirical values were
collected through bootstrap resampling as described in section 4.3.6 and 4.3.7. We chose to use the
upper bound of this empirical estimate, the mean plus standard error, as the metric to measure the
presence of a module for both phenotypic and genetic correlation values.
The GO term enrichments described in this chapter for the BIT modules were published in Preininger
et al. [114]. All transcripts associated with the modules were used in the enrichment analysis to
increase the power to detect enrichments.
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4.3.5 Heritability of gene expression
The narrow sense heritability (h2) is a measure of the proportion of total additive genetic variance in
each trait over the total phenotypic variance. h2 is estimated by fitting the following linear model in
GCTA:
y= g+ ε (4.8)
With g ∼ N(0,Gσ2g ) and ε ∼ N(0, Iσ2ε ). yis a vector containing the adjusted phenotypes in (ε) from
(Equation 4.6), is a vector of random polygenic effects and ε is a vector of residuals. G is a genomic
relationship matrix obtained from SNP-based IBS calculations (A from Equation 4.6) with a threshold
(IBS > 0.05) where all values below that specified threshold were set to 0. This leaves an approximate
IBD matrix that focuses on closely related individuals [328].
4.3.6 Phenotypic Correlations
Phenotypic correlations (rP) were calculated for each pair of BITs in a module using Pearson corre-
lations. rP was calculated on the BSGS and MuTHER datasets corrected for polygenic effects (ε2)
(Equation 4.7) to ensure independent samples. To calculate the significance of module correlation
values, we took all the correlation values between probes in the BIT modules and performed a Wilcox
signed rank test with the same number of correlation values from randomly sampled probes. rP values
calculated from modules comprised of ten probes randomly sampled from the whole transcriptome
enabled the calculation of the empirical p-values for rP. This sampling was repeating 10,000 times
with replacement. The empirical p-value was calculated as the number of p-values≤ the nominal test
p-value divided by 10,001 tests.
4.3.7 Genetic Correlations
Genetic correlations (rA) were estimated using the bivariate linear mixed model. Equation 4.8 is fitted
for transcripts x and y. The variance-covariance matrix (V) is defined as:
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V =
Gσ2gx + Iσ2ex Gσgygx
Gσgxgy Gσ2gy + Iσ
2
ey
 (4.9)
where gx,y and ex,y represents the genetic and environmental variances of transcripts x and y respec-
tively. The estimation of rA between the probes was carried out using GCTA software [295,324]. The
bootstrapping method described in section 4.3.6 to calculate the null empirical value of rP was used
to calculate null empirical value for rA.
4.3.8 Proportion of phenotypic correlation explained by genetic effects
rP is driven by both genetic and environmental components (Equation 4.5). The total genetic contri-
bution to rP is a combination of rA, scaled by the square root of the narrow-sense heritability of the
two transcripts measured (hxhy)).
The environmental component can be calculated as the remainder after the additive heritability has
been accounted for and can comprise of various environmental factors and non-additive genetic ef-
fects. The contribution of environmental effects can be calculated as rE scaled by the square root
of the environmental remainder (ex) of the two traits (i.e. ex =
√
1−h2x). The proportion of genetic
components driving rP are calculated as follows:
pA =
|rAhxhy|
|rAhxhy|+ |rEexey|
pE =
|rEhxhy|
|rAhxhy|+ |rEexey|
(4.10)
The proportion of rP driven by rA (pA) was estimated for each module using the expected values
across all transcripts in a module. Therefore Equation 4.10 was modified to
pˆA =
|E(rA)E(h2)|
|E(rA)E(h2)|+|E(rE)(1−E(h2))| and pˆA measures were used throughout the article.
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4.3.9 eQTL analysis
eQTLs summary data was collected from the blood eQTL browser
(http://genenetwork.nl/bloodeqtlbrowser/) [57]. EQTLs that occur within +/-1MB of the Transcrip-
tion Start Site (TSS) are called local-eQTLs while eQTLs located elsewhere are termed trans-eQTLs
[2]. Due to the location close to the gene of interest, local eQTLs are likely to arise from disrup-
tions in the regulatory regions of the genes, particularly in the binding sites of transcription factors,
RNA polymerase and other proteins involved in RNA transcription. The presence of long-range act-
ing elements can potentially blur the boundaries between distal and local eQTLs occurring on the
same chromosome [329]. Distal eQTLs can result from transcription factors or other genes that are
involved in regulating the transcripts of interest and affect both alleles of the target gene. We ex-
amined the transcripts in this study for known local and distal eQTL associations from a replicated
meta-analysis performed in whole blood samples of 5,311 individuals and replicated in a further 2,775
individuals [57]. The authors performed this eQTL analysis by testing 15,578 transcripts for associ-
ations with SNPs previously identified as GWAS hits. The focus only on GWAS hits help to narrow
the focus of the study to biologically-relevant SNPs and reduced the power to detect and replicated
association. Local and distal eSNPs were considered significant at an FDR < 0.05 in [57] and also
within this study.
The LD between significant local and distal eSNP was calculated using the online tool SNP Anno-
tation and Proxy search (SNAP) [330]. The chromosomal region and the LD between eSNPs were
plotted using LocusZoom [331]. The National Human Genome Research Institute (NHGRI) GWAS
Catalog was used to determine which GWAS phenotype the shared eSNPs belonged to [332].
Next, we wanted to estimate the significance of the number of common eSNPs obtained. To calculate
significance, we counted the number of shared eSNPs per module of ten transcripts that would be
expected by chance from sampling the Westra et al. 2013 [57] eQTL database. We re-sampled sets of
ten transcripts that were present in the Westra et al. 2013 [57] eQTL database and recorded how many
times a significant eSNP (FDR < 0.05) was shared between two or more transcripts in that randomly
generated module. This sampling procedure was repeated 10,000 times to create an empirical null
estimate of the number of common probes expected by chance within a module.
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4.3.10 Transcription factor enrichment
Vaquerizas et al [1] published results of 1,391 manually curated sequence-specific DNA binding tran-
scription factors. This study published tissue-specific regulation of the transcription factors and the
Interpro DNA-binding family. We interrogated this list of known transcripts factors for the occurrence
of the BITs. A Fisher’s exact test was used to calculate significance of enrichment for transcription
factors in the modules. This contingency table (Table 4.2 (a)) contained: (a) the number transcription
factors found amongst the BITs, (b) 1,391 known transcription factors in the genome [1] - a , (c ) 90
BITs - a and (d) The approximate 140,000 transcripts that are known in the genome [333–335] - (b
and c). Enrichment analysis for the individual modules was also performed where (c) is 10-a (Table
4.2 (b)).
4.4 Results
4.4.1 Defining the presence of modules using phenotypic correlations
The nine modules which are driven up ten highly co-expression probes, the BITs, were discovered
from decomposing 28 transcriptomic modules that previously associated with changes in diseases
such as SLE [228]. Within healthy individuals, these modules these 28 modules of transcripts coa-
lesced into six meta-modules. After correcting for these six meta-modules, the authors identified an
additional three modules independently. 90 transcripts, called BITs, (10 per module), were selected
to represent all transcripts within a module [114]. These modules were replicated in nine independent
data sets.
All the gene expression data sets involved in identifying and replicating the modules were whole
blood. Between these five studies, the between or intra-module correlation values changed drastically,
indicating a further connection between the modules does not exist. The changes in intra-module cor-
relation values represent shifts in the technical generation of the data, sources of blood, platforms
or environmental conditions. The BIT transcripts that make up the modules are the only transcripts
with correlations that remain the same between different studies and conditions. While some mod-
ules appeared to condense into meta-modules in one study, other studies did not replicate this effect.
Therefore it is the specific co-expression within the modules, as defined by the BITs, which is vali-
dated and examined in this study.
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Extensive co-expression (rP) structures are ubiquitous in transcriptomic datasets. This co-expression
between genes is often attributed to shared functionality within transcripts, arising from gene networks
or protein complexes. By decomposing the rP into the constituent rA and rE values we can gain an
understanding of the mechanisms of that are driving this covariance structure between transcripts. We
employed the BSGS, a data set comprised of 846 unrelated and related individuals with whole blood
microarray samples to quantify the degree of co-regulation driving these transcripts.
Initially, we verified the presence of the modules within the BSGS cohort and by examining the
pairwise phenotypic correlations (rP) between BITs within the nine modules (Table 4.2, Table 4.1).
As expected, on average probe pairs within modules exhibit positive rP (0.36 - 0.89, mean 0.64)
(Figure 4.1A, Table 4.2).
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Table 4.1: Table of BIT transcript information. Gene name, Illumina ID, starting base pair (BP)
and chromosome (CHR) of the BIT probes
Module Gene Probe Illumina ID BP CHR
1 BIN1 ILMN 2309245 127805917 2
1 C5ORF39 ILMN 2098616 43075279 5
1 DDX24 ILMN 1700628 94517543 14
1 GLTSCR2 ILMN 1703565 52951763 19
1 IMP3 ILMN 1733696 73718651 15
1 LAGE3 ILMN 1708151 153706351 23
1 LIME1 ILMN 2183687 61840848 20
1 OCIAD2 ILMN 1700306 48887582 4
1 SAE1 ILMN 1657204 52405148 19
1 SNRPD2 ILMN 2369785 50882589 19
2 EPB42 ILMN 1814397 41276900 15
2 GMPR ILMN 1729487 16403382 6
2 IFIT1L ILMN 1759155 91134663 10
2 OR2W3 ILMN 1811927 246126108 1
2 SELENBP1 ILMN 1680652 151337014 1
2 SLC4A1 ILMN 1772809 39682702 17
2 SLC6A10P ILMN 1704446 32888901 16
2 SNCA ILMN 1766165 90869394 4
2 TNS1 ILMN 1807919 218375994 2
3 AFF3 ILMN 1775235 100163843 2
3 BLK ILMN 1668277 11420520 8
3 CD19 ILMN 1782704 28857792 16
3 CD72 ILMN 1723004 35600249 9
3 CD79A ILMN 1734878 42385350 19
3 EBF1 ILMN 1778681 158058476 5
3 FAM129C ILMN 1664063 17525344 19
3 FCRLA ILMN 1691071 159950596 1
3 POU2AF1 ILMN 1811049 110728486 11
3 VPREB3 ILMN 1700147 22425107 22
4 BCLAF1 ILMN 2357272 136622495 6
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Module Gene Probe Illumina ID BP CHR
4 DYRK1A ILMN 2374293 37808642 21
4 HNRPK ILMN 2378048 85773503 9
4 NPTN ILMN 1792997 71639809 15
4 PAPD4 ILMN 1681845 79017369 5
4 SLK ILMN 1700834 105763023 10
4 SRP54 ILMN 2312275 34568048 14
4 TRIM33 ILMN 1682316 114935759 1
4 WASPIP ILMN 1668417 175133267 2
4 ZFAND5 ILMN 1795228 74159604 9
5 CXCR1 ILMN 1662524 219027895 2
5 C5AR1 ILMN 1689836 47824990 19
5 NUP214 ILMN 1666049 133097510 9
5 AQP9 ILMN 1715068 56265152 15
5 PHC2 ILMN 1808047 33789971 1
5 SIRPA ILMN 2372974 1868085 20
5 TSEN34 ILMN 2368292 59389241 19
5 MBOAT7 ILMN 1722218 59369210 19
5 HCK ILMN 1791771 30153066 20
5 AMICA1 ILMN 1778723 117570158 11
6 USP49 ILMN 1680279 41873670 6
6 ZNF14 ILMN 1692145 19821836 19
6 DTWD2 ILMN 2054554 NA NA
6 NLRP8 ILMN 2075794 56499648 19
6 BLZF1 ILMN 2106658 167632205 1
6 DMC1 ILMN 2162367 38915178 22
6 N4BP2 ILMN 2222101 39833337 4
6 ZNF682 ILMN 2313889 20116068 19
6 OCIAD1 ILMN 2330495 48558245 4
6 IL17RD ILMN 2407851 57099591 3
7 IFIT2 ILMN 1739428 91058378 10
7 HERC5 ILMN 1729749 89427202 4
7 RSAD2 ILMN 1657871 6954552 2
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Module Gene Probe Illumina ID BP CHR
7 EPSTI1 ILMN 2388547 43462293 13
7 OAS3 ILMN 1745397 111894837 12
7 IRF7 ILMN 2349061 613117 11
7 SAMD9L ILMN 1799467 92759562 7
7 SERPING1 ILMN 1670305 57138571 11
7 MX1 ILMN 1662358 41752921 21
7 DDX58 ILMN 1797001 32467874 9
8 HERPUD2 ILMN 2066348 35638909 7
8 CD164 ILMN 1783852 109794680 6
8 HIF1A ILMN 2379788 61284383 14
8 SERINC3 ILMN 1713752 43127901 20
8 MCTS1 ILMN 1751816 119628902 23
8 PPP3CA ILMN 2044226 102163876 4
8 TMEM167A ILMN 1742813 82388598 5
8 ROCK1 ILMN 1739583 18529964 18
8 SP3 ILMN 2389844 174773391 2
9 GRB2 ILMN 1748797 70833600 17
9 PTPRC ILMN 2340217 196875068 1
9 TMED4 ILMN 1804148 44619131 7
9 PTPRC ILMN 1653652 196875072 1
9 PLEKHB2 ILMN 1698323 131606970 2
9 SLA ILMN 2291954 134156378 8
9 MCL1 ILMN 1756806 150550866 1
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Table 4.2: Summary of values for each module in Blood in the BSGS cohort.Values are averaged across all transcripts within a module. Information is
provided for BIT heritability (h2), Phenotypic correlations (rP) , Genetic correlations (rA)) and Shared genetic associations. Values provided are the mean
or expected value (E), standard error (SE) and p-value (p-val). The column ”Number of probes” shows the number of BIT probes that were available for
analysis in the BSBS cohort after QC. The column ”Number of probes with significant h2” shows how many BITs in the BSGS cohort had significant
h2 estimates. The column ”eSNPs” lists all the SNPs that were significantly (FDR < 0.05) associated with BIT in this module. The column ”eQTLs”
contains the number of independent regions (groups of eSNPs in high LD with each other) that were associated with the BIT in this module. For example,
in module nine eSNPs made up one eQTL associated with two transcripts and two eSNPs made up another eQTL associated with three transcripts.
Module information Probe heritability Phenotypic Correlations Genetic Correlations Shared genetic associations
Module Number of probes E(h2) SE(h2)
Number of probes
with significant h2 E(rP) SE(rP) p-val(rP) E(rA) SE(rA) eSNPs eQTL
1 10 0.28 0.04 10 0.6 0.02 2x10−4 0.6 0.03 0 0
2 9 0.46 0.01 9 0.81 0.009 1x10−4 0.82 0.02 11 2
3 10 0.47 0.02 10 0.65 0.02 1x10−4 0.88 0.01 0
4 10 0.3 0.02 10 0.65 0.015 1x10−4 0.72 0.03 0 0
5 10 0.38 0.02 10 0.52 0.016 1x10−4 0.62 0.02 0 0
6 10 0.35 0.01 10 0.89 0.014 1x10−4 0.96 0.01 0 0
7 10 0.3 0.03 9 0.73 0.014 2x10−4 0.73 0.02 2 1
8 9 0.19 0.03 8 0.51 0.022 2x10−3 0.62 0.04 0 0
9 7 0.48 0.05 7 0.35 0.042 5x10−2 0.56 0.06 0 0
Figure 4.1: These graphs are a visual representation of the correlation values between module
probes in the BSGS dataset. Panels A, B, and C are heat maps for the correlation matrices for A)
phenotypic (rP), B) genetic (rA) and C) environmental (rE) value between all pairs of the BIT probes.
The BITs are ordered from module one to nine. Red values represent high correlation values (˜1) and
blue values represent low correlation values (˜-1). In all of the heat map plots below, the intra-module
correlation values are all highly positive, demonstrating their unique correlational structure captured
by the BITs. There are many low to moderate intra-module correlations, showing similarity between
the modules. These values, however, are not pertinent to the module identity, for reasons described
in section 4.4.1. Panel D represents the values from panels A, B, and C as boxplots. Modules are
ordered on the x-axis with ”R” representing the empirical null values for the modules, collected from
10,000 randomly sampled transcripts. From D) this is evident that the correlation values in all the
modules are higher than what would be expected by chance. This graph shows that rA values are the
highest for all modules, while the rP and rE approximately the same.
To robustly evaluate the significance of the intra-module rP we created an empirical distribution of
intra-module mean rP by calculating the mean rP from randomly sampled sets of ten probes (Figure
4.1D). The bootstrap sampling enabled the estimation of the mean and sampling variance of intra-
module rP, also known as the empirical null value. For blood the empirical null rP was 0.07 with
a standard error of 0.03. Using the upper bound on the empirical null estimation (mean + standard
error), we determined the presence of a module when the rP > 0.1.
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Although not all of the BIT made it through QC in the BSGS dataset, all of the nine modules were
present in the BSGS cohort having between 7-10 transcripts present. The correlation values between
the transcripts in the BSGS modules were statistically significant (p< 0.05), compared to the empirical
null (Table 4.2). We investigated the presence of modules in skin, LCLs and subcutaneous fat from
the MuTHER cohort (˜700 samples) [182] (Figure 4.2F and Table 4.3).
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Figure 4.2: Stacked histogram comparisons across all modules and tissues. (A) Heritability (B)
Phenotypic correlations, (C) Genetic correlations, (D) Environmental correlations, (E) Proportion of
phenotypic correlation ( pˆA) attributed to genetics and (F) Modules that are present. The y-axis of
the graph is scaled to 1 so that the contribution of each tissue can be easily visualized. The actual
correlation values are labeled on the graph. In (F) 1 means the presence of a module based on the
empirical null value on phenotypic correlations (all modules are significant when examining genetic
correlations). The parts of the graph that are hashed out represent modules that are not significant
using the modules minimum method for that particular measure. In (F) the hashed out values are the
modules that are not considered to be present overall - based module minimum genetic correlations.
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The average rP was lower for all tissues except for blood, and some modules did not demonstrate
covariance higher than the empirical mean calculated within the BSGS cohort. Modules 4, 6-9, were
present across all four tissues (rP >0.1). Module 1 was present across three tissues (blood, fat and
LCL), Module 3 (blood, LCL) and 5 (blood, fat) are present across two tissues and Module 2 was
only present within blood.
4.4.2 Genetic contribution
The rA values for blood ranged between 0.56 (module 9) and 0.96 (module 6) with an average of
0.64 indicating that between half to nearly all of the genetic variance (h2) driving transcripts is shared
between transcripts. We performed a bootstrap analysis of 10,000 randomly sampled transcripts to
identify the empirical null rA (0.06 with a standard error of 0.05). We used the upper bound of this
estimate rA ¿ 0.11 (empirical null rA + standard error), as the measure to determine whether module
rA values are notable across the tissues. We calculated the significance of the BSGS dataset using the
values from 10,000 bootstrap analysis and found that all the rA across the modules were significant
(p <0.05). The significant rA values found in the blood modules indicates that the same loci are
controlling all the transcripts within the module. This of interest since the BIT transcripts are located
across the genome and not clustered in specific hotspots. Therefore the shared loci must be exerting
their effects distally.
The contribution of rA to the rP, is dependent on the h2 of the transcripts (Equation 4.5 and Equation
4.10). The average BIT h2 in blood is 0.36, which indicates that genetic regulation controls just under
half of the transcript variability. The average proportion of genetic contribution to rP, pˆA (see 4.3.8),
is 0.42, ranging from 0.28 in Module 1 to 0.75 in Module 9. The remainder of the variance is driven
by environmental variation (e2), with an average rE of 0.58 between the BITs in the modules. While
the genetic component driving the measured rP in the modules is high, these values also indicate the
presence of coordinated environmental responses. The genetic coexpression could build a framework
that enables simultaneous transcript responses to environmental stimuli.
pˆA were marginally higher in LCLs than blood, 0.46 on average. The range of these values, however,
extended to values that were lower than those found in blood modules (0.16 in module 4) and less
than the maximum found in blood (0.66 in module 8). h2 estimates that are higher than blood (0.4
BITs average) and lower rE measures (0.28 BITs average) could drive the larger pˆA values in LCL
modules. Therefore a high pˆA estimate for a module indicates that the rP is widely driven by rA,
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which is influenced by a large h2 or particularly low rE values.
Skin demonstrated a pˆA that was similar to blood, with an average pˆA of 0.4. Skin pˆA values ranged
from 0.19 in module 5, a module which was not significantly present in this tissue, to 0.64 in module
9. Fat has an unusually low average pˆA of 0.27. Modules 1 and 5, which were significantly present
in fat, had a pˆA value of 0, indicating that there entirely driven by environmental covariance. The pˆA
values in fat were high (0.44 and 0.78) in modules two and three which were not present in this tissue.
This result could indicate that there is the presence of discordant environmental effects that negate
presence of the modules in these tissues. In the other modules present in fat (modules 4 and 6-9), the
pˆA is low, ranging from 0.1 (module 8) to 0.31 (modules 4 and 9).
4.4.3 Identifying modules across tissues
Correlation values higher than the upper bound of the empirical null estimates for rP (>0.1) and rA
(>0.11) represent correlation values that are higher than would be expected by chance. However,
while the empirical null value describes whether the correlation values found between a set of tran-
scripts is statistically significant, this metric may be overly conservative. Since the null empirical
value is so low, it may not be a sufficiently high enough measure to define the large-scale covariance
structure that defines BIT modules. Since the modules were verified in blood, we used the ”module
minimum” values obtained from this tissue. This module minimum value is obtained from the module
with the lowest values for rP (0.36), rA (0.57) and pˆA (0.23) for blood. The minimum values of the
BITs modules represent the base correlation values required for the module structure. Therefore, we
used the minimum blood values to identify the presence of modules in the rest of the chapter. Since
the importance of the genetic covariance to the modules is evident in blood, (average rA=0.72), it
should be noted that shared genetic variance appears to be the defining feature driving the modular
structure of co-expression between BITs. Therefore rA is potentially a better measure to detect the
presence of a module across a tissue.
Using the module minimum metric on the rP values, only modules 4 and 6 were present in all tis-
sues. When taking into account rA and pˆA values, however, module 4 is no longer present in LCLs
(4.2C).Module 6 has the strongest co-expression of all the modules, with an average rP of 0.9 across
all tissues, followed by module 4 (0.54). The strong presence of these genetic correlations between
tissue indicates that there is enrichment with transcripts that are essential to cellular function these
particular modules. The GO term enrichments from Preininger et al. 2013, for module 4 include GO
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terms such as ”mRNA metabolism and splicing” and ”intracellular transport,” which are all critical
cellular functions [114]. Module six had no enrichments, which could indicate a lack of specificity
in the transcriptomic pathways but instead a collection of transcriptions with various capacities. The
enrichment for core cellular functions are usually ubiquitous across tissues [336] and could, therefore,
explain why these particular modules exhibit such a high degree of tissue non-specificity.
In LCLs, seven modules were identified based on the empirical null rP (modules 1,3,4,6,8 and 9,
Figure 4.2F). Modules 1 and 3 both had a low rP (˜0.1) and rA values (˜0.08), followed by module 7
(rP=0.14 and rA=0.22), indicating that these modules have very little co-expression and are unlikely
to be driving modules. Module 4 had a moderate rP (0.44). However, both measures of rA (0.21) and
pˆA (0.16) were well below module minimum and are predominantly driven by environmental effects.
Therefore using the module minimum measures of both rP and rA, only modules 6,8 and 9 appear to
be present in the LCL cells, with modules 8 and 9 only present in blood and LCL and not in other
tissues. Enrichments pertinent to transformed B-cells that make up LCLs, such as ”RNA processing”
and ”B-cell activation,” were present in module 8. Module 9 demonstrated enrichment for the GO
terms ”Signal transduction by phosphorylation,” ”Programmed cell death,” ”B-cell number” and ”T-
cell morphology,” which are again relevant to LCL and whole blood tissue samples.
The remaining modules 1-3,5 and 7 were only present in blood when using the minimum module
metric on both rP and rA values. Module 2, was one of the modules only present in blood (using
all correlation measures) and had the highest average module rP for all the blood modules (0.81).
This module was driven by a strong genetic component (rA=0.82) and genetic contribution to rP
(( pˆA=0.47). This strong specificity of blood indicates that module 2 could potentially be a critical
regulatory hub for many blood specific transcriptomic processes. GO term enrichments for module
two obtained from Preininger et al. 2013 [114] provide further support for the role of module two to
blood-specific transcriptomic processes. Module 2 showed enrichment for terms involving ”Oxygen
transporter activity” and ”Wound healing”, which are specific to blood, namely red blood cells and
platelets. With the transcript enrichment for processes that can only occur in specific blood cells, it is
not surprising that module 2 was found only in the whole blood samples.
Module 1 and Module 5 had similar rP and rA values (˜(0.6)) and were both enriched for terms specific
to whole blood. Module 1 showed enrichment for blood specific terms such as ”T-cell physiology”
and ”Leukopoiesis.” Module 5 demonstrated enrichment for ”Cytokine receptor activity,” ”Adaptive
immunity,” ”Inflammatory response” and ”Innate immunity.” Module 3 has particular high rA (0.88)
and pˆA (0.64) measures indicating a strong genetic contribution. Enrichments for blood specific terms
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including, ”B-cell activation,” ”B-cell morphology” and ”Immunoglobulin level” were also found in
module 3.
Module 7 was present across all tissues when using the empirical null value. However, it had one
of the lowest rP and rA values across the tissues (0.26 and 0.28 resp. on average between three
tissues). When using the module minimum values as the cut-off value for these modules, module 7 is
only present in blood. In blood rP and rA values for module 7 were high (0.74 and 0.73 resp.). GO
term enrichments from Preininger et al. 2013 showed that module seven demonstrated enrichment
for immune responses, in particular, viral responses. These included ”viral response (to infection)”
and ”interferon-mediated signaling.” The presence of module 7 only in whole blood is therefore not
surprising since immune cells make up a part of whole blood samples. It would have also been
expected for module 7 to be present LCL cells, which are immortalized B-cells. It is possible that the
anti-viral responses enriched in module 7 are indicative of cell-mediated viral responses that originate
from T-cells, NK and macrophages, which are only be present in whole blood samples.
4.4.4 eQTL analysis
We have established that is the genetic regulation that drives the high covariance observed with BIT
modules. We next sought to identify the genomic regions that were responsible for the genetic regu-
lation of the modules.
To determine the genomic loci that shared between BITs in a module, we queried the online database
for eSNPs produced by Westra et al. [57] for loci significantly associated with probes with the mod-
ules. This database contains eSNPs identified in a meta-analysis of 5,311 individuals with replication
in a further 2,775. We subsequently determined the number of eSNPs shared between BIT probes in
a module.
At an FDR of 0.05, nine eSNPs were shared between two probes in module 2 at an FDR (Table
4.4, Figure 4.3A). Examining the haplotype block of these nine eSNPs revealed that all the SNPs
were in moderate LD (r2 ∼ 0.5) with each other (Figure 4.4), indicating that they are a part of one
eQTL. These eSNPs were located on chromosome 2 within the intronic region of the BCL11A gene.
BCL11A encodes a transcription factor which has implicated in a wide variety of functions including
lymphoma pathogenesis [337], lymphoid development [338], fetal hemoglobin levels [339] and brain
development [340]. The biological functions of BCL11A was reflected by GWAS traits in which
the SNPs were associated. The traits include fetal hemoglobin cells (F-cell) distribution [341, 342],
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fetal hemoglobin levels [343–345], sickle-cell anemia [346–348], beta thalassemia or hemoglobin E
disease [349]. These GWAS traits all appear to be affected by the dysregualation of fetal hemoglobin
that is exerted by BCL11A.
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Table 4.4: SNPs associated with transcripts in modules two and seven. Information on the signifi-
cantly shared SNPs and their associated transcripts. ”SNP CHR” is the chromosome of the associated
SNP. ”Probe Gene” is the gene tagged by the Illumina probe used in this study. ”Gene CHR” is the
chromosome in which the gene, tagged by the Illumina probe, is located. In module two, nine SNPs
were associated with two genes. LD between the nine SNPs ranged between 0.3 and 1, indicating that
all of these nine SNPs are linked, forming one eQTL. Two additional SNPs in high LD (R2 = 0.9),
comprising one eQTL, were associated with three genes in module two. In module seven, two genes
were associated with one SNP (one eQTL).
Module SNP SNP CHR Probe Illumina ID Probe Gene Gene CHR
2 rs4671393 2 ILMN 1729487 GMPR 6
2 rs766432 2 ILMN 1729487 GMPR 6
2 rs1427407 2 ILMN 1729487 GMPR 6
2 rs10172646 2 ILMN 1729487 GMPR 6
2 rs1896294 2 ILMN 1729487 GMPR 6
2 rs10195871 2 ILMN 1729487 GMPR 6
2 rs7557939 2 ILMN 1729487 GMPR 6
2 rs11886868 2 ILMN 1729487 GMPR 6
2 rs7584113 2 ILMN 1729487 GMPR 6
2 rs4671393 2 ILMN 1759155 IFIT1L 10
2 rs766432 2 ILMN 1759155 IFIT1L 10
2 rs1427407 2 ILMN 1759155 IFIT1L 10
2 rs10172646 2 ILMN 1759155 IFIT1L 10
2 rs1896294 2 ILMN 1759155 IFIT1L 10
2 rs10195871 2 ILMN 1759155 IFIT1L 10
2 rs7557939 2 ILMN 1759155 IFIT1L 10
2 rs11886868 2 ILMN 1759155 IFIT1L 10
2 rs7584113 2 ILMN 1759155 IFIT1L 10
2 rs9468692 6 ILMN 1814397 EPB42 15
2 rs10947055 6 ILMN 1814397 EPB42 15
2 rs9468692 6 ILMN 1772809 SLC4A1 17
2 rs10947055 6 ILMN 1772809 SLC4A1 17
2 rs9468692 6 ILMN 1807919 TNS1 2
2 rs10947055 6 ILMN 1807919 TNS1 2
7 rs4917014 7 ILMN 1729749 HERC5 4
7 rs4917014 7 ILMN 1662358 MX1 21
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Figure 4.3: eSNP association between BITs. eSNP associations in Module two (A) and Module
seven (B) Genes are represented as blue boxes (gene labels above). Black and Purple lines represent
two intances of shared eSNPs between BITs in Module two
A
B
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Figure 4.4: Chromosome location and LD map of the SNPs significantly associated with two
probes in module two. The -log10 (fdr) of the association between two SNPs is plotted as dots
(y-axes on the left) with the relevant effect size (r2) colored as per the legend in the top right hand
corner. The recombination of that section of the chromosome is represented by the blue line (y-axes
on the right). The purple diamond is the selected SNP for which from which the association analysis
statistics are performed (r2 and the FDR values). All SNPs are in moderate LD with each other. There
appear to be two groups within this set that are in higher LD with each other.
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Another three BITs in module 2 were associated with two eSNPs in high LD (R2 = 0.91) and therefrore
comprising one eQTL on Chromosome 6 (Table 4.4, Figure 4.3B). These two eSNPs are located
within the coding region of TRIM10. TRIM10 plays a role in the terminal differentiation of erythroid
cells. One of these SNPs was a GWAS hit for human immunodeficiency virus (HIV) infection [350],
indicating a potential link between erythroid cells and infecting virus. The second SNP was associated
with cardiac hypertrophy (Table 4.5) [351].
One eSNP shared between two probes in module 7 (Table 4.5) is located in an intergenic region
between the Refseq genes C7orf72 and IKZF1. IKZF1 is a gene that is a key regulator of lymphocyte
differentiation, and dominant negative isoforms of this gene are associated with acute lymphoblastic
leukemia and other B-cell malignancies [352, 353]. This eSNP is a GWAS hit for SLE [354, 355], an
interesting observation since these modules were initially identified in a cohort of SLE patients [114,
228]. rs4917014 is also associated with the GWAS traits of lipid levels [356] and Stevens-Johnson
syndrome or toxic epidermal necrolysis [357]. These results indicate the presence of dysregulated
immune responses.
To calculate the significance of the number of shared loci between BITs, we calculated the expected
number of shared eSNPs between 10 randomly sampled transcripts. We repeated this bootstrapped
calculating 10,000 times. We found that on average less than one shared loci is present between 10
randomly sampled probes, with the two modules (2 and 7) having shared eSNPs at a higher frequency
than would be expected by chance.
4.4.5 Transcription factors
The eSNP associated with the BIT in section 4.4.4 were all functioning distally (in trans) to co-
ordinate the expression of the transcripts. We sought to examine functional mechanisms upon which
these distal effects may occur. To do this, we tested whether the BIT modules were enriched for any
transcription factors [1]. Transcription factors are proteins that bind to specific fragments of DNA
and thereby controlling transcriptionally activity of the gene.
Six of the nine modules contained transcripts that identified as transcription factors in blood cells
(Table 4.6). Enrichment analysis (Table 4.7) for the ten probes in the 85 BITs demonstrated that there
was significant enrichment (p=3.3x10−4) of transcription factors. The enrichment of transcription
factors in these modules provides insight into the genetic architecture that is driving the co-expression
of the probes. It is possible that changes in the expression of a transcription factor lead to coordinated
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Table 4.3: Correlation and heritability values for BIT modules. Mean/expected value (E) and
standard error (SE) for heritability (h2), phenotypic correlation rP and genetic correlation rA values
for all the BITs in each modules, within each tissue. The genetic contribuiton to rP is reported ( pˆA).
Transcripts that are labelled ”R” are the randomly selected transcripts used to evaluate the empirical
null value.
Modules Tissues E(h2) SE(h2) E(rP) SE(rP) E(rA) SE(rA) E(rE ) pˆA
1 Blood 0.28 0.04 0.6 0.02 0.6 0.03 0.6 0.28
1 Fat 0.13 0.02 0.27 0.04 0 0.09 0.31 0
1 LCL 0.51 0.03 0.12 0.03 0.09 0.04 0.15 0.38
1 Skin 0.34 0.04 0.1 0.04 0.18 0.06 0.06 0.61
2 Blood 0.46 0.01 0.81 0.01 0.82 0.02 0.8 0.47
2 Fat 0.21 0.03 0.09 0.03 0.19 0.07 0.06 0.44
2 LCL 0.18 0.04 0.03 0.02 0.05 0.1 0.03 0.3
2 Skin 0.18 0.05 0.06 0.02 0.21 0.1 0.03 0.63
3 Blood 0.47 0.02 0.65 0.02 0.88 0.01 0.45 0.64
3 Fat 0.12 0.05 0.02 0.02 0.23 0.12 -0.01 0.78
3 LCL 0.51 0.03 0.11 0.04 0.08 0.05 0.14 0.37
3 Skin 0.21 0.04 0 0.01 0.04 0.08 -0.01 0.5
4 Blood 0.3 0.02 0.66 0.01 0.72 0.03 0.63 0.33
4 Fat 0.27 0.03 0.51 0.03 0.59 0.05 0.48 0.31
4 LCL 0.31 0.03 0.41 0.05 0.21 0.06 0.5 0.16
4 Skin 0.22 0.01 0.6 0.03 0.7 0.03 0.57 0.26
5 Blood 0.38 0.02 0.52 0.02 0.62 0.02 0.46 0.45
5 Fat 0.09 0.03 0.22 0.03 0 0.11 0.24 0
5 LCL 0.38 0.03 0.06 0.02 0.09 0.04 0.04 0.57
5 Skin 0.26 0.06 0.07 0.03 0.05 0.07 0.08 0.19
6 Blood 0.35 0.01 0.89 0.01 0.96 0.01 0.85 0.38
6 Fat 0.25 0.02 0.89 0.01 0.96 0.01 0.87 0.27
6 LCL 0.43 0.01 0.92 0.03 0.94 0.03 0.9 0.44
6 Skin 0.26 0.01 0.91 0.01 0.93 0.01 0.9 0.27
7 Blood 0.3 0.03 0.74 0.01 0.73 0.02 0.74 0.3
7 Fat 0.21 0.03 0.38 0.03 0.35 0.08 0.39 0.19
7 LCL 0.41 0.04 0.14 0.04 0.22 0.08 0.08 0.64
7 Skin 0.27 0.06 0.27 0.03 0.28 0.08 0.27 0.28
8 Blood 0.19 0.03 0.51 0.02 0.62 0.04 0.48 0.23
8 Fat 0.08 0.02 0.35 0.02 0.43 0.11 0.34 0.1
8 LCL 0.45 0.01 0.64 0.03 0.94 0.01 0.39 0.66
8 Skin 0.13 0.04 0.27 0.02 0.45 0.08 0.24 0.22
9 Blood 0.48 0.05 0.36 0.04 0.56 0.06 0.18 0.75
9 Fat 0.13 0.03 0.17 0.03 0.41 0.09 0.13 0.31
9 LCL 0.41 0.02 0.4 0.03 0.57 0.03 0.28 0.58
9 Skin 0.21 0.03 0.15 0.03 0.46 0.08 0.07 0.64
R Blood - - 0.07 0.03 0.06 0.05 - -
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Table 4.5: Module associated GWAS SNPs. Chromosome, genome location, nearby genes, GWAS associated disease/traits and citations for the shared
BIT SNPs (as listed in 4.4)
Module SNP Chromosome: Position Location Gene Disease Trait Citation
2 rs7584113 2:60,494,176 intron-variant BCL11A F-cell distribution [342]
2 rs11886868 2:60,493,111 intron-variant BCL11A
F-cell distribution [342]
Fetal hemoglobin levels [343]
2 rs7557939 2:60,494,212 intron-variant BCL11A F-cell distribution [342]
2 rs10195871 2:60,493,454 intron-variant BCL11A F-cell distribution [342]
2 rs1896294 2:60,491,939 intron-variant BCL11A F-cell distribution [342]
2 rs10172646 2:60,493,622 intron-variant BCL11A F-cell distribution [342]
2 rs1427407 2:60,490,908 intron-variant BCL11A
Fetal hemoglobin levels [344]
F-cell distribution [341, 342]
2 rs766432 2:60,492,835 intron-variant BCL11A
Sickle cell anaemia [346–348]
F-cell distribution [346]
Fetal hemoglobin levels [345]
Beta thalassemia/hemoglobin E disease [349]
2 rs4671393 2:60,493,816 intron-variant BCL11A
Hemoglobin levels [358]
F-cell distribution [359]
2 rs9468692 6:30,119,890 utr-variant-3-prime TRIM10 HIV infection [350]
2 rs10947055 6:30,093,364 intergenic TRIM31 - TRIM40 Cardiac hypertrophy [351]
7 rs4917014 7:50,305,863 intergenic C7orf72-IKZF1
Systemic lupus erythematosus [354, 355]
Lipid Levels [356]
Stevens-Johnson syndrome/toxic epidermal necrolysis [357]
changes in expression of its target transcripts. In the case of the modules, it is possible that the
transcription factors could modify the expression of other module genes either directly or through
other intermediate genes that genetically regulate (and are identified as eQTLs) other BITs.
Table 4.6: List of BITs that are transcription factors. ”Probe illumina ID” is identifier the BIT
transcripts used in this study, ”Probe” is the gene in which the BIT probe is tagging. ”Tissue” is
where this transcript/transcription factor is predominantly expressed in the body.
Module Probe Illumina ID Gene Tissue
2 ILMN 1784678 PBX1 -
3 ILMN 1775235 AFF3 -
3 ILMN 1778681 EBF1 -
4 ILMN 2357272 BCLAF1 Smooth muscle
6 ILMN 1692145 ZNF14 General
6 ILMN 2162367 DMC1 -
6 ILMN 2313889 ZNF682 -
7 ILMN 2349061 IRF7 Heart, lung, lymph node, thymus, tonsil, whole blood
8 ILMN 2379788 HIF1A Smooth muscle
8 ILMN 2389844 SP3 Whole blood
Table 4.7: BITs Transcription factor enrichment. (a) The number transcription factors found
amongst the module probes, (b) 1,381 known transcription factors elsewhere [1], (c) the number of
probes within modules that are not known transcription factors and (d) The number of genes that are
not known transcriptional factors in whole blood. Details of the transcription factors is given in [1].
In Modules In Genome
TF (a) 10 (b) 1381
Not TF (c) 75 (d) 20609
The enrichment of transcription factors within the BITs indicates that these modules could be a part of
a regulatory genetic network of genes. Since the BITs themselves are the representative genes for each
module, it is possible that the BITs represent the regulatory machines that control the downstream
expression of many genes.
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4.5 Discussion
Preininger et al. [114] identified and replicated nine distinct modules comprising of co-expressed
transcripts that covaried in response to various environmental factors [115]. The presence of mod-
ules that co-vary in response to disease or environmental conditions suggests that individual gene
expression levels vary along pre-defined axes of variation. The degree of co-ordinated transcriptional
responses within these axes to environmental or genetic perturbations could predefine an individual’s
susceptibility to disease. PCA scores of BIT modules were able to differentiate individuals based
on environmental conditions such as infection or geographical location [114, 115]. The mechanisms
for this covariance is not yet well understood. However, the pervasive nature of gene coexpression
indicates that there is a core regulatory mechanism constraining the expression of transcripts.
The majority of transcripts in CHDWB and Morocco cohorts share the covariance structure captured
by the BIT modules. This covariance structure defined up to 50% of the transcriptome variance in
these two cohorts [114]. The high correlation between all genes in a module enables the data to be
represented and even recreated by a smaller number of representative transcripts. Therefore the ten
BITs represent a much larger number (between 99 and 1028 as recorded in [114]) of transcripts. The
robust intra-module correlations found between the BITs suggests that genetic regulation drives the
rP. This feature is reflected by rA values since rE between transcripts are likely to disappear between
cohorts exposed to different environmental conditions. This was supported by high rA values for
each module, which was 0.72 on average across all BIT transcripts. Therefore these modules are
extensively driven by genetic correlations and therefore a strong genetic component can be a good
measure of the the presence of a BIT module.
We used two measured to identify the presence of the modules in this study. To determine the signifi-
cance compared to random chance, we calculated the empirical null for the three types of correlation
values between ten probes. This method takes transcripts that have expected correlation values of
zero and calculates the empirical null values between them. Therefore the empirical null value is ex-
tremely low correlation values. Since that BIT modules exhibit an incredibly high correlation value,
the criteria for identifying the presence of the modules should include a higher correlation metric that
is more representative the BIT correlation structure. Since the BIT modules were only validated in
blood, we used the minimum correlation values for the modules in this cohort to establish a new met-
ric to identify transcripts. This module minimum metric was much more discerning of the presence
of the modules in the other tissues. The modules selected using the module minimum metric were
128
much more appropriate, i.e., had notable rA values, than those flagged by the empirical null value.
Therefore high rA and rP values are an important feature of the BIT modules.
In this study, we quantified the extent of the genetic regulation driving the representative 10 BITs
for each module. We found that the BITS had significant intra-module correlation rP (Pearson’s
correlation) within the BSGS cohort Figure 4.1D, Table 4.2). The average h2 for BIT modules was
0.34, therefore, the amount of genetic contribution to the rP comprised a little under half (pˆA=0.42).
Therefore the environmental and genetic effects had roughly similar contributions to the high rP
(average 0.64 across all modules)) between BITs. The rE values between BITs (0.58) were much
lower than the average rA values (0.72) (Figure 4.1D). This indicates that the rE had larger contribution
to rP than rA due to the low h2 values of the BITs (0.36). With the high average rA (0.72) found in
the BITs within each module confirming that genetic regulation is a core feature driving the modules.
Therefore, in healthy individuals, the BIT modules represents biologically meaningful transcriptional
units. We also examined the presence of the modules in three different tissues: fat, skin and LCLs.
We observed notable differences in the heritability of the BITs as well as the mean within-module rP
and rA across tissues. Differential genetic regulation between tissues has been found in several studies
[41, 163, 182, 360]. These studies discovered a notable difference in the eQTLs regulating transcripts
between tissues [184], sometimes with different allelic effects [102], demonstrating a different genetic
architecture between the tissues. The persistence of these modules in other tissues can provide context
on the extent to which this particular regulatory covariance structure is present in the cells in the body.
The context specificity of modules provides valuable information regarding the utility of using these
modules are molecular markers in other tissues besides whole blood [114, 115]).
The nine modules investigated here were identified and analyzed from whole blood samples; however,
tissues specificity may occur within other cell types in the body. To investigate this, we examined
the genetic control of BITs in three different tissues: fat, skin and LCLs. We observed notable
differences in the heritability of the BITs as well as the mean within-module rP and rA across tissues.
Differential genetic regulation between tissues has been found in several studies [41, 163, 182, 360].
These studies quantified various eQTLs regulating transcripts between tissues [184], sometimes with
different allelic effects [102].
GWAS and eQTL studies have discovered many regulatory loci for individual transcripts. Little
research has been performed to identify regulatory loci affecting co-expression. In this study, we
interrogated a well-powered and replicated independent dataset of eQTLs [57] to determine the target
loci driving the coexpression in each module. In particular, we looked for loci that are =shared
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between probes in a module. We found many SNPs associated with five BITs in module two and
one with module seven. The presence of loci associated with two or more transcripts in a module
uncovers the pleiotropic regulation driving the high genetic covariance and consequently rP within
the modules.
Module two appears to have a crucial role in blood. From all the tissues studied in this project,
this module was only present in the blood cohort. Module two had one of the highest correlation
measures and h2 in the blood cohort. Enrichment analysis performed in [114] for all of the transcripts
associated with module two showed enrichment for terms related to RBC and platelet functions. Nine
eSNPs in high LD with each other were associated with two BITs in module two. These SNPs were
in high LD with each other and were located in the intronic region of the BCL11A gene. BCL11A
is a TF associated with variable phenotypes, with the most notable being lymphoid development
[338] and the production of fetal hemoglobin levels [339]. The eSNPs located within BCL11A were
GWAS hits for a number of phenotypes related to red blood cell functionality, including include
fetal hemoglobin cells (F-cell) distribution [341, 342], fetal hemoglobin levels [343–345], sickle-cell
anemia [346–348], beta thalassemia or hemoglobin E disease [349]. These highlight the importance
of BCL11A in dysregulating the production of hemoglobin (Table 4.5).
Since the BITs in modules two are located in across the genome (Table 4.5), are regulated distally to
each other via soluble factors. It is possible that BCL11A interacts or is interacted with by the BITs
either directly or through the recruitment other TFs, making up a regulatory network of transcripts
and TFs. In fact, module two itself contains a TF that could expand upon on the regulatory network
that is encompassed by this module. In fact, two-thirds of modules had a least one TF present, with
11% of the BIT modules in total being TFs. Therefore TFs appear to be a mechanism upon which the
BITs are co-regulated.
The two genes in module two that were associated with the SNPs in BCL11A were IFIT1L and GMPR.
IFIT1L is a gene up-regulated by interferons and acts as an inhibitor of viral replication [361]. GMPR
has more of a housekeeping function in the recycling of nucleotides [362]. The immune-related
functions of IFIT1L and BCL11A associated with module two indicate that the transcripts in this
module are also involved in the function of immune cells present in blood tissues as well as platelets
and RBCs. Another two SNPs in high LD were associated with three transcripts in module two.
These SNPs are located within TRIM10 and are GWAS hits for HIV infection [350]. This SNP was in
LD with another SNP, also associated with three transcripts, that was located in an intergenic region
and was a GWAS hit for cardiac hypertrophy [351]. TRIM10 itself is involved in differentiation of
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RBCs [363]. It is possible then that RBCs play a role in the infection rates and pathogenesis of HIV. In
fact, there is a link between hemoglobin levels and the development of neurological disorders that are
the results of HIV infection [364]. The three genes associated the two SNPs linked to TRIM10 (TNS1,
EPB42 and SLC4A1) were all involved in red blood cell physiology. TNS1 is an important structural
component to signaling molecules and involved in facilitating cellular attachment to the extracellular
matrix [365]. EPB42 is a membrane protein that has an important role in the shape of red blood
cells [366]. Finally, SLC4A1 is another protein in the cellular membrane of red blood cells that takes
part in carbon dioxide processing [367]. Module two clearly shows enrichment of various aspects
of red blood physiology, linked with immune function. The connection between RBC and immune
function is highlighted by PBX1 a BIT TF in module two, which is a gene that is essential to the
development of common lymphoid progenitor cells (B and NK cells) and T-cell development [368].
It could, therefore, be hypothesized that the functionality of red blood cells could have a direct impact
on immune cells [369, 370].
Module seven is another module that was only present in blood and contains transcripts that are
predominantly involved in viral immune responses [114]. The soluble signaling molecule, the TF, of
module seven (IRF7) is involved in up-regulating anti-viral genes [371]. Two transcripts in module
seven were associated with one eSNP found in an intergenic region between IKZF1 and C7orf72
on Chromosome 7 (Table 4.5 Figure 4.3B). IKZF1 is a transcription factor has a critical role in the
hematopoietic system and is a key regulator of lymphocyte differentiation, which are cells that are
important to viral defenses. In chip-seq studies, this protein had higher binding affinity to other
genomic regions when compare to other genic regions in the genome [57]. Similar to BCL11A, the
two BITs in module seven are associated with a TF, suggesting that the network of regulations present
in this model.
The two genes associated with this eSNP were HERC5 and MX1. HERC5 is a gene that is upregulated
by pro-inflammatory cytokines and produces a protein ligase that has a significant role in antiviral
functions [372]. MX1 is involved in antiviral responses through the interference of the ribonucleo-
protein complex [373]. The eSNP associated with the two BITs in module seven is a GWAS hit for
two immune diseases, SLE [354, 355] and Stevens-Johnson syndrome or toxic epidermal necroly-
sis [357] as well as lipid levels [356]. There has been a link between immune dysfunction after severe
inflammation and lipid levels [374]. Diet has demonstrated an association with the development of
autoimmune disease, in particular, the high-fat Western diet. The diet related autoimmune diseases
were predominantly carried out through T-cells [375]. Exaggerated responses to viral infections have
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contributed to the development of autoimmune disorders in healthy individuals [376,377]. Therefore
it is possible that dysregulation of the viral pathways could contribute to the development of immune
disorders in healthy individuals.
The original 28 modules, used to identify the BITs, were identified in gene expression samples from
patients with SLE [228]. Therefore, it is interesting that there was an association between two BITs
in module seven with a SNP that is an SLE variant. This association indicates that the co-expression
networks expressed in patients with SLE remain present within the BITs. These SLE networks are
potentially core regulators of immune function, notably viral immune function. Changes to this coex-
pression from genetic perturbations or environmental conditions could lead to shifts in SLE disease
susceptibility.
In additional to modules two and seven, modules one, three and five were also only present within the
blood tissue. The transcripts within these modules show enrichment for immune responses. Module
three contained two TFs, AFF3 and EBF1 which are both involved in lymphocytes development
[378, 379]. Since there is an enrichment for immune function and these modules are not also present
in LCLs. Therefore, these modules could hold networks that are predominantly occurring within
T-cells and not B-cells.
LCLs are immune cells that are immortalized with Epstein-Barr virus. LCL have been used ex-
tensively in gene expression studies as they provide a stable and replenishable source of RNA and
DNA [177]. Previous studies have shown that the genetic architecture of gene expression is different
between LCL and similar cells found in whole blood [179, 181, 380], including studies done on the
MuTHER cohort used in this study [182]. We found that the correlation structures between tran-
scripts differed between LCLs and blood with only modules 8 and 9 shared between the two tissues.
These changes in transcript co-expression in LCLs can arise from a combination of gene expression
perturbations that occur during the LCL immortalization process and B-cell tissue-specific genetic
regulation that is enriched in LCL samples when compared to whole blood. Transcripts in both mod-
ules eight and nine showed enrichment for B-cell functionality, explains their presence in the LCL
tissue.
All modules, except for four and six, were found only within blood/LCL cells. The blood tissue
specificity of the BIT modules is not surprising since these modules are enriched for cellular functions
that would only occur in blood or immune cells. Module four was present in all tissues except for LCL
based on the rA values. Module four showed enrichment for housekeeping functions which are not
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tissue specific. Module four also contained one TF, BCLAF1, which was involved in apoptosis [381].
Module six has the highest correlation values for all tissues, including blood, and demonstrated no
enrichment for any particular processes amongst the transcripts associated with it [114]. Module six
had three TFs, the highest of any module. Two of Module six TFs were involved in the repression of
zinc finger proteins (ZNF14 and ZNF682). Zinc-finger proteins are involved in a wide variety of core
processes within the cell [382]. The third transcription factor was DMC1, which is a conserved gene
involved in repairing double-stranded breaks in the DNA [383]. The housekeeping or core cellular
functions expressed within modules four and six are inherently tissue non-specific and could explain
the presence of these modules across all of the tissues studied [181, 336, 384, 385]. Module six had
the largest number of TFs of any module. This large number of TFs could be indicative of a primarily
regulatory role of the BITS in this module.
This study examined the genetic architecture of a set of nine modules that showed promise as a
potential diagnostic tool to measure disease susceptibility and progress [114, 115]. These modules
represent set of highly correlated transcripts, which are representative of a much larger group of
transcripts that control up the half of the variance in the transcriptome. By decomposing rP values,
often used as measures of coexpression, into rA values we were able to quantify the extent of the
genetic regulation driving the high covariance structure observed in many gene expression datasets.
It was also evident that all of these modules have correlation structures between the transcripts. This
regulation was identified by shared eQTLs between two more transcripts in modules two and seven,
indicating a network between the BITs in the modules. One of the eQTLs shared between two BITs
in module two was a transcription factor. Transcription factors are one means in which a gene can
regulate the expression of another gene. The enrichment of transcription factors within the BITs
indicates that a strong genetically controlled network between the genes is driving the correlation
structure observed here. These modules show enrichment for a variety of functions, which ranged
from blood cell physiology to general housekeeping processes. In fact, the concordance between
the genetic associations, transcript enrichment and tissue presence in these modules indicates that
these modules could provide biological insights into the cellular functions and interactions of blood
and immune cells. The tissue non-specificity of modules four and six shows that they represent a
regulatory network that that is core to cellular functioning.
The network architecture between the transcripts through the use of TFs facilitates the coordinated
expression of multiple genes that rapidly adjust to responses to environmental conditions. Genomic
perturbation in any of the genes within a module could have a cascading effect throughout and entire
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module. The genomic profile of an individual can have subtle effects across a molecule, influence
their ability to respond to environmental conditions. This factors could be a driving force behind
the differences in susceptibility to diseases and conditions observed throughout a population. This
interplay between genetic regulation and environmental conditions within the modules can, therefore,
provide a model upon which to study the etiology of complex traits and diseases.
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Chapter 5
Discussion and Conclusion
5.1 Transcriptomic variability
5.1.1 Gene expression as a quantitative trait
The variability of gene expression across a population is one of the driving forces behind pheno-
typic variation [386].The process of translating genes into RNA transcripts is the starting point upon
which genetic information flows from the DNA into the production of cellular products, essential for
cell structure and function. The expression levels of all characterized transcripts can be quickly and
cheaply quantified using microarray technology. Gene expression is a quantitative, complex traits,
influenced by a mixture of genetic and environmental factors. Expression levels are regulated through
a variety of mechanisms that include repression of transcription, modification of transcriptional ma-
chinery, degradation of mRNA transcripts and changes in chromosome confirmation.
Gene products rarely function alone and often make up networked and highly co-regulated biological
processes, e.g. signal transduction, metabolic networks, multi-subunit proteins and immune signaling.
Coordinate functions of genes were observed in chapter 2 where the first set of high variance principal
components were able to pick up whole networks of genes alongside the batch effects. These coordi-
nated functions within the transcriptome present themselves as coexpressed modules of genes. These
networks of genes can comprise up to half of the total variance within the whole transcriptome [114].
The association of distal-eQTLs to several coexpressed genes has provided further weight on the im-
portance of studying networks of genes instead of individual transcripts to understand the architecture
of a system [39]. Up to 11% of eQTLs are shared between multiple transcripts [65]. In chapter 4, we
quantify the extent of genetic control driving sets of highly correlated transcripts in blood [114] and
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identify several shared eQTLs between these transcripts. We also identified TFs, enriched in these
modules, as a potential mechanism of the shared regulation.
5.1.2 Biological impact of common SNPs
GWAS have been very prolific in identifying polymorphisms that underpin many complex traits and
diseases. At the start of 2016, over 16,000 SNP-trait associations have been reported [332]. The next
challenge is to annotate the SNPs obtained from these studies. Gene expression provides a highly
accessible intermediate phenotype between the genome and higher-order traits. Gene expression
variability in an HWE population provides a readily accessible phenotype to which to assess the direct
biological impact from common SNPs (MAF > 0.05) in a population. This information enables the
validation and functional characterization of GWAS SNPs.
GWAS/eQTL analysis was performed in two chapters of this thesis. In chapter 2, we demonstrate
that networks of SNPs that are picked by PCs can have eQTLs associated with them(Table 2.2). With
the removal of the batch effects, which affects networks of genes, eQTLs across all of the transcripts
become easier to detect 2.1. In chapter 4, we identified two eQTLs shared between two and three
transcripts respectively. These eQTLs were previous GWAS hits for hemoglobin levels and other
blood-related disorders. The association with SNP associated with hemoglobin is consistent with the
biology of the associated transcript in the modules, which were predominantly involved in red blood
cell functionality. Therefore incorporating genetic and transcriptomic data can provide insight into
the biological mechanisms driving the etiology of complex diseases and the regulatory architecture of
complex traits [60].
5.1.3 Additive and non-additive genetic variability
Transcriptomic variability can be partitioned into additive genetic variation using GREML approaches
[295] or family-based designs [21]. Additive genetic variation is of interest to quantitative genetics as
it is the source of variation that passed down between generations. Additive genetic variation drives
almost all of the genetic variation between measured in complex traits [20]. Additive genetic variation
is also a key driver of global gene expression variation [2, 43, 44, 387].
Genetic-dependent variance not attributed to additive genetic variation can arise from dominance and
interaction effects. Dominance and overdominance effects have demonstrated a negligible effect in
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gene expression studies with only 5.3% of probe even having a significant measure of dominance
variation, usually in conjunction (and well below) additive effects [44] (as discussed in section 1.4.1).
Interaction effects include effects between genes, known GxG interactions or epistasis (as mentioned
in section 1.4.2) and with the environment, known as GxE interactions or GEIs (as examined in
section 1.4.3).
Only a few gene expression transcripts have had epistatic effects identified and replicated [85]. Al-
together these did not have a significant impact on gene expression variability [44]. The extent of
GEI in gene expression still needs to be characterized. The reason behind this is the difficulty in
collecting easily comparable samples across a wide range of the environmental conditions. The inter-
action effects between particular loci and environmental conditions could be a factor that influences
the adaptability of individuals to certain stimuli and the development of certain health conditions/
diseases in the presence of specific environmental factors [44, 79].
One key regulatory feature that is driving the shared transcript regulation in modules is TFs. TFs
have been documented to exhibit environmentally-specific binding [113]. The BITs in chapter 4
demonstrated strong enrichment for TFs. These modules demonstrate a great deal of co-ordinated
variability to varying environmental conditions [114, 115]. Whilst this cannot be confirmed in this
study, it is possible that a number of GEIs drive the responses of these modules. A genetic change in
one part of a regulatory network could result in the effects across the entire system. The co-ordinated
changes across the modules, however, may not be attributed to the effects of strong GEIs but instead
to the natural biological responses required for cell to survive. The high genetic structure driven by
TF enable the requires responses to be initiated by the modules.
5.1.4 Non-genetic variability
There are two key types of non-genetic variability that will be present in any transcriptomic dataset.
This will be environmental variability, can be described as any variability that is ”not genetic” (1-
h2). Common family environmental variation is a confounder of h2 estimates. Common family
environmental effects occur when traits are measured within families, and similarities between the
individuals are attributed to genetics are actually related to the shared environment between them. In
the BSGS dataset, used in all of the chapters in this thesis, common family effects were very small,
with ˜0.001% transcripts having any significant common family effects. The second type of non-
genetic variability would be attributed to technical artifacts. This kind of variation is ubiquitous to
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transcriptomic datasets and is often overlooked. However, technical artifacts can be hard to define and
identify and they can present themselves as both genetic and environmental trends within the datasets
and is a serious confounder that require specific models to remove. Technical artifacts are examined
in chapter 2.
Environmental variability can be driven by various types environmental conditions and it comprises
the largest portion of variance in gene [44] expression and other complex traits. The magnitude of dif-
ferent components driving environmental variability make it difficult to distinguish any features from
population-wise transcriptomic data. However, knowledge of any macro environmental (as discussed
in section section 1.5.2) could provide a sufficient variable upon which meaningful information could
be obtained from. This was performed in chapter 3, where seasonality information for each sample
was used to distinguish transcripts that were significantly affected by naturally occurring variations
across the year. Studies involving differential expression often want to dissect the cellular responses
to particular environmental conditions or disease states [388–390] and are therefore looking for tran-
scripts that exhibit a great deal of environmental variation in response to such stimuli.
5.2 Technical variability
A form of non-genetic variability that poses as a serious confounder in gene expression studies are
technical artifacts, such as batch effects. These arise from minute fluctuations between batches of
samples that occur during collection, processing, microarray chip hybridization and reading of the
data [160]. This form of artificial variability can become incorporated into the natural genetic and
environmental variation in the dataset.
In chapter 2, we used prerecorded processing dates to evaluate the extent of batch effect in gene
expression data. We found that up to 29% (Figure 2.1) of the variance of the data was comprised
of batch effects. Within the principal components generated from the data, these batch effects were
located within the first 60 principal components, which contain the majority of the variance and the
largest linear structures. Due to this structure of batch effect it was assumed in many studies that
removing the first 50 PCs would eliminate the data. We show that whilst this is correct, the batch
effects have integrated themselves amongst other heritable information and therefore require a more
accurate correction method.
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5.2.1 Batch effects
It is the first step when analyzing transcriptomic datasets to normalize and cleaning the data. Batch
effects add artificial correlation structures to the dataset that can induce spurious associations with
the variables of interest. In order to identify the batch effects present within a dataset, recorded pro-
cessing dates throughout the generation of the data must be kept. The detailed records of processing
dates within the BSGS dataset enables the examination of the variance and distribution of batch ef-
fect. During the generation of transcriptomic data there are many factors that can generate technical
artifacts can occur during the generation of the data that may not be recorded during the generation
of the data. However, from the records available for the BSGS dataset it is evident that batch effects
have the largest effect on transcriptomic variance. Batch effects often occur when, due to large sample
sizes, samples are processed in smaller groups or batches. Approximately 19% of the BSGS dataset
was attributed to measuring of the data on the microarray chips [152].
5.2.2 Principal Component correction
There have been many transcriptomic datasets that do not have any batch effects recorded. Inaccurate
record keeping makes the removal of batch effects much more difficult and leads to the usage of
ad-hoc methods such as PC correction to remove unknown variables. Since PC decomposition is an
efficient method of isolating trends within the data, it provides a means of correcting for batch effects
when there are no known recorded processing dates [157, 163, 164, 170]. The correlation structure
induced by the batch effects are easily identified within the first few PCs generated on a dataset. PCs
are ordered based on decreasing amounts of variance explained, with variance plateauing to 1% or
less very quickly. Therefore the first few PCs often hold the most information about a dataset. The
ability of PCs to decomposed the dataset into independent component comprised of linear trends in
the data makes PCs a good method to capture to covariance structure of batch effects. In our study,
we detected the presence of batch effects within the first 58 PCs generated from the data (Figure 2.3)
indicating that the removal of a vast number of components will be required to completely eliminate
these technical artifacts. Up to 50 PCs have been removed in previous studies [77, 163], however
since the variables included in these PCs are unknown, the selection of the exact number of principal
components to remove can be ambiguous.
The ability of PCs to capture the covariance structure of gene expression data means that any source of
variation with the same linear trend will be detected. This can include highly correlated genes in co-
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expressed transcriptomic networks such as metabolic pathways, immune processes, and muti-subunit
proteins. Other correlated sets of genes can include sets of transcripts that have common functionality
and shared genetic regulation as demonstrated with the BITs within the modules examined in chapter
4. These biologically-relevant sources of variation can become entangled with the batch effects in the
dataset and therefore be present simultaneously within the PCs. All the processing information during
the generation of the BSGS dataset were recorded, enabling the analysis of the distribution of batch
effects across PC. The results in Chapter 2 revealed that both batch effects and biologically meaning
pathways can be present at the same time within one PC. Therefore, PC correction is a blind method
to correct for batch effect and can result in the over-correction of the dataset and the the removal of
genetically regulated information.
To examine whether PC correction removes genetic information we reviewed the impact of the batch
effect correction techniques on probe heritability. We demonstrated that the average probe heritability
dropped from 0.32 in the uncorrected dataset to 0.18 when corrected with 50 PCs. In linear models,
the average probe heritability fell to 0.23 (Figure 2.6). These results indicate that the uncorrected
dataset had inflated heritability measurements due to confounding with systemic technical artifacts.
The higher drop in both mean probe heritability and a skewed distribution towards a probe heritability
of 0 (Figure 2.6) indicates that PC is removing heritable variation.
To examine whether the PCs are removing biological information we interrogated the first 50 PCs
from the BSGS datasets for any evidence of biological enrichments. Since PC detect correlation pat-
terns within the dataset, it was expected that biological networks of genes are likely to be present in
these PCs. We found that 11 of the 50 PCs to be removed from the dataset had a significant enrich-
ment for a number of different biological processes including immune function, metabolic processes,
ribosomal components and RNA degradation. Since batch effects are artificial trends within the data,
they are unlikely to be enriched with biological networks and therefore indicates that a number of net-
works genes are being detected within the first 50 PCs alongside the batch effects. Further evidence
of biological information being present with the first 50 PCs is also given by the detection of genomic
loci associated with the PCs (Table 2.2). Together this provides evidence that PC correction removes
a wide variety of information in a dataset that may not be associated with batch effects.
In previous studies, the number of PCs used for batch effect correction was selected based on the
impact observed on eQTL detection. In Fehrmann et al. 2011, a gene expression study comprised of
1,469 individuals, removal of 50 PCs resulted in a two-fold increase in cis-eQTLs detected [77]. The
removal of PCs eliminated noise from systemic errors (such as batch effects), environmental sources
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and physiological effects such as cell types. This removal of noise and confounders increased the
power to detect eQTLs associations. Within the BSGS dataset, ˜90% of known batch effects were
eliminated when 50 PCs were removed (Table 2.1), demonstrating the effectiveness of PC removal in
eradicating batch effects from the dataset. The removal of 50 PCs from the BSGS dataset resulted in
35% increase in local eQTLs and a 77% increase in distal eQTLs at an FDR 0.05. This was replicated
in the CHWDB dataset with a 32% and 69% increase in local and distal eQTLs respectively at FDR
0.05 when 50 PCs are were removed from the dataset. Linear model correction increased power to
detect eQTL association by a greater degree, with a 193% and 188% increase in local and distal eQTL
hits respectively in the BSGS and 82% and 82% increase in local and distal eQTLs respectively in
the CHDWD dataset. These results therefore demonstrate the removal of batch effects either using
PC correction or linear models can improve the power to detect eQTL association. However, due to
the overcorrection that is produced by the PCs, a more precise correction method of the batch effects
in a dataset can improve the eQTL detect even more. This is due to a greater removal of batch effect
and also the prevention of the accidental removal of genetic variation, which can lead to a drop in the
power or complete elimination of the associations that can be detected.
Altogether, PC removal is an effective method of removing batch effects in a dataset (Figure 2.3),
thereby increasing power to detect eQTL associations (Table 2.1). PC correction would be an appro-
priate method to correct for batch effects in datasets that lack detailed records of processing times
which could alternatively be used as surrogate markers for batch effects. PCs can additionally incor-
porate environmental or physiological factors such as cell counts, population differences, and other
unknown factors. It can be difficult to identify which PCs generated from a PCA decomposition
would hold this information and to what extent are the PCs comprised of artifacts.
In chapter 2, we examined only one dataset in which PC correction proved to be an efficient model to
remove batch effects. It would be expected that the distribution of batch effects across the PCs and the
number required to remove such artifacts will vary widely across different datasets and would require
careful examination of the data. Therefore the effectivity of PC correction may differ substantially
between the various study designs. The BSGS dataset also had quite a small sample size, which
mean that the resulting number of PCs would be lower than what would be lower than some of the
studies that have employed PC correction. Therefore the distribution of variance across the first 50
PCs may constitute more of the variance in this dataset than others. This difference in sample size
therefore makes comparisons between the BSGS studies and the previous studies correcting for PCs
difficult. From our results, we can conclude that PC removal is a delicate balance between removing
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unknown technical artifacts and environmental confounders at the expensive of over-fitting the data
and removing genetic variation.
In summary, the appropriate cleaning of the data is the first step that is required for further analysis
of gene expression data. The widespread and systematic effects of batch effects provides and exam-
ination of the extensive correlation structures that are present in the gene expression datasets. Batch
effects integrate within the covariance structures between genetics and the environment and therefore
the decomposition of the is variance into principal components, highlights the presence of these corre-
lation structures enriched for a variety of biological functions. Therefore the study of gene expression
in the major interconnected groups of genes instead of single independent transcript will help in ex-
panding our knowledge of the genetic architecture of gene expression. In chapter 4 we examine how
co-ordinated genetic regulation between genes drives highly correlated modules of genes.
5.2.3 Environmental variability
The most prominent source of variation in global gene expression is environmental effects (Equation
1.1) [44]. The examination of transcriptomic variation attributed to environmental effects can elu-
cidate the transcripts and associated molecular processes that are either modulated by or represent a
targeted response to, specific environmental stimuli [19]. These environmental effects can be divided
into macro environmental effects, which affect the majority or all of the individuals in the population,
and micro environmental factors, which are specific to individuals [125].
Across a large enough sample size, as found with the BSGS, the environmental variation detected
are driven by a magnitude of different environmental conditions. These micro environmental effects
are likely to be diluted across a population and are therefore unlikely present themselves as serious
confounders to study design. On the other hand, macro-environmental effects, such as seasonality can
become potential confounders since all individuals are exposed to this source of variation. In chapter
3, a significant seasonal signature for a number of transcripts across the transcriptome was identified.
This highlighted seasonality as an important macro-environmental factor in transcriptomic data.
5.2.3.1 Seasonal variability
Seasonal effects have been reported to have an impact of global gene expression variation [275,391].
In chapter 3, we examine the impact of a pervasive source of environmental variation, seasonality, on
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a gene expression dataset that was collected over a number of years. To isolate the cyclic seasonal
component for each transcript, a loess smoothing function was applied to the dataset. This model
separates the cyclic components, from yearly trends and noise within the dataset (Figure 3.1). The
significance of a 12-month repeating weather cycle was tested with a cosinor regression model (Figure
3.5) and confirmed with an orthogonal autocorrelation test for cyclic repeating patterns. We identified
in total 135 transcripts, 1% of all 13,311 transcripts tested, that were associated with a 12-month
seasonal cycle (Table 3.1).
5.2.3.2 Enrichment
We found that there were distinct biological processed that were enriched among the transcripts that
were associated with seasonality. The significant seasonal transcripts were enriched for the pro-
cesses of DNA repair and binding. This provides potential clues in the underlying biology that drives
seasonal trends that have been reported in a number of physiological traits and diseases, such as
cardiovascular disease [281] and multiple sclerosis [287, 288].
5.2.3.3 Causality
The direct causal factor driving seasonal transcriptomic variation are likely to be due to a number
of secondary factors. These factors could include seasonal changes in influenza transmission fre-
quency [289], weather patterns or temperature (Figure 3.5) and therefore cannot be identified in this
study. Transcripts associated with significant seasonal cell count variation (as discussed later), further
complicated the line of causality. With these transcripts, it is unclear whether it was the change in cell
count that caused the increased in detectable transcripts or whether it was a transcriptional change that
modified the cell count numbers. Either way, it can be concluded that a seasonal signature influencing
cell count can be detected within the transcriptome.
5.2.3.4 Impact of seasonal effects
The identified seasonally-affected transcripts have provided evidence for two distinct notions. Firstly,
we have identified biologically relevant processes that demonstrate a seasonal trend. These biological
effects require replication in a different dataset for validation. The presence of an opposite seasonal
effect in the north hemisphere for these transcripts involved in DNA function and repair will further
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confirm this biological trend in seasonal fluctuations.
Secondly, since the BSGS was not collected as a part of a time-series design, the presence of clear
seasonal effects highlights the ubiquity of this macro-environmental effect on the variation in gene ex-
pression datasets. Therefore, it is likely that any transcriptomic data obtained from samples collected
over time will contain seasonal signatures.
Whilst the overall impact of seasonal variability in the BSGS dataset is small, the detectable seasonal
signature indicates that any samples measured over a period of time could be susceptibility for natural
seasonal variation. This additional source of variation could complicate gene expression analyses
performed with samples that are collected over time or as a part of a time-series experiment and
therefore should be examined during data cleaning process in these instances.
5.2.4 Physiological variability
5.2.4.1 Cell counts
5.2.4.1.1 Seasonal effects Seasonal variation found in gene expression datasets have been at-
tributed to changes in cell counts [275, 391]. In chapter 3, we found 94 additional transcripts that
had a significant seasonal signature that was driven by cell count, notably lymphocytes, and the tran-
scripts were enriched for various immunological processes indicating a strong immune signal that is
associated with seasonality. It is reasonable to hypothesize that this signature is due to the influence
of seasonal infections of several respiratory viruses such as influenza [289].
Altogether, we identified 168 transcripts that were significantly associated with seasonality were en-
riched for cellular markers for lymphocytes (Table 3.3). Evidence for confounding with cellular
abundance was further confirmed when the cell count of five distinct cell types was significantly asso-
ciated with the cosinor seasonal model that was used to model a 12-month seasonal cycle in the study
(Figure 3.4). When corrected for cellular abundance, 94 transcriptomic associations disappeared and
additional 61 were identified (Table 3.3).
The 94 transcripts associated with cellular abundance were enriched for various immunological pro-
cesses (Table 3.2 and Figure 3.6). This enrichment suggests that it is either change in lymphocyte
cell counts or the increased expression of immunological genes that follow a seasonal trend. Both
expression changes or cell count changes can be detected within the transcriptome. Similar results
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in much larger sample sizes in both European and Oceanic samples have demonstrated increases in
pro-inflammatory transcription and change changes in cellular blood composition associated with
seasonality [391].
Together with having a strong seasonal signature, blood cell count also appears to have a significant
contribution to the transcriptomic variability in the BSGS datasets [138]. Therefore it contributes
what we classify as physiological variability to the dataset. These identification of variation from
the transcriptome indicates that transcript levels can provide accurate markers that can detect the
composition of blood and an individuals physiology.
Altogether these results provide information on the importance of examining environmental effect on
the expression of genes. Whilst individual environmental effects are difficult to determine, macro en-
vironmental effects are experiences by everybody and are therefore important when modeling global
factors that change the expression levels of a gene. The incorporation of these environmental factors
can improve the predictability of genetic models. This is particularly important since, as demonstrate
here, some gene respond to environmental conditions more than other. Therefore by collect a catalog
of transcriptomic environmental responses, we can incorporating this information to predict individ-
ual responses alongside their expected genetic responses. These environmental response do not only
occur on the individual transcript level. Genes that are co-regulated and are a part of a larger holistic
network are likely to exhibit response to environmental condition in a co-ordinated fashion. This was
observed in the modules examined in chapter 4.
5.2.4.1.2 Cellular heterogeneity This form of physiological variability occurs in samples com-
prised of a heterogeneous source of cells, such as whole blood. Whole blood is a tissue source that
is easily obtained from donors and therefore frequency used in transcriptomic research. The multiple
cell types present in blood pose several challenges to transcriptomic inferences that can be made from
this kind of tissue. First of all, even within the same cell types, there is extensive stochasticity be-
tween cells [392]. Over a large population of cells, this variability follows a normal distribution [392].
Secondly, different cell types can have, to varying degrees, dissimilar transcriptomic profiles [393].
Therefore the transcriptome obtained from whole blood represents an average across all the various
cell types [394].
Different environmental conditions can contribution to physiological variability induced by cell counts
in whole blood. The occurs when an increased proliferation of specific cell types is invoked in blood,
i.e. infection causing increases in circulating leukocyte numbers, can change the composition of the
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transcriptome. Increases in cell counts modify the ratio between various cells in blood and therefore
the quantity of certain transcript to others [275, 395]. Differences in the transcriptome as a result
of the abundance of different cell types that can represent a significant driving factor behind inter-
individual variability found in transcriptomic datasets. Overall these results demonstrate the practical
importance when working with whole blood samples to ensure that cell count abundance is collected
and ruled out as a confounder in downstream analyses.
5.2.4.2 Tissue specificity
When comparing transcriptomic samples collected between different tissues, the tissue-specific nature
of gene expression can create an extreme form of physiological variability. Tissue-specific expression
can drastically modify the expression landscape observed within the same individual and has been
characterized in many previous studies( [40, 41, 71, 74, 181, 182, 393, 394, 396–398] to name a few).
These changes are not surprising since each cell has its specific cellular functions that are unique to
it. Housekeeping genes have essential functions within the cell and as a result demonstrate less tissue
specificity [181, 336, 384]. The non-specific tissue presence of housekeeping genes was observed in
chapter 4, where the modules enriched for housekeeping functions were present across all tissues in
the studies. Modules that contained genes with specific blood or immune cell functionality were only
present within the blood or LCLs. Therefore the genetic regulation and transcripts that are required
to carry out functions particular to a cell are going to have cell-specific expression and regulation.
Since cells and tissues work together to perform biological functions, an understanding of the genetic
regulation across all the different tissues in the body is essential to obtain a global picture of human
physiology. As demonstrated in chapter 4, co-ordinated transcriptomic expression occurs in a tissue-
specific manner, indicating the networked expression of genes does not dissolve between tissue but is
instead a universal regulatory structure in the transcriptome that varies according to cellular function.
Diseases also are restricted to particular regions of the body and therefore an understanding of the
transcriptomic processing across tissues will assist in understanding the mechanism driving these
conditions.
5.2.4.2.1 eQTLs Each tissue type has its own unique differentiated biological functions and this is
reflected in their transcriptomic profile. In whole blood each cell type has its own unique expression
profile [397] and in additional to that there is a variety of cell-free circulating RNA from various tissue
sources in the body [385]. The unique transcriptional profile of cells contributes to the gene expression
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trends observed from changes in cell counts throughout the seasons in chapter 3. The Genotype-Tissue
Expression (GTEx) project showed that the majority of genes were conserved between tissues, with
about 21% of transcripts showing varying degrees of dissimilarity between tissues and over 50% of
detected eQTLs are shared between tissues [393]. Therefore inferences made from transcriptomic
analyses in blood may not be directly applicable in other tissues.
5.2.4.2.2 BIT In chapter 4, the co-regulation between BIT modules different between the four
tissues measured: blood, LCLs, fat and skin (Figure 4.2). The extent of shared genetic control, mea-
sured as the genetic correlation between transcripts, also varied between modules. The tissue-specific
difference in genetic covariance indicates that the base genetic architecture regulating transcripts dif-
fers between cell types and tissues. These differences are likely contributing to the highly specialized
structure of the approximately 200 different types of cells in the human body [399]. Previous stud-
ies on tissue-specificity have focused on single transcripts. This study provides an example of the
covariance and genetic covariance varying between tissues showing a networked difference between
tissues.
The modules were identified and validated in whole blood tissue samples. Within the BSGS dataset,
all nine modules were present with a high average rA of 0.72 across all BIT module pairs. The
presence of the modules were more accurate determined when they were based on the values obtained
from BIT modules in blood. Using this measure, modules 1-3,5 and 7 were only present in blood with
modules 8 and 9 also present in LCL cells. Modules 4 and 6 were present across all of the tissues.
The universal presence of the modules 4 and 6 can be attributed to the predominantly housekeeping
functions of the transcripts.
5.3 Genetic covariance
The extensive covariance structure of the transcriptome indicates that the high degree of network
interactions between transcripts take place within a biological system to carry out a number of tasks.
This complex system of regulation and network is an emergent property found within the -omics
datasets as information is transmitted from the DNA into the complex cellular infrastructure required
to keep the cell alive. This covariance structure shares the variance between multiple transcripts and
provides a means of tracking entire biological pathways instead of individuals transcripts. These
pathways can comprise of biological networks of genes can include, for example, metabolic and
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immunological that require the precise coordination of genes to maintain homeostasis.
5.3.1 BITs
In chapter 4 we examined the mechanisms driving transcript co-expression using nine modules that
were identified and replicated in a previous study [114,228]. These modules were primarily enriched
from immunological and blood cell biological functions. The BIT modules have a large impact on the
variance present in the transcriptome, with the majority of transcripts having 50% or greater of their
variation associated with PCA-derived axes of the modules [114].
These modules were decomposed into a smaller set of ten transcripts, called BITs that represent the
variance structure of the whole module. These BITs were used as proxies for characterizing the
variance captured by the whole modules. These modules were identified in whole blood samples and,
as mentioned previously, four of these modules appear to be tissue-specific (Figure 4.1).
5.3.2 Phenotypic correlations
Phenotypic correlation between transcript levels, as measured by Pearson’s correlation form the basis
of which coexpressed modules are identified the transcriptome [114, 115, 228, 229, 322, 400]. Pheno-
typic correlations between transcripts can be a driven by genetic factors, environment influences, and
random chance.
Correlation between transcripts, which is an estimate of scaled covariance, between transcripts is
highly susceptible to noise and have low repeatability [401]. The BIT modules were replicated across
several studies across five independent studies that comprise of different population groups confirming
the co-expression found in the modules [114].
Transcriptomic covariance, using a bivariate extension of GREML in GCTA [324], can be partitioned
into genetic and environmental components (Equation 4.1). The genetic correlation between tran-
scripts (Equation 4.2) provides a measure of the degree of genetic regulation that shared between
transcriptions and the proportion of total covariance attributed to genetic effects.
Since these modules represent such a significant portion of the variance in the datasets, the quan-
tification of the degree of genetic and environmental effects driving BIT covariance can give insight
into the regulatory architecture driving covariance across the whole transcriptome. Since rP can be
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driven by environmental effects, the measure of genetic contribution to rP (pˆA) could provide a greater
insight into the modules that are under genetic control, will have stable covariance across different
groups and are likely to have import biological functions within the cells. Since the BIT modules
were replicated in several studies, they are likely to be strongly regulated by genetic loci as observed
in Chapter 4.
5.3.3 Genetic contribution to phenotypic correlations
As expected, the modules have a high degree of genetic correlation between intra-module BITs. How-
ever, the extent to which the rA impact rP is dependent on the h2 between the pair of transcripts (Equa-
tion 4.5). A low h2 will give environmental correlations too much weight to the rP. The h2 of the
transcripts varied between 0.19-0.48, indicating that rE values have slightly more weight on the rP.
Coincidentally, the average pˆA across the modules was under half (0.42). In the BSGS dataset, the
genetic and environmental correlations were similar (Figure 4.2) thereby almost equally contributing
the high rP exhibited by the BITs.
The rA estimates themselves, however, were very high ranging from 0.56-0.96. This demonstrates that
while the on average the total genetic regulation of the individual BITs is 0.36, the genetic control
driving that portion of variance is almost entirely shared between BITs in a module. The robustness of
the modules can, therefore, be attributed to the high genetic regulation driving the co-expressed BITS.
The genetic regulatory structure driving these modules provides a backbone upon which coordinated
responses to environmental conditions can take place.
5.3.4 Shared eQTLs
Taking these ten probes we demonstrated that their pairwise phenotypic correlations were higher than
what would be expected by chance (Figure 4.1). The phenotypic correlations were driven roughly
equally by both genetic and environmental factors (Figure 4.1). There was a significant enrichment
for eSNPs in two modules (Figure 4.2) shared between probes. Within module two, there were loci
located within the TRIM10 genes associated with three BITs and loci within BCL11A associated with
two probes (Table 4.3). eQTLs found within intergenic regions were associated with two probes in
module seven, providing further evidence of the extensive shared genetic regulation between these
highly co-expressed transcripts.
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These results hint at the possible effects of distal-eQTLs as regulatory hotspots for multiple genes
[75]. Since the genetic variation shared between eQTLs probes could be the result of multiple loci
with small effect sizes, it is likely that there is insufficient power to detect many of the shared associ-
ations driving the genetic co-regulation of BIT probes.
5.3.5 Transcription Factors
One mechanism upon which distal-eQTLs can regulate the expression several genes is through tran-
scription factors [1]. Across all the BITs there was a significant enrichment for the presence of
transcription factors, providing some insight into the potential biological mechanism upon with the
shared eQTLs are exerting their effects across the modules. Further analysis of the BITs and the other
transcripts associated with each module [114] could help to elucidate the network of genetic control
that propagates the genetic regulation of multiple transcripts.
5.3.6 GWAS enrichment
Nearly all of the shared eQTLs between BITs in module two were GWAS studies for blood diseases
or heart conditions or traits (Table 4.5). The transcripts within module two are enriched for blood
phenotypes such as platelet aggregation and hematopoiesis [114].
The information from the transcriptional modules has provided further information into the mecha-
nisms upon which these loci contribute to disease. It is likely that these blood conditions arise due to
disruption of biological pathways are the key to maintaining blood cell homeostasis.
Module two appeared to have the strongest correlation values in blood and had the most extensive
degree of shared loci, with over half of the transcripts sharing a genetic loci. The transcripts in this
module were enriched for a variety of blood cell functionality, predominantly red blood cells with
some immune functionality. Two of the eQTLs associated with two BITs were located within a tran-
scription factor involved in modulating hemoglobin and immune cell development. The association
to a transcription factors indicates that mass regulation of multiple genes through a network of tran-
scription factors is the genomic architecture that is driving the co-expression of this module. The
enrichment for transcription factor in the BITs themselves confirm that the modular structure iden-
tified here is a result of networked regulation of transcripts. Some of the GWAS traits associated
with the BITs in transcripts suggested greater functionality of red blood cells. Particularly in HIV
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function [364], the development of cardiac hypertrophy, the interplay between red blood cells and
immune function [369, 370], most of which have been suggested before and examined within the
literature. This suggests the networked interactions between multiple transcripts and their regulating
loci provide clues into the biological nature of the tissues in which they are examined.
Module seven was also present only within blood and enriched for anti-viral functions. This was
the only other modules in which a shared eQTL was observed. The eSNP associated with the two
transcripts was located within the TRIM10 genes, which is also a TF. The eSNP associated with two
transcripts in this module was associated with two immune-related conditions SLE [354, 355] and
Stevens-Johnson syndrome [357]. This eSNP was also associated with lipid levels suggesting that a
link between fats and immune disorders, which has been observed before [374]. Viral responses have
also been linked to autoimmune disorders through the aggravation of immune cells after inflammation
[376, 377].
The fact that one of the eQTLs associated with two transcripts in module seven was associated with
SLE is an interesting result because the original studies from which the nine BIT modules were
derived, isolated 28 modules from transcriptomic data of patients with SLE [228]. This result sug-
gests that this particular module represents normal immunological processes within the cell, however,
disruption of the regulatory architecture of the transcripts can lead to irregular immune response, re-
sulting in the development of SLE. This study highlights that the origin of transcript detection can
influence downstream analysis.
Since the modules were identified from SLE patients, the immune pathways were strongly enriched
in the modules identified in [228]. These immune pathways were subsequently present within healthy
individuals. Had these modules been initially identified in healthy individuals, there is a chance that
this module may have been overlooked in favor of more prominent co-expression networks. Along-
side the tissue-specific effects identified in the modules these origin-effects highlight the importance
that the original conditions of which transcripts or networks of transcripts were identified can have
for downstream analysis and interpretation of results.
The genetic associations found within module two and seven have not only identified the part of
the regulatory architecture driving the covariance structure of the BIT modules but have provided
information on underlying biological processes. By examining transcripts as part of shared regulatory
networks, we can gain a broader global view of the emergent biological properties and gain insight
into the genetic architecture driving these systems.
151
5.4 Conclusion
Within this thesis, several sources of transcriptomic variance were examined in detail. The exam-
ination of these key sources of variation provided an understanding of the impact of confounders,
which can arise not just from technical processing but also from pervasive environmental factors and
physiological variability from tissue-specific effects.
The examination of environmental variability demonstrates the power of transcriptomic data to eluci-
date specific molecular processes that are influenced by external stimuli. Macro-environmental effects
have a significant impact not only the variance of individual transcripts across a population but also
change the covariance between co-expressed probes as observed with the high contribution of rE to
rP in the BIT modules.
The high genetic co-regulation between BIT transcripts could provide a regulatory framework that
constrains the transcriptomic response BITs will have in response to environmental conditions, thereby
influencing the flexibility of transcriptomic response. Changes in the degree of transcriptomic flexi-
bility frequently occur in neurological disorders [37].
The intricate genetic regulation of transcripts imposes and an extra layer of complexity in tran-
scriptomic data. From examining the global influence of environmental influences and genetic co-
regulation, it is clear that networked holistic approaches are necessary to gain an accurate portrait
of the dynamics that drive gene expression and its emergent properties that ultimately give rise to
complex traits.
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